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Owing to its complex structure and dynamic loading, surgical repair of the heart’s mitral 
valve poses a significant clinical burden.  Specifically, repair of ischemic mitral 
regurgitation, which is caused by the geometric disruption of the mitral apparatus in the 
setting of ventricular dysfunction, results in poor long-term patient survival.  Clinical data 
have shown that the preferred surgical treatment, restrictive mitral annuloplasty, may 
result in 15-30% early (< 6 months) recurrence of mitral regurgitation; this may exceed 
70% after five years.  Studies have suggested that isolated annuloplasty may not be a 
comprehensive repair suitable for all patients because ischemic pathology is multi-
factorial and results in variable ventricular and valvular geometric distortions.  Therefore, 
in this thesis, a new surgical planning paradigm was developed through three specific 
aims.  In specific aim 1, in collaboration with Philips Healthcare,  a novel tool to more 
accurately and quantitatively assess mitral valve insufficiency was developed and 
rigorously validated using the Georgia Tech Left Heart Simulator.  This tool was found to 
be more efficacious and robust than the current clinical standard.   Ultimately, this 
improved diagnostics may better inform surgical indication, specifically, to identify 
patients that may not benefit from simple ring annuloplasty.  In specific aim 2, targeted 
adjunctive surgical repair for such patients were investigated.  Anterior leaflet 
augmentation and basal papillary muscle relocation were observed to restore mitral valve 
function while reducing the leaflet-subvalvular tethering associated with ischemic left 
ventricular remodeling.  These efficacious repairs were found to be robust to variability 
in surgical implementation, which may encourage more widespread clinical adaptation.  
Finally, in specific aim 3, an integrative experimental framework was developed to 
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promote pre-operative patient specific evaluation of mitral valve surgical repair using 
novel computational methods.  The experimental framework combined high-resolution 
state of the art imaging with clinical imaging to provide the most realistic anatomical 
reconstructions possible.  For the first time, ventricular flow fields through and proximal 
to a native mitral valve were acquired using stereoscopic particle image velocimetry.  
These data were combined with measurements of leaflet dynamics and subvalvular forces 
to create a comprehensive database for the rigorous validation of mitral valve finite 
element and fluid-structure interaction models.  Collectively, these studies comprise a 







The heart’s mitral valve is the left atrioventricular valve, which maintains unidirectional 
oxygenated blood flow from the left atrium into the left ventricle.  Owing to its complex 
structure and dynamic mechanical loading, mitral valve dysfunction is a complex and 
morbid condition with increasing clinical prevalence that challenges cardiac surgeons and 
cardiologists alike.  If left untreated, mitral valve insufficiency is associated with high 
rates of patient mortality and with adverse patient prognosis [10,22,23]; these 
relationships are further strained with increasing regurgitation severity [10].   
Although surgical repair of the heart’s mitral valve is the preferred mode of 
treatment for valvular insufficiency [24], reported repair rates are as low as 40% of total 
mitral operations [25].  Complex surgical repairs are often eschewed in favor of mitral 
replacement, despite several studies which report the superiority of surgical repair [26-
29].  The reasons behind the underutilization of surgical repair are multifactorial, but may 
be attributed to two principle causes: (i) accurately identifying valve dysfunction and 
disease severity, and (ii) surgeon experience and understanding of targeted repair therapy 
[30,31].  Understanding valve dysfunction and accurately quantifying mitral regurgitation 
are necessary for surgical indication and to best inform cardiologist referral.  Moreover, 
the median number of mitral valve operations among cardiac surgeons is five per year 
[25]; this alarming statistic highlights the relative surgical inexperience in most low 
volume centers. 
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Aside from referring all mitral valve patients to high volume specialized centers, 
cardiologists and cardiac surgeons need new tools to inform their decision making 
process.  To this end, in this thesis, a new treatment planning paradigm is being 
developed on the strength of recent advances in medical imaging technology, targeted 
etiology specific repairs, and computational mitral valve repair models.  This integrative 
multi-factorial approach to mitral valve disease treatment seeks to improve diagnostic 
tools, provide a mechanistic understanding of post-repair valvular function, and validate 
novel predictive computational mitral valve models, which may make patient-specific 
surgical planning possible. 
In this thesis, in collaboration with Philips Healthcare, a novel mitral regurgitation 
quantitative assessment tool will be systematically validated using the well-established 
pulsatile Georgia Tech Left Heart Simulator [32-39] over a range of clinically relevant 
regurgitant fractions.  The efficacy and robustness of this tool will be compared against 
the current clinically preferred method, 2D Proximal Isovelocity Surface Area.  The 
validation of this tool offers the promise of simple and accurate quantification of mitral 
regurgitation, which can replace the current limited qualitative grading scheme.  This will 
remove uncertainty associated with surgical indication, which is dependent on mitral 
regurgitation severity, observations of valvular lesions, and left ventricular dysfunction. 
Following clinical diagnosis, informed clinical referral may promote 
appropriately targeted surgical therapy based on patient specific valvular dysfunction.  
This should improve long-term repair durability as it has long been purported that 
recurrent mitral regurgitation is a consequence of patient valvular dysfunction to surgical 
repair mismatch; this is most often observed in the treatment of ischemic mitral 
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regurgitation [40-48].  While typically effective, the preferred surgical repair, mitral 
annuloplasty, has been shown to result in recurrent or persistent mitral regurgitation, have 
low rates of reveres left ventricular remodeling, and exhibit poor survival [13-17].  
Several studies have sought to identify preoperative characteristics which are predictive 
of simple annuloplasty failure, including mitral regurgitation grade [49] and jet 
characteristics[46].  These and similar studies [48,50-52] [53] have identified excessive 
leaflet restriction through tethered chordae and pathologically displaced papillary 
muscles as the key contributor to repair failure.   
Consequently, new adjunctive surgical strategies have been attempted to 
compensate for severe leaflet-chordal tethering [17,54-58].  Of note, anterior leaflet 
augmentation [57,58] and basal papillary muscle relocation (Kron Procedure) [17,56] 
have been recently demonstrated to restore leaflet coaptation and mobility, while 
potentially relieving subvalvular tethering. In this thesis, a mechanistic understanding of 
these complex surgical repairs is sought to: (i) identify their functional efficacy as 
compared to the preferred surgical option, (ii) understand their impact on leaflet-
subvalvular tethering, and (iii) understand the impact of surgical variability on resultant 
valvular function and mechanics.  Ultimately, this knowledge will add to the toolbox at 
the surgeon’s disposal, allowing them to tailor repairs based on informed diagnosis and 
an intimate understanding of the mechanistic effects of applied repairs.   
The definitive step in the new surgical planning paradigm is to expand the 
mechanistic understanding of mitral valve function and repair through the use of novel 
computational mitral valve modeling platforms.  These computational models provide a 
unique and non-invasive analysis of mitral valve function and biomechanics for direct 
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surgical applications, such as ring annuloplasty [59-62], edge-to-edge [20,63] and 
neochordea [64,65] implantation, and stress analysis [66,67].  Currently however, these 
models vary considerably in their execution owing to differences in anatomical 
construction (mainly simplifications to leaflet and chordal geometry), material laws, 
boundary conditions, and preferred numerical solvers methods.  These limitations affect 
the clinical accuracy and applicability of such computational simulations.  Therefore, in 
this thesis, an experimental framework was developed for the direct one-to-one 
validations of computational methods against comprehensive, time-resolved experimental 
data with multiple measured endpoints and well defined boundary conditions. 
Collectively, the work in this thesis will seek to improve mitral valve repair 
incidence and efficacy.  This will be accomplished through developing the tools to: (i) 
improve diagnosis, (ii) demonstrate the efficacy of novel targeted repairs, and (iii) help 





2.1 The Mitral Valve 
The human heart is comprised of four unidirectional valves that control the direction of 
flow through its four distinct chambers and out through the pulmonary and systemic 
circulatory systems.  Of these valves, the left atrioventricular valve, or the mitral valve, is 
a complex structure that ensures unidirectional flow of oxygenated blood from the 
pulmonary veins to the left ventricle.   During the diastolic phase of the cardiac cycle, 
following isovolumic relaxation, the mitral valve opens to allow filling of the left 
ventricle.  After the onset of systole, following ventricular contraction, the mitral valve 
closes, and the blood is directed to the outflow tract, through the aortic valve.  The 
morphological construction of this atrioventricular valve consists of four components, 
which include the annulus, leaflets, chordae tendinae, and papillary muscles (Figure 2-1). 
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Figure 2-1 The mitral valve.  The ventricular side of a porcine mitral valve is 
displayed, highlighting the mitral leaflets, chordae tendinae, and papillary muscles.  
The valve was excised from an explanted heart and cut in half at the P2 scallop of 
the posterior leaflet. 
Overall, the normal function of the mitral valve is dictated by the structural 
interplay of the individual components synergistically opposing the left ventricular 
pressure forces.  These includes: mitral annular contraction and bending, apical-basal 
motion and membrane deformation of the leaflets, restraining tensile chordal forces, and 
the tension generated by the contracting papillary muscles (Figure 2-2).  
Further, the structure-function relationships within the mitral valve are closely 
associated with the dynamics of left atrium and ventricle.  Therefore, pathophysiological 
conditions affecting left atrial and ventricular musculature can in turn impact mitral valve 
functionality.  This is most readily observed in functional mitral valve disease where 
deleterious remodeling of the left ventricle, most often due to myocardial infarction, leads 
to impaired leaflet motion and subsequent mitral regurgitation.  This manifests as 
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decreased annular contraction, restricted systolic leaflet motion, and larger restraining 
forces transmitted through the papillary muscles and chordae tendineae (Figure 2-2). 
 
 
Figure 2-2 Forces acting on the mitral apparatus. Overall mitral force balance 
requires the structural interplay between each of the individual components.  This is 
most commonly disrupted in functional mitral valve disease where left atrial and 
ventricular dilation lead to restricted leaflet closure and mitral regurgitation. 
2.1.1 The Mitral Annulus 
The mitral annulus is the anatomical junction between the left atrium and the left 
ventricle and serves as the insertion site for the mitral leaflets.  It is a discontinuous band 
of connective tissue existing within the atrioventricular junction of the left heart.  Due to 
its unique location, the geometry of the mitral annulus changes throughout the cardiac 
cycle from contraction of adjacent myocardial fibers and expansion of the aortic root.  
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The anterior annulus is delimited by two structurally supportive fibrous trigones and is 
continuous with the left and non-coronary aortic leaflets through the intra-valvular 
curtain.  For these reasons, the area of the mitral annulus is asymmetrically reduced and 
conforms to the shape of a three-dimensional saddle during systole – low points 
correspond to the antero-lateral and postero-medial commissures.  During diastole, the 
annulus assumes a flattened profile with its largest annular area for maximal filling.     
2.1.2 The Mitral Leaflets 
The function of the mitral valve in controlling flow between the left atrium and left 
ventricle is ultimately conveyed through the combined motion of the anterior (or aortic) 
and posterior (or mural) leaflets. The two mitral leaflets have relative asymmetry in size 
and shape but with nearly similar surface area. The mitral leaflets originate from one 
continuous piece of tissue, with the free edge showing two distinct indentations called 
commissures. The commissures serve dual purposes of dividing continuous tissue into 
two leaflets for maximal opening during diastole and allowing for proper coaptation 
(closure) during systole. The base of the leaflets attaches to the mitral annulus; chordae 
tendinae through papillary muscles support the free edges. 
The posterior leaflet is quadrangular in shape, inserts into two-thirds of the mitral 
annulus circumference, with a typical width and height of 55 mm 13 mm respectively. 
The posterior leaflet is connected to the muscular base of the left ventricle and its surface 
shows two indentations known as scallops that are supported by numerous chordae 
tenindae. These indentations divide the posterior leaflet into three regions known as 
lateral (P1, smallest in size), central (P2, largest in size) and medial (P3) scallops. The 
anterior leaflet is semi-circular in shape, inserts into approximately one-third of the mitral 
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annulus circumference, and has a typical width of 32 mm and height of 23 mm.  The 
regions of the anterior leaflet geometrically opposing the posterior leaflet scallops are 
denoted as A1, A2 and A3 (Figure 2-3). 
 
 
Figure 2-3 Schematic of Mitral Leaflets.  Atrial view of the mitral leaflets during 
systole shows the anterior leaflet extends to cover two-thirds of the mitral orifice.  
The posterior leaflet is comprised of three scallops P1, P2, and P3, which are 
opposed by similarly named regions of the anterior leaflet.  AC: Anterior 
commissure.  PC: Posterior commissure. 
The total surface area of both mitral valve leaflets is approximately twice of the 
valvular orifice [68]. This geometric relationship provides redundancy during closure and 
prevents retrograde flow from the ventricle to atrium [69]. Geometrically, either leaflet is 
divided into the base (closest to annulus), belly (central) and free edge (distal to the 
annulus) regions. Due to numerous chordal insertions, the free edge of the leaflets is 
thicker, has an irregular texture, and is identified as the rough zone.  Conversely, the clear 
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zone lies between the line of coaptation and the mitral annulus, has minimal chordae 
attachment, is thin, regular in texture, and is translucent. 
The structure of the mitral leaflets primarily consists of fibrous tissue comprising 
three types of collagen (type I, III and V), along with smooth muscle cells and 
nonmyelinated nerve fibers. The anterior leaflet base is vascularized from branches of the 
coronary arteries.  Histology of the mitral leaflets has shown a discrete and layered 
microstructure (Figure 2-4).  From the atrium down to the ventricle are the atrialis, 
spongiosa, fibrosa, and ventricularis, with either side covered with endothelial cells 
[70,71].  The fibrosa is the thickest layer comprised of dense organized collagen fibers, 
which provide the majority of load-bearing support to the leaflet.  The collagen fibers 
align preferentially along the circumferential direction.  The atrialis contains a layer of 
loose connective tissue made up of collagen and elastin fibers, which are supported by a 
proteoglycan and glycosaminoglycan gel in the spongiosa.  This aids in lubrication and 
distribution of compressive loads, while the thin ventricularis is rich in elastic fibers [72].  
This layered arrangement is thought to decrease the resistance of leaflets to bending, and 
decrease the overall bending stresses on the leaflet. [62,73]  Taken together, the adaptive 




Figure 2-4 Histological cross-section of the mitral leaflets.  Histological cross-
sections of the mitral leaflets reveal an organized layered structure.  In addition to 
elastin, collagen (main load bearing element) and proteoglycans, the mitral leaflets 
are known to contain smooth muscle cells, nonmylenated nerve fibers, and 
vasculature at their base.  (Images adapted with permission from Grande Allen et 
al. [130]). 
2.1.3 The Mitral Chordae 
The leaflets are attached to the LV via the subvalvular apparatus that functions as a 
suspension system, facilitating leaflet opening during diastole and preventing the upward 
displacement of the leaflets into the LA during ventricular systole. This subvalvular 
apparatus consists of the papillary muscles (PMs) and chordae tendineae (CT). The CT 
extend from the mitral leaflets to the PMs and display wide variation in branching as well 
as PM attachment. 
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In general, three types can be recognized:  
 primary (marginal) chordae that are attached uniformly via bifurcations or 
trifurcations to the free edge of the leaflets, 
 secondary (intermediary) chordae that are inserted in layers to the rough zones 
of the anterior leaflet,  
 and tertiary (basal) chordae that extend either from the PMs or directly from 
the LV free wall and attach to the base of the posterior leaflet or directly to the 
MA [74,75].  
It must be noted that two thickened secondary chordae, known as the strut chordae, 
attach to the belly region of the anterior leaflet, and highly branched fan-like chordae 
attach to the commissures.  Anatomically, marginal chordae are typically thinner than 
basal chordae, while strut chordae are the thickest in human valves [1,74]. In porcine 
valves, which closely mimic human valves in anatomy and function, posterior leaflet 
chordae are thinner than the corresponding anterior leaflet chordae [76]. Average length 
and thickness properties obtained from autopsied human mitral valves can be found in 
[74]. 
The chordae tendineae are made of two major components – an outer elastin 
sheath with scattered collagen and an inner core of collagen with traces of elastin [77]. 
These are enclosed by layers of endothelial cells on a basal lamina [70]. Scanning 
electron microscopy has revealed the collagen fibers in the chordae’s central core exhibit 
a wavy undulated pattern that contributes to the extensibility of chordae [78,79]. During 
PM contraction, the crimped collagen fibrils straighten, thus reducing the peak strain 
developed in the chord. Additionally, the high crosslinking of collagen within the chordae 
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prevent creep during valve closure. Transmission electron micrographs have additionally 
shown the density of collagen fibrils decrease with increases in chordal size between 
chordal types. 
2.1.4 The Papillary Muscles 
The primary role of the PMs is to stabilize MV function by adjustment of tension during 
the cardiac cycle, and their functionality is intimately associated with the ventricular free 
wall to which they are attached.  Two groups of PMs are attached to the LV free wall and 
are typically identified based on their relative position below the two MV leaflet 
commissures, anterolateral and posteromedial. 
Morphological variability exists amongst the PM groups, with some notable 
arrangements including:  
 single ‘bulky’ PM with a single head (type I) attached to multiple CT  
 single ‘bulky’ PM with multiple heads (type II) attached to multiple CT  
 narrow PM with few CT (type III) 
 arch-shaped PM with multiple CT (type IV) 
 PM attached to the LV free wall with multiple CT 
Detailed anatomic descriptions of the MV anatomy can be found elsewhere [68,74,80-
82]. 
The anterolateral PM is vascularized by multiple branches of the anterior 
descending coronary artery and the circumflex vessels, while the posteromedial PM is 
supplied from either the circumflex artery or branches of the right coronary artery. These 
differences in vascularization of the papillary muscles explain why the posteromedial PM 
is more prone to necrosis and dysfunction than the anterolateral PM. 
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The PMs actively contract during ventricular systole, yet, despite the complex 
dynamics of the left heart, the PM tips have been demonstrated to maintain a near 
constant distance with the annulus. Additionally, it is hypothesized that the PMs act as 
shock absorbers, by maintaining a consistent mitral valve geometry through the entire 
cardiac cycle [83]. Sonomicrometry studies in healthy sheep and transesophageal 
echocardiography (TEE) studies in humans have demonstrated that the PMs elongate by 
2-5 mm during diastole, compared to their systolic length [84,85]. Mechanistically, the 
net force experienced by a particular PM is the vectorial resultant of the forces 
experienced by the chordae inserting into that PM as well as the force imparted by the 
relaxing/contracting PM. This force is expected to be transmitted to the LV wall, 
ensuring proper valvular-ventricular force continuity. 
2.2 Mitral Valve Mechanics 
2.2.1 Mitral Annular Mechanics 
2.2.1.1 Quantification of Cyclic Mitral Annular Areal Reduction 
The mitral annulus is a pliant fibro-muscular structure and shows dynamic variation in 
shape throughout the cardiac cycle.  The cyclic areal reduction of the mitral annulus plays 
a significant role in valve competence and mechanics.  Numerous studies have been 
conducted to visualize the motion and quantify annular velocities in normal [86,87] and 
pathological conditions [88-90] using echocardiography, Doppler Tissue Imaging and 
Cardiac Magnetic Resonance Imaging techniques.  
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During ventricular diastole, the annulus is more circular whereas at peak systole 
the annulus takes on a kidney-shaped orifice. In healthy humans, the mitral annulus can 
reduce its area and circumference by 26 ± 3 % and 13 ± 3 % from diastole to mid-systole 
respectively [86].  The cyclic reduction of mitral annular area has been demonstrated to 
be preserved in sheep. In healthy ovine models, the mitral annular area and circumference 
reduce by approximately 15% and 9% respectively [91,92]. Further, Rausch et al. 
demonstrated a significant difference between the percent reduction in the septal-lateral 
(12%) and transverse (5.5%) annular diameters [91].    
Diseases of both the mitral valve and left ventricular complex have been 
demonstrated to impair the cyclic mitral annular contraction. In 149 patients, left 
ventrinuclar dysfunction correlated to significant depressed mitral annular contraction 
[93]. Similar significant decreases have been determined in patients with dilated 
cardiomyopathy and ischemic mitral regurgitation [94]. These trends have been shown to 
be conserved in ovine chronic ischemic mitral regurgitation models [95]. Compared to 
healthy ovine subjects, ischemic mitral regurgitation animals exhibit significant decreases 
in the reduction of the mitral annular area. 
2.2.1.2 Quantification of Mitral Annular Saddle and Flattening with Disease 
The three-dimensional mitral annular geometry has historically been described as a 
hyperbolic paraboloid or saddle shaped. First observed by Levine, the non-planar 
geometry of the mitral annulus has been demonstrated in both healthy human and 
mammalian species [96-99]. The mechanisms by which the annulus conforms to the 
saddle geometry has been described and proposed by two mechanisms. In the first, 
unequal apical-basal translation of the mitral annulus during left ventricular contraction 
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(due to aortic root tethering) causes annular folding across the inter-commissural axis 
[100].  In the second, expansion of the aortic root during systolic left ventricular 
contraction displaces the anterior annulus laterally, which folds the anterior and lateral 
portions of the mitral annulus across the intercommissural axis [101,102]. 
The saddled shape of the mitral annulus has been investigated in both 
experimental and computational studies and demonstrated to change by as much as 30% 
throughout the cardiac cycle [66,95,96]. The annular saddle is typically quantified in one 
of two manners - as either an annular height or annular height to commissural width ratio 
(AHCWR). In healthy humans, the annular height has been observed to range from 0.6 
mm to 1.4 cm with an AHCWR approaching 20 to 25% [95,96]. In ovine models, the 
AHCWR has been reported to range from 12 to 15% [40,97]. With functional mitral 
regurgitation due to left ventricular ischemia, the annular saddle has been shown to 
flatten with only subtle changes throughout the cardiac cycle. In humans, the AHCWR 
has been shown to significantly decrease to 12-15 %, whereas in a chronic ischemic 
mitral regurgitation ovine model, the AHCWR hovers between 11% and 12 %. Beyond 
its quantification, the non-planarity of the mitral annulus is believed to confer several 
mechanistic benefits. 
The saddle shape of the mitral annulus has been demonstrated in numerical 
studies to reduce stress in the mitral leaflets [66]. In the same study, echocardiographic 
mitral valve images acquired in humans, sheep, and baboons, as well as sonomicrometry 
array localization in sheep, demonstrated that the annular saddle lay within the stress-
optimized range found in the computational studies. Based on these findings, the authors 
suggested the non-planarity of the mitral annulus conferred a mechanical advantage to the 
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leaflets by adding curvature and reducing stress. Reductions in leaflet strain with a saddle 
annulus have been additionally confirmed through carefully controlled in vitro studies 
[103,104]. The saddle annulus has been additionally shown to reduce chordal tethering by 
altering coaptation and leading to an optimally balanced valvular configuration [105]. 
2.2.2 Leaflet Mechanics 
2.2.2.1 Mechanical Properties 
Ex vivo uniaxial and biaxial testing (Table 1: control; Table 2: disease) have shown the 
mitral leaflets exhibit classical soft tissue biomechanical responses to stretch, which is 
mainly a result of the mechanical response of the load-bearing collagen fibers [106-114].  
Initially, there is very little resistance to applied load in the “toe” region of the stress-
strain curve (Figure 2-5). This is observed as a long region of relatively low tensile 
modulus and is due to the uncrimping of the collagen fibers.  This is followed by a non-
linear transition region where collagen fibers are recruited and aligned, effectively 
increasing the leaflet’s stiffness.  The transition is succeeded by a final linear region of 
relatively large tensile modulus where the collagen fibers have reached their maximum 
distension and recruitment is saturated.   Additionally, this mechanical response is strain 
rate independent, and has minimal hysteresis [4,115].   Post-transitional modulus is on 
average, two orders of magnitude greater than the pre-transition modulus.  Inverse finite 
element analysis of in vivo valvular function calculated a substantially larger post 
translational modulus [111-113].  The discrepancy between in vivo and ex vivo data may 
be attributed to the hypothesized active contraction of the mitral leaflets in vivo, which 
can transiently modulate stiffness throughout the cardiac cycle [111,112,116].  The 
variability of the data is mainly due to the experimental errors associated with uniaxial 
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and biaxial testing, the inherent variability in leaflet structure and composition, relative 
age of the sample [114], and interspecies differences (ovine, porcine, and human). 
 
 
Figure 2-5 Leaflet Stress-Strain Curve Non-linear stress strain curve of the mitral 
leaflets shows directionally dependent response and minimal hysteresis.  There is 
minimal stress developed in the “toe” region due to uncimping of the collagen fibers.  
A non-linear transition region (recruitment and alignment of collagen fibers) is 
followed by a linear, high tensile modulus regime (locking of collagen fibers). (image 









Table 1-1 Modulus of elasticity for posterior and anterior leaflets. 

















0.021 ± 0.002  
2.0 ± 0.7 
Uniaxial testing was 
performed with two 
loading cycles: 5 
mm/min and 10 
mm/min.  Data for 5 
mm/min tabulated. 





0.044 ± 0.004 





0.055 ± 0.005 





0.027 ± 0.003 





0.040 ± 0.005 













0.061 ± 0.044 
2.4 ± 1.5 
Uniaxial and biaxial 







0.089 ± 0.092 





0.043 ± 0.024 





0.094 ± 0.052 










0.02 – 0.05 
0.26 – 1.01 
Biaxial testing of 
leaflet-strut chordae 
transition zone.  Range 












2.29 ± 0.83 
Control leaflets 
harvested from 
autopsy of patients 
who died of non-
cardiovascular related 
deaths. (Study also 





3.55 ± 2.05 
Posterior  
Circ. 






(N = 5) 












48 ± 16 – 68 ± 19 
Material properties 
were tuned using an 
orthotropic linear 
elastic FEM to match 









34 ± 10 – 54 ± 13 
Anterior Radial 
Free Edge 
42 ± 14 – 59 ± 17 
Anterior Circ. 
Base 
17 ± 4 – 26 ± 6 
Anterior Circ. 
Belly 
12 ± 3 – 19 ± 5 
Anterior Circ. 
Free Edge 
15 ± 4 – 23 ± 5 
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Table 1-2 Measured significant differences in leaflets’ stiffness between normal and 
pathological valves. 







(N = 23) 
 Anterior leaflet radial /circumferential 
tensile modulus/stiffness increased from 
control  




who presented with 









(N = 11) 
 Rheumatic leaflets stiffer than 
control/degenerative at base/belly/free 
edge    
 Degenerative leaflets stiffer at free edge, 
















 Blocking active contraction of leaflets 
reduced basal/belly leaflet stiffness during 
isovolumic contraction. 
Regional effects of 
active stiffness were 
investigated by 
blocking contraction 






(N = 5-8) 
 With increasing age, 
radial/circumferential pre-/post-
transitional stiffness increased. 
Testing was 
performed on 6 
week, 6 month, and 
year old porcine 
leaflet tissue. 
 
Complementary studies have been used to characterize dynamic leaflet 
deformation during physiologic valvular function (Table 3: control; Table 4: disease).   In 
short, in vitro studies have utilized dual camera stereo-photogrammetry to track the 
deformation of a superficial grid (graphite or tissue dye markers) on the mitral leaflets in 
mitral valve simulators (Figure 2-6) [103,104,108,118-120].  Similarly, in vivo 
techniques have utilized a localized array of piezoelectric sonomicrometry crystals or 
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video-fluoroscopy of radiopaque tantalum markers to measure dynamic leaflet 
deformation. [6,7,121,122].  Using finite element analysis, Euler-Almansi strain is 
subsequently calculated throughout the cardiac cycle.  These studies found that the mitral 
leaflets experience rapid, and large anisotropic, or directionally dependent, stretch during 
closure, followed by minimal further deformation while the valve is closed (Figure 2-6).  
Both mitral leaflets were stiffer and less extensible in the circumferential direction than 
the radial direction.  The observed anisotropy is a result of the preferential alignment of 
the underlying collagen fibers. 
 
 
Figure 2-6 (Top Panel) Superficial grids marked on mitral leaflets include tissue 
marker dye (in vitro), sonomicrometry crystals (image courtesy of Dr. Gorman), and 
radio-opaque markers (image adapted with permission from Rausch et al. [5]).  
(Bottom Panel) Leaflet strains calculated over the cardiac cycle show large and 
rapid aniosotropic stretch.  (Images adapted with permission from Sacks et al. [6].) 
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Table 1-3 Anterior and Posterior leaflet strain and strain rates from in vivo and in 
vitro data. 












30 ± 8 
11 ± 3 
47 ± 10 
750 – 900 
300 – 400 
1000 – 1300 
16 graphite markers in 4 










30 ± 18 
8 ± 6 
42 ± 20 
~ 750 
~ 300 
973 ± 517 
16 graphite markers in 4 
x 4 array 
(Study also investigated 













-1 ± 2 to 14 ± 2 
2 ± 2 to 4 ± 2 
(From annulus towards coaptation) 
30 – 50 leaflet surface 
markers, statically 











16 ± 3 
3 ± 0.4 
15 ± 0.8 





crystals in a 3 x 3 array 
(Range of pressures) 











22 ± 7 
11 ± 5 
36 ± 14 





5 x 8 tissue dye 
(Study also investigated 










7 ± 5 to 9 ± 5 
5 ± 4 to 7 ± 3 
-- 
16 radiopaque markers 
equally distributed 
(Study also investigated 











8 ± 4 
5 ± 3 
13 ± 5 
332 ± 150 
112 ± 59 
432 ± 174 











31 ± 3 






crystals in a 2 x 2 grid 
Data presented for 150 
mmHg LVP 
(Study also investigated 











23 ± 14 
3 ± 10 
30 ± 17 
273 ± 156 
27 ± 83 
313 ± 171 
16 graphite markers in a 
4 x 4 array 
(Study also investigated 











29 ± 8 
10 ± 8 




16 tissue dye markers in 
a 4 x 4 array (Study also 




Table 1-4 Significantly measured difference in leaflet strain from normal to 
pathological and repaired conditions.  







(N = 11) 
 No significant differences observed 
between altered conditions and control. 
Investigated the effect 
of taut (3-5 mm 
apical) and slack (5 







(N = 9) 
 Little effect of elevated pressure on 
leaflet strain.   
 Only peak circumferential strain 




elevated from 90 






(N = 8) 
 Major/areal strains decreased from a flat 
(0%) annulus to a physiologic annulus 
(20%) height.   
 Radial strain unaffected.   
Systematically 
decreased saddle 
height from 30% to 







(N = 59) 
 Circumferential strain increased from 
control with the RSAR, Physio, and 
ETlogix.    
 Radial strain increased with the RSAR. 
 Cosgrove did not significantly affect 
strain. 
Similar experiments 
were performed with 5 
annuloplasty rings: 
Cosgrove, RSAR, 







(N = 10) 
 Physio increased radial strain 
 Circumferential strain reduced.  
Implanted a flat 
annuloplasty ring 







(N = 18) 
 No significant differences observed 
between altered conditions and control. 
Investigated the effect 
of taut (3-5 mm 
apical) and slack (5 







(N = 8) 
 Radial/circumferential/areal strain 
decreased between flat and 20% saddle 
height.   
Systematically 
decreased saddle 
height from 20% 





Further heterogeneity was observed within each leaflet as the base (near the 
annulus) and belly region of the leaflets were less extensible and stiffer than the 
corresponding free edge (Figure 2-7) [7,108,109].  Finally, the posterior leaflet, which 
has a higher density of chordal insertions (1.5-1.8 posterior to anterior chords) to provide 
mechanical support [107], is more extensible and less stiff compared to the anterior 
leaflet.  These findings are consistent with the mechanical behavior that has been 
extensively characterized using uniaxial and biaxial testing. Collectively, these 
characteristics allow for optimal mitral valve closure.  With increasing left ventricular 
pressure, the leaflets may undergo considerable deformation to promote coaptation.  
Following closure, a tight seal is maintained because of the organized microstructure, 
large post-translational stiffness, and minimal creep [115], which provide the strength to 
withstand the large pressure gradient. 
 
 
Figure 2-7 In vivo areal, circumferential, and radial strain are shown at maximum 
left ventricular pressure.  The strain is aniosotropic, and largest in the radial 
direction due to the preferential alignment of collagen fibers.  The largest stretch is 
observed at the free edge, which helps create redundant coaptation. (Image adapted 
with permission from Rausch et al. [7].)  
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Recently, the selection of a referential configuration of the mitral leaflets for 
corresponding strain and stretch measurements has been challenged, which is typically 
selected as the time frame of minimum left ventricular pressure.  Rausch et al. showed 
strain magnitude is insensitive to choice of diastolic reference frame [7].  Perhaps more 
importantly, however, Amini et al. showed the mitral leaflets contract up to 29% from in-
vivo to ex-vivo excision, in what is perceived to be the stress-free state. This indicates the 
leaflets experience some amount of “pre-strain” in-vivo. [122].  Consequently, the strain 
magnitude calculated was affected by the selection of the reference configuration, from 
minimum in-vivo pressure, to excised heart, to excised valve.  This also confounds where 
on the non-linear stress-strain curve the mitral leaflets may reside during experimental 
and computational experiments.  However, a more laborious study is still needed due to 
the small sample size (n = 5) and the elementary marker grid used (2 x 2). 
Using a left heart simulator with control over annular geometry, complementary 
studies showed both anterior and posterior leaflet strain is significantly reduced with 
increasing mitral annular saddle [103,104].  These results are consistent with numerical 
analysis of the mitral leaflets [123].  As a result, many annuloplasty ring devices now 
feature a prescribed saddle height in the hopes of improving long-term repair durability.  
Conversely, animal studies report increased strain following annuloplasty ring 
implantation [121].  However, this is likely to be a result of the rigid ring implantation, 
which ablates the natural dynamic motion of the healthy animal annulus.  For the in-vitro 




2.2.2.2 Adaptive Remodeling Due to Mechanical Stimuli 
Altered mechanical stimuli have been hypothesized to elicit changes in leaflet 
microstructural composition, which in turn affects mechanical properties and valvular 
function [124].  More specifically, secondary valve pathologies, due to left atrial or left 
ventricular dysfunction disrupt the mechanical environment through mitral annular 
dilation and papillary muscle displacement with concomitant mitral regurgitation.   
These changes were first observed in retrospective analysis of explanted patient 
hearts.  Grande-Allen et al observed that leaflets from patients with dilated and ischemic 
cardiomyopathy were stiffer, less extensible, and less viscous compared to normal 
controls [117].  These changes appeared to represent a fibrotic remodeling, as there was 
an associated increase in collagen, glycanoaminoglycans, and cell count, with a decrease 
in water content. [62,72].  Such changes were shown to lead to reduced coaptation and 
increased valve stresses, which hints at a troubling feedback.  Chaput et al. showed that 
leaflet area can increase up to 35% with inferior wall motion abnormality or dilated 
cardiomyopathy [125,126].  This growth was proportional to corresponding annular 
enlargement, such that the ratio of leaflet to annular area remained relatively constant. 
To isolate the mechanistic causes of these observed changes, animal models have 
been pursued.  Timek et al showed both mitral leaflets remodel in an ovine model of 
cardiomyopathy [127].  In particular, they found regions closer to the free edge of both 
leaflets underwent significant lengthening, which is consistent with knowledge that this 
region experiences the largest deformation.  Stephens et al showed this lengthening is 
associated with greater cell density, delineation between organized layers, greater 
collagen and elastic fiber turnover, and an increase in myofibroblasts [128].  Again, 
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remodeling was heterogeneous as the belly to the free edge experienced the most 
pronounced changes.  In a follow up study, the same group showed isolated mitral 
regurgitation was sufficient to induce active matrix turnover, represented by a reduction 
in type I collagen and an elevation in type III collagen (lower tensile strength), matrix 
metalloproteinase, and elastin fiber turnover [129].  In a model of isolated papillary 
muscle displacement, leaflet tethering induced significant increase in leaflet area and 
thickness [130].  Associated cell activation is believed to progress through a 
developmental pathway, which supports a hypothesis of an actively adapting mitral 
valve.  Understanding the mechanisms of adaptive leaflet remodeling may create new 
potentials for therapeutic repairs to augment leaflet area in response to post-myocardial 
infarction LV dilation [5]. 
2.2.3 Chordae Mechanics 
Considered in isolation, the chordae tendineae of the mitral valve experience 
counteracting tensile loads from the apically contracting PMs and basally directed 
pressure forces acting on the valve leaflets (coapting force). Additionally, the passive 
elongation and active contraction of the left ventricle influences the magnitude of tension 
experienced by a chord. The chordae experience maximum tension during systole when 
the pressure load acting on the leaflets is transmitted to the chordae, and this tension is 
relieved during ventricular diastole. Since chordal structure, size and insertions are 
uniquely complex, many in vitro and in vivo investigations have focused on identifying 
the role and function of the various chordae [33]. 
From a mechanistic standpoint, the intermediary/strut chordae carry a majority of 
the systolic load acting on the valve leaflets, and maintain proper left ventricular function 
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and geometry [131]. Basal chordae provide a constant connection between the annulus 
and papillary muscles, while marginal chordae maintain leaflet flexibility, governing 
proper valve closure. Further, the anterior basal chordae play a role in balancing the 
elastic recoil of the ascending aorta, and transection of these chordae can reduce the 
aortomitral angle and potentially result in post-repair systolic anterior motion (SAM) 
[132]. 
2.2.3.1 Mechanical properties of chordae tendineae 
Uniaxial testing studies of chordae tendineae have demonstrated non-linear viscoelastic 
behavior with a discrete transition in the tensile elastic modulus [133-136]. Initially, the 
inner collagen core straightens upon application of tension, after which it ‘locks’. At this 
point, the outer elastin fibers begin to stretch and withstand the effects of constant strain 
and prevent the plastic deformation of collagen fibers. However, the gross mechanical 
properties of the chordae are primarily determined by the collagen core, since removal of 
the outer elastin sheath does not change their non-linear stress response [134]. The 
thinner marginal chordae have the greatest average fibril density, and are the stiffest of all 
chordal groups [1]. Although the marginal chordae have the least extensibility among 
chordae, they also have the smallest failure tensions [76]. The thicker strut chordae have 
smaller tensile modulus and greater extensibility, primarily due to the extensively 
crimped collagen, which can elongate upon the application of tensile forces [77]. Table 5 




Table 1-5 Mechanical properties of various chordal groups, reproduced from [1]. 
Chordal Type Marginal Basal Strut p-value 
Extensibility (% strain) 4.3 ± 1.6 8.5 ± 2.0 17.5 ± 3.3 p<0.001 
Tensile Modulus (MPa) 84.4 ± 21.2 86.1 ± 20.9 64.2 ± 13.5 p=0.002 
Average cross-sectional area (mm
2
) 0.38 ± 0.18 0.71 ± 0.25 2.05 ± 0.40 p<0.001 
 
2.2.3.2 Experimental measurement of chordal forces: Physiological conditions 
Various in vivo and in vitro studies measuring chordal forces under pulsatile 
physiological conditions have been listed in Table 6. Due to inherent procedural 
difficulty, in vivo studies have been unable to measure the chordal forces across all types 
of chordae, due to which an entire force balance cannot be constructed from in vivo data 
alone. Most of these studies utilized a C-shaped strain gauge based transducer, first 
described by Salisbury et al and refined by Nielsen et al [8,137]. Briefly, strain gauges 
mounted on a C-shaped brass ring measure the tensile forces in the chordae as a change 
in voltage (Figure 2-8). By implanting the C-ring transducer on various chordae, the 
loads carried by them can be measured at every time point in the cardiac cycle. This 
transducer has been successfully implanted in multiple in vitro and in vivo studies [137-
146]. Another recent strain gauge based transducer has been designed with the intent of 
instrumenting smaller chordae, however this transducer has not been tested in a dynamic 




Figure 2-8 Miniature C-arm force transducers selectively record chordal forces 
throughout the cardiac cycle (Image adapted with permission from Nielsen et al. 
[8]). 
 
Table 1-6 Experimental measurements of physiological chordal forces.  Types of 
chordae are: AA – anterolateral PM to anterior leaflet; AP – anterolateral PM to 
posterior leaflet; PA – posteromedial PM to anterior leaflet; PP – posteromedial PM 




Peak Forces (N) 










Increasing SV=> Increased 
CT; 
Increased systemic pressure 









LVP alone determines CT. Did 









  Flat 
Only marginal chordae were 
instrumented in this study. 
AA, Marginal  0.46 ± 0.08 
PA, Marginal  0.45 ± 0.06 
AP, Marginal  0.44 ± 0.05 








0.81 ± 0.10 (PA, strut) 
0.52 ± 0.08 (AA, strut) 
Acute study only, no chronic 
data available. PA tension is 








 Flat Saddle Comparison of CT with and 
without saddle shape of 
annulus. Results were not 
separated based on PM of 
origin. Conditions with 
significant differences are 
highlighted (p<0.05) 
AA/PA, Marginal 0.31± 0.07 0.35±0.07 
AA/PA, Strut 1.22±0.21 0.95±0.14 
AP/PP, Marginal 0.03±0.02 0.06±0.03 
AP/PP, Strut 0.25±0.06 0.30±0.08 
AP/PP, Basal 0.19±0.04 0.31±0.10 









 F Fp 
Fp is the force normalized by 
LVP of 100mmHg. Chordal 
forces with IMR were also 
studied (Refer Table 7) 
AA, Marginal 0.35±0.09 0.33±0.07 
PA, Marginal 0.25±0.04 0.28±0.06 
AP, Marginal 0.32±0.07 0.34±0.07 








 Flexible Flat Saddle Pathological forces with PM 
displacement (Table 7). 
Significant differences are 
highlighted (p<0.07) 
Marginal 0.14±0.05 0.20±0.06 0.23±0.06 
Strut 0.66±0.17 0.78±0.19 0.65±0.13 








 Porcine Human 
No significant differences 
found between porcine and 
human MVs. 
AA/PA, Marginal 0.26±0.08 0.41±0.09 
AA/PA, Strut 1.02±0.27 1.16±0.23 
AP/PP, Marginal 0.29±0.13 0.25±0.10 
AP/PP, Strut 0.43±0.21 0.30±0.07 
AP/PP, Basal 0.21±0.12 0.22±0.06 








 Porcine Ovine Peak systolic valve 
configuration was simulated 
using a static reservoir of 














0.69 ± 0.46 (PA, strut) 
0.83 ± 0.41 (AA, strut) 
LVP generated using static 
pressure reservoir. 3 levels of 
LVP were generated, 








0.66 ± 0.24 (AA/PA, strut) 
Forces were not classified 
based on instrumented chord 
type 
 
Overall, the anterior strut chordae carry the highest load amongst all chordal 
groups. The marginal chordal forces are lower than the strut forces, particularly if the 
marginal chordae insert into the coaptation zone of the leaflets [105,138,143,144].  
Dynamic deformation of the mitral annulus increased basal chordal forces without 
affecting other chordae, demonstrating that the role of the basal chordae is to maintain a 
constant distance between the annulus and PMs [143]. The saddle shape of the native 
mitral annulus results in a more even distribution of forces among the chordae, which is 
expected to be mechanically beneficial. This is accomplished due to alterations in the 
physical distance between the PMs and various chordal insertions into the leaflet due to 
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the conferred 3D annular shape [105]. Among the anterior leaflet strut chordae, chordae 
originating from the posteromedial PM carry significantly higher forces [142]. Amongst 
marginal chordae, the origin of the chordae did not affect the magnitude of forces 
significantly, although the magnitude of forces measured in vitro were higher than the 
corresponding forces measured in vivo. This could be a result of the PM positions used to 
simulate normal geometry and the lack of a dynamic left ventricular complex in the in 
vitro studies [139,142]. 
Discrepancies in force measurements listed in Table 6 could be due to multiple 
reasons: 
1. Variations in animal models, particularly in valve sizes and chordal distributions. 
2. Variations in specific conditions used to simulate normal valvular function. 
3. Chordal classifications are broad, and the differences exist in the specific leaflet 
insertions and branching of chordae. Any such differences in PM positioning and 
chordal anatomy across studies can result in alterations in chordal force 
distribution across valvular groups. 
2.2.3.3 Experimental measurement of chordal forces: Pathological conditions 
The most commonly simulated pathological condition for chordal force measurement is 
annular dilation and papillary muscle displacement, as would be seen with functional or 
ischemic mitral regurgitation (Table 7).  The specific changes in chordal force 
distribution are a consequence of the alterations in chordal insertion angles and distance 
from annular plane due to PM displacements [148]. The only in vivo study measuring 
IMR chordal forces showed an increase in force in the anterior leaflet marginal chordae 
originating from the anterolateral PM, while a decrease in force was noted in the 
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marginal chordae from the posteromedial PM, primarily due to the tethering caused by 
the IMR [139]. However, this study did not quantify PM positions and annulus size post-
infarction. 
 
Table 1-7 Changes in chordal force due to pathological and surgical repair 
conditions as compared to normal physiology. 
Condition 
Anterior Leaflet Posterior Leaflet 
Marginal Strut Basal Marginal Strut 
Comm-
issural 
In vivo porcine IMR model [139] ↑/↓ N/A N/A = N/A N/A 
(Lat.+Post.+Api.) PM displ. [141] ↑ N/A N/A ↓ N/A N/A 
(Lat.+Post.+Api.) PM displ. [105] = ↑ = = ↑ ↑ 
(Lat.+Post.) PM displ. [144] = = ↓ = = ↓
(Lat.+Post.+Api.) PM displ. [144] = ↑ ↑ = ↑ ↑
(Lat.+Post.+Api.) PM displ. + 
Annular Dilatation [149] 
↑ N/A N/A ↑ N/A N/A
 
Multiple in vitro studies showed no changes in marginal chordal force due to 
isolated PM displacement, whereas the inclusion of annular dilatation causes an increase 
in the marginal chordal forces [143,144,149]. This suggests that these chordae can adapt 
better to geometric changes of the MV.  The increase in force with annular dilatation 
could be due to increased mitral annular orifice area, resulting in a migration of the 
marginal chordal insertion points out from the leaflet coaptation zone into the pressure-
bearing portion of the leaflet.  Changes in forces in other chordae are directly related to 
the direction of PM displacement. Apical PM displacement causes increased forces in 
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most chordal groups due to leaflet tenting, which has been observed in human and animal 
models of IMR. Lateral and/or posterior PM displacement in isolation causes a 
redistribution of chordal loads such that the chordae near the displacement direction show 
a reduction in force. Basal and commissural chordae show higher sensitivity to PM 
displacement due to pre-straining of the chordae. Due to the non-linear mechanical 
response of chordae, PM displacement causes increases in chordal forces in pre-strained 
chordae. 
Other pathological conditions studied include heart failure, where it was observed 
that changes in force could depend on several factors - reduction in coronary perfusion 
pressure reduced chordal force, ventricular pressure overload increased chordal force, 
while chordal force remained constant with ventricular volume overload [137]. Finally, 
hypertension is seen to increase chordal forces as expected, although this has only been 
shown in a statically pressurized system [147]. 
2.2.3.4 Experimental measurement of chordal forces: Mitral Valve Repair 
Most repair techniques for IMR focus on the annular level, with mitral ring annuloplasty 
(MRA) being the most common MV repair. With undersized MRA, the total amount of 
leaflet exposed to pressure load decreases, resulting in a reduction in the strut chordal 
tension; marginal chordae don’t show any change in force since they are not the primary 
load bearing chordal structure [150]. Ostli et al (2012) showed a reduction in anterior 
leaflet strut chordal force after anterior leaflet patch repair compared to control in a static 
pressurization system [151]. However, the implantation of a patch without mitral annular 
dilatation can provide misleading results, since a dilated annulus should have a larger net 
pressure load on the leaflet, potentially causing an increase in strut chordal force. The 
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decrease in force was perhaps due to the patch relocating the strut chordal apically 
towards the free edge.  This decreases the tension on the chords as their leaflet insertions 
are moved closer to the papillary muscles. 
Chordal cutting, particularly of the strut chordae, has been proposed as a potential 
repair technique for alleviating leaflet tethering due to progressive PM displacement, 
which is expected to alter the chordal force distribution [152]. Using static pressurized 
porcine hearts, He et al showed increased marginal chordal forces as a result of strut 
chordal cutting, specifically on the marginal chordae originating from the same leaflet 
and PM [153]. Finally, the altered chordal force distribution in the marginal chordae as a 
result of strut chordal cutting depend on the specific manifestation of the disease, and is 
sensitive to direction of PM displacement [149]. 
2.2.4 Papillary Muscle Mechanics 
2.2.4.1 Experimental measurement of PM forces 
The measurement of PM forces are critical to the understanding of the mitral valve force 
balance because of its force transfer to the left ventricle, and adverse LV remodeling is 
the most common chronic manifestation of MR. The three components of PM forces 
measured can be combined to obtain a total force magnitude, and this magnitude follows 
the transvalvular pressure very closely. Hashim et al reported PM force changes in an in 
vitro mitral valve model at two hemodynamic conditions – (1) High flow: 5L/min, 
150mmHg peak transmitral pressure; (2) Low flow: 3.5L/min, 90mmHg peak transmitral 
pressure. These forces were measured with a strain gauge based transducer, capable of 
providing all three components of PM force. The peak force at high flow and low flow 
were measured to be 4.16N and 2.71N respectively [154]. Jensen et al utilized an 
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improved version of the same transducer and measured PM forces in normal and IMR 
conditions, simulated by PM displacement. Results of this study are presented in Table 8 
[2]. 
 
Table 1-8 Papillary muscle force measurements reproduced from [2].  P*A is the 
product of transvalvular pressure (P) and leaflet surface area (A).  
PM Position FT (N) FM1 (N) FM2 (N) Frms (N) P*A (N) 
Normal 4.1 0.1 0.2 4.1±0.9 3.9±0.7 
Apical 5.5 0.4 0.7 5.6±1.3 5.8±0.3 
Apical+Posterior 6.9 1.6 2.4 7.5±1.8 8.1±0.6 
 
This study demonstrated that there were no significant differences between the 
peak forces at normal condition between the APM and PPM. The total pressure force 
acting on the leaflets is very closely related to the total PM force, since the two forces 
should counteract each other. Particularly, this will hold true in in vitro simulators where 
confounders such as PM contraction and annular motion do not exist. With IMR, the PM 
forces increased due to two factors - increased force transmitted to the PMs from the 
larger leaflet area experiencing the transvalvular pressure; and increased tension of the 
chordae tendineae as shown in the previous sections, which are transmitted down to the 
PMs. 
An in vivo study by Askov et al (2012) conducted in a normal porcine model 
(N=8) utilized a strain gauge based transducer designed to be implanted between the PM 
and the LV wall after dissecting the PM from the ventricle (Figure 2-9). PM forces 
rapidly increase during early systole, with the peak force occurring between early and 
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mid-systole, slightly lagging the LVP peak [9]. The peak values of FAPM and FPPM were 
5.9±0.6N and 5.8±0.7N respectively. These values were slightly higher than the forces 
observed in vitro, which could be related to the sizes of the valves used in this study, as 
well as due to differences between static and dynamic systems [2]. 
 
 
Figure 2-9 Papillary muscle force transducers: Force transducers sutured between 
severed papillary muscles record forces throughout the cardiac cycle (Image 
adapted with permission from Askov et al. [9].) 
2.3 Mitral Valve Insufficiency 
Mitral valve disease is often described as a complex and morbid condition which has 
challenged cardiologists and cardiac surgeons alike.  There are two main classifications 
of mitral valve disease relating to the pathological effect of the valve’s ability to regulate 
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flow: (i) mitral stenosis describes the total or partial obstruction of the mitral orifice 
affecting ventricular filling, and (ii) mitral insufficiency describes the valve’s 
incompetency during systole which allows regurgitation, or backflow, into the left atrium.  
Mitral regurgitation can be further classified as congenital, degenerative, or functional.  
Functional mitral regurgitation occurs in the absence of structural valvular abnormalities 
and is the result of the geometric perturbations to the surrounding myocardium.  It is the 
least understood of the valvular pathologies and is the most challenging to manage 
clinically; functional mitral regurgitation is the focus of the thesis herein, specifically 
ischemic mitral regurgitation.  
 The clinical burden of mitral regurgitation following ventricular ischemia has 
been well characterized.  Doppler echocardiography studies report that the prevalence of 
mitral regurgitation following myocardial ischemia is between 13 and 59%, and 
approximately a third of these patients develop at least moderate regurgitation severity 
[155].  Ischemic mitral regurgitation is associated with a 2-fold increase in mortality 
[10,22] and with adverse patient prognosis [23].  Patients that develop mitral 
regurgitation following an ischemic even have a lower 5-year survival than those that do 
not (Figure 2-10) [10].  Mortality also increases even when ischemic mitral regurgitation 
is only mild [10,22,156]. Further, there is a graded relationship between regurgitation 






Figure 2-10 (Left) Patient survival is significantly decreased with the presence of 
mitral regurgitation following myocardial ischemia.  (Right) This relationship is 
proportional to regurgitation severity. [10]  
 Functional mitral regurgitation may result from isolated left atrial dilation or more 
commonly with concomitant ventricular remodeling following myocardial infarction 
(also known as ischemic mitral regurgitation) or hypertrophy.  These remodeling events 
induce dilation and flattening of the mitral annulus (Figure 2-11) [11], and displacement 
of the papillary muscles away from the mitral annular plane (Figure 2-12) [12].  
Together, these geometrical changes restrict systolic leaflet closure (type IIIb 




Figure 2-11 Mitral annular dilation and flattening result from ischemic remodeling 





Figure 2-12 Following myocardial ischemia, papillary muscle displacement away 
from the mitral annular plane results in restricted leaflet closure and mitral 
regurgitation [12]. 
 Changes in mitral annular geometry associated with ischemic mitral regurgitation 
have been well documented.  Using three-dimensional echocardiography, Ahmad et al. 
quantified several dimensions along the human mitral annulus in patients with ischemic 
mitral regurgitation; these were compared to healthy control subjects [3] (Table 2-1).  In 
a similar clinical study conducted by Watanabe et al. mitral annular circumference and 
area where found to be significantly different between control subjects and ischemic 
mitral regurgitation patients [11].  In another study, Watanabe et al. also reported 
significant mitral annular flattening and leaflet tenting with ischemic mitral regurgitation 
[157].  These changes to annular geometry were further corroborated by Vergnat et al. 
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[158], who additionally identified that papillary muscle to annular distance was 
significantly increased between control subjects and patients with myocardial infarcts.  
More comprehensive studies of the changes to the subvalvular apparatus where 
performed on large animal models using more invasive experimental techniques. 
 
Table 2-1 Changes in mitral annular dimensions associated with ischemic mitral 
regurgitation [3].  
Variable Controls IMR p Value 
Annular perimeter [cm] 8.6 ± 0.2 10.7 ± 0.7 0.03 
Anterior annular perimeter [cm] 4.1 ± 0.2 5.0 ± 0.4 0.06 
Posterior annular perimeter [cm] 4.5 ± 0.2 5.6 ± 0.5 0.06 
Intertrigonal distance [cm] 2.1 ± 0.1 2.8 ± 0.3 0.06 
Annular Area [cm
2
] 5.7 ± 0.3 9.1 ± 1.2 0.03 
Anterior annular area [cm
2
] 2.5 ± 0.2 4.0 ± 0.7 0.08 
Posterior annular area [cm
2
] 3.2 ± 0.3 5.1 ± 0.9 0.08 
 
 Such quantitative studies were performed in parallel at the Stanford (Principle 
Investigator: Craig D. Miller) and University of Pennsylvania Labs (Co-Principle 
Investigators: Joe and Rob Gorman) using independently developed ovine ischemic 
mitral regurgitation models. Both groups strategically placed markers on the mitral 
annulus, ventricular myocardium, and papillary muscles, which were monitored before 
and after myocardial infarction.  Figure 2-13 summarizes the statistically significant 
geometrical changes observed between animals that did (+) and did not (-) develop 
chronic ischemic mitral regurgitation (CIMR) in an ovine model following myocardial 




Figure 2-13 Mitral annular dilation and posteromedial papillary muscle 
displacement was significantly different between animals that did and did not 
develop chronic ischemic mitral regurgitation after myocardial infarction [13]. 
 In these studies, it was not possible to isolate the independent effect of annular 
dilation and papillary muscle displacement on mitral valve function. Therefore, to 
understand the contribution of these geometrical changes towards mitral regurgitation, 
additional studies were necessary.  In carefully controlled in-vitro studies using a 
pulsatile left heart simulator, He et al. showed that the mitral leaflets were sufficiently 
large to compensate for 80% mitral annular dilation in the absence of papillary muscle 
displacement (Figure 2-14) [14].  However, this compensatory mechanism was lost and 
significant mitral regurgitation occurred at smaller magnitudes of annular dilation in the 
presence of papillary muscle displacement, particularly asymmetric tethering.  Mitral 
regurgitation was largest with posteromedial papillary muscle tethering, which is 
consistent with clinical evidence that suggests ischemic mitral regurgitation incidence is 
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highest with inferior myocardial infarction (localized to the posterior wall resulting in 
preferential displacement of posteromedial papillary muscle displacement) [159].   
 
 
Figure 2-14 Isolated and combined effects of annular dilation and papillary muscle 
displacement on mitral valvular function [14]. 
 2.4 Surgical Repair for Mitral Valve Insufficiency 
Among treatment options for mitral regurgitation, surgical repair (over pharmacological 
therapy or surgical replacement) is the preferred mode, specifically ring mitral 
annuloplasty [48,160,161].  Ring mitral annuloplasty remodels the native mitral 
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annuloplasty through the use of an artificial band to restore its physiological shape and 
size (Figure 2-15).  Annuloplasty rings are available in a wide spectrum of size, stiffness, 
and shape.  More recently, etiology specific annuloplasty rings have targeted ischemic 
mitral regurgitation through rigid (titanium) complete rings that drastically undersize the 
septal-lateral diameter.   
 
 
Figure 2-15 Ring annuloplasty aims to surgically restore physiological size and 
shape of the native mitral annulus (image adapted from Carpentier’s 
Reconstructive Valve Surgery).   
 Overall, clinical outcomes of mitral annuloplasty for functional mitral 
annuloplasty have been suboptimal.  High rates of persistent or recurrent regurgitation 
have been observed in echocardiographic follow up as early as 3 years after surgical 
repair (Figure 2-16) [15].  This is further detailed by an excellent review by Magne et al., 
which shows that late regurgitant recurrence following annuloplasty repair can exceed 




Figure 2-16 Three year follow up of patients treated with mitral annuloplasty for 
functional mitral regurgitation reveals high rates of recurrence as early as 3 years. 




Figure 2-17 Recurrent mitral regurgitation following ring annuloplasty of ischemic 
valve disease has been observed in a wide range of studies [12].   
It has long been purported that ring annuloplasty failure is a result of incompatible 
choice of mitral annuloplasty ring type for the functional pathology.  To this point, recent 
studies systematically performed undersized (by two sizes) rigid complete annuloplasty 
have claimed long-term freedom of mitral regurgitation [48,160,162].  However, this 
success was limited by the patient’s preoperative left ventricular geometry (end diastolic 
diameter < 65 mm).  Excessive and late deleterious remodeling of the left ventricle have 
been identified as a key contributor to mitral annuloplasty ring failure [41,42,163].  These 
studies underscore the importance of addressing the pathologically tethered subvalvular 
apparatus in this setting of secondary mitral regurgitation.   
Of note, anterior leaflet augmentation [57,58] and basal papillary muscle 
relocation (Kron Procedure) [17,56] have been recently demonstrated to restore leaflet 
 48 
coaptation and mobility without the need to unnaturally undersize the mitral annulus 
while relieving subvalvular tethering.  Anterior leaflet augmentation is performed by 
making an incision in the anterior leaflet parallel to the mitral annulus and letting the 
anterior leaflet “fall” into the ventricle (Figure 2-18).  The height of the fall can be 
determined by the spread of the incision.  As a result, the chordae which insert into the 
anterior leaflet also displace into the ventricle, which may help alleviate the pathological 
tethering from the displaced papillary muscles.  A pericardial patch is then sutured to the 
anterior leaflet effectively increasing the available surface area to cover the mitral orifice 
and promote coaptation.  In a pilot study by Kincaid et al., 25 patients with severe (84%) 
and moderate (16%) ischemic mitral regurgitation underwent anterior leaflet 
augmentation [57].  Post-operatively echocardiography revealed regurgitation was 
abolished in 80% of patients; the remaining 20% had moderate regurgitation.  At 2 years 
follow-up, actuarial freedom from moderate or greater regurgitation was 81%.  As this is 
a challenging surgical procedure, further mechanistic studies are needed to identify which 
patients would most benefit from such an adjunctive repair and to provide an 
understanding of the mechanical effects produced by displacing the anterior leaflet and its 





Figure 2-18 Adjunctive leaflet augmentation results in larger anterior leaflet surface 
area to promote valve competency while displacing chordal insertion points [16].   
Similar to anterior leaflet augmentation, basal papillary muscle relocation aims to 
repair ischemic mitral regurgitation through a sub-annular adjunctive procedure (Figure 
2-19).  First pioneered by Dr. Kron, surgical relocation of the posteromedial papillary 
muscle was successfully performed in 18 patients with moderate to severe ischemic 
mitral regurgitation [56].  Prolene sutures were passed through the fibrous portion of the 
apically tethered posteromedial papillary muscle, which is then passed up through the 
adjacent mitral annulus at the right fibrous trigone.  The papillary muscle was then drawn 
upwards towards the mitral annulus until sufficient coaptation was achieved through 
saline testing.  In a 1:1 randomized study, Fattouch et al. compared repair efficacy of 
adjunctive papillary muscle relocation to the preferred surgical treatment, mitral 
annuloplasty [54].   At 5 years, recurrent regurgitation equal to or greater than moderate 
severity was significantly more prevalent in the isolated ring annuloplasty repair group 
(11.5%) as compared to the adjunctive papillary muscle repair group (3.7%).   While 
these data are favorable, more detailed studies are needed to standardize this repair 
technique to maximize its clinical applicability.  In particular, two questions need further 
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investigation: (i) to where on the mitral annulus should the papillary muscles be 
relocated, and (ii) how much basal relocation is needed to promote valve competency.    
 
 
Figure 2-19 In the Kron procedure, the posteromedial papillary muscle is surgically 
relocated to the adjacent mitral annulus to relieve subvalvular tethering caused by a 
severely dilated left ventricle [17].    
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2.5 Quantification of Mitral Regurgitation 
The first step in surgical indication for mitral valve repair is proper clinical referral 
through accurate diagnosis of mitral regurgitation severity and valvular dysfunction.  The 
current guidelines utilize an integrative assessment of mitral regurgitation.  The 
quantitative techniques include regurgitant volume, fraction, and orifice area.  Using the 
clinical standard through noninvasive imaging, mitral regurgitation is quantified through 
the 2D color Doppler Proximal Isovelocity Surface Area measurement (PISA).  The 2D 
proximal isovelocity surface area method is derived from the principle of conservation of 
mass: as blood approaches a regurgitant orifice, its velocity increases, forming concentric 
shells of increasing velocity and decreasing surface area [18,164-166]. 
 Key assumptions of the PISA method are that the orifice is small and round, that 
the sourcing and sinking chambers are large (left ventricle and left atrium respectively), 
and that the location of the orifice is on a planar surface.  If these conditions are met, the 
proximal flow will be axially symmetric, and locations of constant velocity will be 
hemispherical in shape.   
 Using continuity principles the volumetric flow rates on either side of the mitral 
regurgitation orifice are equal:  
 
Q1 = Q2 
 
Volumetric flow rate may be defined as: 
 
Q = Area x Velocity 
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From this, it follows that: 
 
Area1 x Velocity1 = Area2 x Velocity2 
 
Proximal to the regurgitant orifice (in the left ventricle), the surface area can be estimated 







The radius is determined from the 2D color Doppler echocardiography as the radial 
distance from the regurgitant orifice area to a predetermined isovelocity surface area.  
The isovelocity surface area is chosen by defining an Aliasing Velocity which gives a 
clear delineation of isosurfaces.  From this, it follows that: 
 
Velocity1 = Aliasing Velocity 
 
Downstream of the regurgitant orifice (in the left atrium), the area may be defined as the 
Effective Regurgitant Orifice Area: 
 
Area2 = EROA 
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The Effective Regurgitant Orifice Area is the cross-sectional area observed downstream 
of a nozzle at the point of the vena contracta.  At this point, velocity is also the largest (as 
area is the smallest).  Therefore, it follows: 
 
Velocity2 = Vmax 
 
Vmax can be determined using continuous wave (CW) color Doppler measure along the 
central axis of the regurgitant jet.  Rearranging the continuity equation to solve for the 




 x Aliasing Velocity / Vmax 
 
From this, regurgitant volume can be calculated by multiplying the effective regurigitant 
orifice area by the Velocity Time Integral, or the stroke distance over which blood travels 
in one cardiac cycle.  VTI can be measured from the continuous wave color Doppler by 
integrating the velocities over the regurgitant portion of the cardiac cycle.  Finally, 
regurgitant volume can be calculated as follows: 
 
Regurgitant Volume = EROA x VTI, or 
Regurgitant Volume = 2πR
2
 x Aliasing Velocity x VTI / Vmax 
 




Figure 2-20 The 2D PISA method is explained in this schematic from the 
echocardiographer.org.    
 This method is not without limitations.  The most crippling of these limitations is 
the hemispherical assumption, which is often violated by mitral regurgitant orifices.  The 
hemispherical assumption is derived from a pinhole source, or a small perfectly round 
orifice.  Often times, the regurgitant orifices are elongated along the length of the mitral 
coaptation line.  Therefore the flow convergence zone may not be defined by a 
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hemispherical approximation, which will result in systematic underestimation of true 
regurgitant volume.   
 A second major limitation is caused by the difficulty in accurately and 
reproducibly identifying the radial distance from the mitral regurgitant orifice to a 
defined isovelocity surface area.  Small errors in this radial dimensions may cause large 
errors in calculate regurgitant volume due to squared weighting of the radial 
measurement. 
 A final major limitation is that Doppler ultrasound can only detect velocity 
components aligned with the direction of the ultrasound beam.  It cannot detect velocities 
oriented perpendicular to the scan lines.  Moreover, velocities observed by the ultrasound 
beam are a projection of the true velocity, that is, there is a loss of velocity magnitude 
defined by the scalar dot product.  Observed velocities are modulated by the cosine of the 






Figure 2-21 The observed velocity vectors along the ultrasound scan lines have 
lower magnitudes than the true velocity field because of the cosine angle correction 
[18].      
 Philips Healthcare recognized these limitations of 2D PISA and sought to create a 
simple new tool that uses 3D color Doppler echocardiography to improve quantification 
accuracy and robustness.  Philips Healthcare developed a complex algorithm, herein 
known as the Field Optimization Method (FOM) to correct for differences in observed 
and true velocity magnitudes (Figure 2-22).  The Field Optimization Method is initiated 
by an approximation of the true velocity vectors.  Ultrasound physics are then applied to 
the guess of the true velocity fields to produce a calculated “observed” velocity field.  
The calculated and true “observed” velocity fields are then compared.  This process is 
iterated until the error distribution between the calculated and true “observed” velocities 
are minimized.  The velocities are then integrated in the flow convergence zone of the 
new true velocity field to calculate the overall regurgitant volume.  This is done to all 
frames in the cardiac cycle.  More detail on this method can be found here [167].   
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Figure 2-22 The observed velocity vectors along the ultrasound scan lines have 
lower magnitudes than the true velocity field because of the cosine angle correction 
[167].      
2.6 Computational Mitral Valve Models 
Simplified numerical models of the mitral valve have been used for over 20 years to 
provide a unique and non-invasive analysis of function and biomechanics for direct 
surgical applications, such as annuloplasty [59-62], edge-to-edge[20,63] or neochordae 
[64,65] implantation, and stress analysis [66,67]. These models vary considerably in 
execution owing to differences in anatomical construction, material laws, boundary 
conditions, and preferred solvers. 
Geometric mitral valve modeling has evolved from simple and idealistic annular, 
leaflet, and chordal profiles to patient specific models based on state of the art medical 
imaging, in particular ultrasound [20,67,168] and computed tomography [19] (Figure 2-
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23).  The mitral annulus and leaflets can be directly segmented from the resultant image 
stacks using manual or semi-automated techniques.  Leaflet thickness must still be 
prescribed in the current models due to inconsistent image quality and relatively limited 
resolution [20].  Annular motion can be imposed to reflect in-vivo tracking [19,169,170]. 
 
 
Figure 2-23 Patient specific anatomical mitral valve models derived from CT (left) 
and three-dimensional echocardiography (right) imaging will ultimately be used for 
predictive surgical planning.  CT imaging is better capable of capturing the detailed 
chordal structure. (Images adapted with permission from Wang et al. [19] and 
Mansi et al. [20].) 
Even greater challenges are presented by the chordae tendineae.  
Echocardiography, the standard of care modality, currently lacks the spatial resolution to 
accurately capture and segment the complex chordal branching and insertion.  While 
computed tomography is capable of capturing chordal structures, it is not the standard of 
care, nor is it capable of finely resolving the cross-sectional areas [19].  As a result, it is 
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typical for chordae number, branching, and insertion to be approximated from literature 
derived data.  This has been shown to lead to inaccurate closure simulations, which 
typically result in billowing mitral leaflets [19]. Additionally, implementing the chordal 
to leaflet transition region is a non-trivial problem.  Point insertions are used for the 
chordal attachments to the leaflets and papillary muscles.  However, physiologically, 
chords seamlessly fuse into the leaflets and the underlying collagen structures radially 
diffuse from the chordal core into the leaflet [108,171].  This can lead to 
uncharacteristically high stress magnitudes or leaflet kinking at the point of insertions.  
Furthermore, as the leaflets are passive membranes, their deformation and motion will be 
a balance of the interaction between the pressure driven flow and constraining chordal 
structure.  Therefore, it is imperative for realistic simulations to develop a reliable 
strategy to physiologically implement the chordae.  The tips of papillary muscles are 
normally modeled as the origins of the chordae, but are not given finite dimensions or 
physical properties; their position and motion can be imposed to reflect in-vivo tracking 
[169,172]. 
Material models for the mitral leaflets vary considerably, but should aim to 
capture the leaflets non-linear and anisotropic mechanical response [170,173,174].  The 
leaflets non-linear mechanical response may be neglected, mainly in modeling the 
isovolumic contraction/relaxation phases of the cardiac cycle, but will underestimate 
developed stresses [113,175]. The mitral chordae are typically modeled as hyperelastic or 
linear elastic tension only elements.  However, regardless of material model 
implemented, the choice of material properties and microstructural fiber orientation 
remains difficult. These parameters can be approximated and iteratively refined such that 
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the computational solutions converge to match empirical data.  Modeling disease tissue 
adds another level of complexity as the microstructure deleteriously remodels with 
altered mechanical loading.  It is not known whether a given deformation can be achieved 
by a unique set of material parameters, which could yield misleading conclusions.  
Additionally, it is not enough to model the mitral valve in isolation, as the interplay with 
the left ventricle contributes strongly to mitral valve function.  Efforts similar to the study 
by Wenk et al. will help target surgical riddles such as recurrent mitral regurgitation in 
patients with ischemic valve disease [176]. 
Initial and boundary conditions, as well as, preferred solver methods vary from 
group to group.  Solvers range from in-house to commercial codes and execute structural 
or fluid-coupled simulations [174,177].  Nonetheless, direct one-to-one validation is 
needed against comprehensive, time resolved experimental data with multiple measured 
endpoints and well defined boundary conditions [37].  Additionally, systematic studies 
are needed to understand whether increasing model fidelity and complexity provides 
measured gains in assessing mitral valve function and structural mechanics, particularly 
as a patient specific surgical planning tool.    
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CHAPTER 3 
OBJECTIVE AND SPECIFIC AIMS 
Owing to its complex structure and dynamic mechanical loading, surgical repair of the 
heart’s mitral valve poses a significant clinical challenge.  Specifically, repair of ischemic 
mitral regurgitation, caused by the geometric disruption of the mitral apparatus in the 
setting of ventricular dysfunction, results in poor long-term patient 
survival[10,12,22,29,43,163,178].  Clinical data have shown that the preferred surgical 
treatment, restrictive mitral annuloplasty, may result in 15-30 % early (< 6 months) 
recurrence of mitral regurgitation (≥ 3 and may exceed 70% after five years +) [178].  
Studies have suggested isolated annuloplasty may not be a comprehensive repair suitable 
for all patients because ischemic pathology is multi-factorial and results in variable 
ventricular and valvular geometric distortions [11,157,179-182].  Recently, novel surgical 
repairs have been explored on a patient specific basis.   
Consequently, it is important to improve clinical diagnostics to better identify 
patients that may benefit from these adjunctive surgical repairs.  These complex repairs 
need to be carefully evaluated to understand their mechanical and functional benefits, 
particularly in maximizing leaflet coaptation and reducing subvalvular tethering.  Finally, 
advances in predictive computational mitral valve modeling may make patient-specific 
surgical planning possible.  To date, such tools are limited, however, without direct 
experimental validation to ensure their accuracy and reliability.   
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Therefore, the central objective of this thesis is to develop and utilize an integrative 
experimental framework to improve mitral valve surgical repair outcome through 
multiple complementary approaches including: (i) advanced diagnostics, (ii) 
mechanistic evaluation of post-repair valvular function, and (iii) validation of novel 
computational surgical planning tools.  These tasks are achieved through three specific 
aims:  
 
Specific Aim 1: In vitro validation of the Philips 3D Field Optimization Method for the 
accurate quantification of mitral regurgitation. 
As patient outcome is correlated to mitral regurgitation severity, it is important to 
accurately quantify mitral regurgitation. Additionally, mitral regurgitation severity is 
associated with ventricular and valvular geometric distortions, which may not be easily 
quantifiable otherwise.  More accurate quantification of valvular function and improved 
diagnostics may better guide surgical repair, particularly the need for more complex or 
adjunctive repair procedures.  Current clinical practices, however, utilize a qualitative 
grading system, while quantitative techniques have been known to underestimate 
regurgitation severity.  Therefore, in collaboration with Philips Healthcare, a novel mitral 
regurgitation assessment algorithm is systematically validated and compared against 
current clinical practices using the pulsatile Georgia Tech Left Heart Simulator.  Multiple 
geometries of regurgitant orifices and flow rates are simulated over a range of 
pathological conditions to identify potential valvular lesions that may cause erroneous 
quantification.  For direct comparison, the clinical standard, 2D PISA method, and a 
manual integrative 3D PISA method, are similarly compared.  Consequently, the Field 
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Optimization Method will be adapted and refined by Philips Healthcare based on 
empirical observations.  The data generated will be available for future evaluation of 
similar analysis techniques.   
 
Specific Aim 2: To elucidate the functional efficacy and mechanical benefit of novel 
adjunct surgical repairs for the treatment of ischemic mitral regurgitation. 
Since ischemic mitral regurgitation is a secondary pathology, or a result of left ventricular 
myocardial injury, we hypothesis that adjunct surgical procedures will restore leaflet 
coaptation  and valve function while reducing subvalvular tethering.  In particular, two 
novel adjunct surgical strategies that intend to compensate for severely dilated ventricles 
are investigated in this thesis: (A) anterior leaflet augmentation, and (B) basal papillary 
muscle relocation.  Each targeted therapy is performed as an adjunct to true-sized mitral 
annuloplasty.  Treatment efficacy is assessed using an integrative approach that combines 
(i) clinical measurements of valve function, (ii) direct flow measurements of 
regurgitation, and/or (iii) chordal force measurements of leaflet and subvalvular tethering.  
These repairs are expected to compare favorably against the current surgical preferred 
treatment for ischemic mitral regurgitation, restrictive or undersized mitral annuloplasty.      
 
Specific Aim 3: Development of an experimental framework and database for the 
direct validation and advancement of novel computational surgical planning platforms 
for mitral valve disease. 
Patient specific predictive surgical planning is a new frontier in mitral valve repair 
enabled by recent advances in computational modeling and medical imaging technology.  
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These models have evolved from simple two-dimensional approximations to complex 
three-dimensional fully coupled fluid-structure interaction models.  To date, however, 
these models have lacked direct one-to-one experimental validation.  Moreover, as 
computational solvers vary considerably, experimental benchmark data are critically 
important to ensure model accuracy.  Moreover, these data need to be adaptable to 
provide a range of boundary conditions and measureable endpoints suitable for the 
various computational methods.  To this end, a multi-modality in-vitro pulsatile left heart 
simulator is designed and developed.  Comprehensive experimental data evaluating 
mitral valve function are acquired including:  
1. Valvular geometry through state of the art micro-computed tomography and 
clinical standard of care echocardiography imaging 
2. Geometric and hemodynamic boundary conditions  
3. Ventricular flow fields through stereoscopic particle image velocimetry  
4. Valvular mechanics (leaflet strain, chordal and papillary muscle force)  
 
Taken together, the results from this thesis will lead to more accurate clinical diagnosis 
and improved surgical treatment for the management of ischemic mitral regurgitation.  
Specific Aim 1 will more accurately quantify valvular dysfunction, which may help to 
identify patients for adjunctive surgical intervention, where simple mitral annuloplasty 
may otherwise have failed.  Specific Aim 2 will investigate novel adjunct surgical 
procedures which may provide new options for patients with pre-operative characteristics 
associated with simple annuloplasty repair failure.  Furthermore, the experimental 
framework and database provided from Specific Aim 3 will be integral in improving the 
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accuracy and reliability of predictive patient specific surgical planning tools. 
Consequently, these validated computational mitral valve models can be used to explore 




In this chapter, the design and operating principles of the major equipment used in this 
thesis are described.  Specifically, the pulsatile left heart simulator and its functional 
components, imaging systems, data acquisition systems and associated transducers, and 
instrument calibrations are detailed.  Additionally, a novel modular left heart simulator 
specifically designed for micro-computed tomography and particle image velocimetry is 
described.  Experimental methods and protocols are detailed in Chapter 5.     
4.1 Pulsatile Left Heart Simulator 
All experiments for Specific Aim 1 and 2 were conducted in an in vitro pulsatile left heart 
simulator previously developed in the Cardiovascular Fluid Mechanics Laboratory.  In 
section 4.5, a new modified left heart simulator is described specifically for completing 
the objectives of Specific Aim 3.  The operating principles of the modified simulator are 
similar to those described herein.  The simulator is a pulsatile, bladder pump driven 
system, in which physiological and pathological hemodynamic function of native mitral 
valves with complete subvalvular apparatus can be studied.  As shown in Figure 4-1, the 
simulator consists of ten main components:  
1. Low pressure atrial/pulmonary reservoir 
2. Left atrial chamber 
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3. Mitral annular plate 
4. Left ventricular chamber 
5. Aortic outflow tract with mechanical valve 
6. Papillary muscle positioning system 
7. Pulsatile bladder pump 
8. Programmable solenoid system (not pictured) 
9. Compliances and resistances 
10. Data acquisition system (not pictured) 
 
 
Figure 4-1 Schematic representation of the pulsatile left heart simulator. 
 An open air reservoir was used to maintain a static low pressure (~10 mmHg) 
head preceding the left atrium.  This reservoir also functioned as a sink for aortic outflow 
distal to the systemic resistance.  A clear, acrylic cuboid chamber was used as a left 
atrium.  The chamber had a thin acrylic basal wall (3.5 mm) to minimize acoustic 
distortion of ultrasound waves and to provide optical access for en face and high speed 
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imaging of the functioning mitral valve.  A second atrial chamber with a side inlet was 
used when needed to provide uninhibited optical and acoustic access to the valve for 
simultaneous high speed and ultrasound imaging (not shown).  The left atrial chamber 
was designed such that its depth would position the functioning mitral valve between 10-
12 mm away from an x7-2 transthoracic pediatric echocardiography probe (Philips 
Healthcare; Andover, MA). 
 An adjustable mitral annular plate was used to secure the native mitral annulus in 
the left heart simulator.  The mitral annular plate consisted of an acrylic base plate and a 
tension spring with a metal wire core, which was embedded in silicone and wrapped in 
water proof cloth to form a D-shaped annulus (Figure 4-2).  The core of the anterior 
portion of the synthetic annulus was constructed out of rigid tube material to prevent 
deformation.  This region corresponds to the between the left and right fibrous trigones 
on the anterior annulus, which is often suggested to be more resistant to pathological 
mitral annular dilation [183].  By controlling the tension on the metal wire drawstring, the 




Figure 4-2 Adjustable mitral annular plate. 
 The synthetic annulus was designed such that the control, or physiologic, 
condition simulated a mitral annular area of 4.4 cm
2
, comparable to a size 30 Physio 
annuloplasty ring.  This was achieved with septal-lateral and commissure-commissure 
dimensions of 19.2 and 34.9 mm respectively.  These dimensions were chosen as they 
were a nominal representation of the ovine mitral valves procured from the local abattoir 
and are comparable to the most prevalent annuloplasty ring sizes used in human 
applications [184,185].  Control valves of different sizes may be used; however, range of 
annular dilation and under-sizing would need to be adjusted correspondingly.     
 The tension on the metal wire drawstring was adjustable to yield an undersized 
(or restrictive) mitral annuloplasty (increase tension), and increasing levels of 
pathological mitral annular dilation (decrease tension).  See Table 4-1 for a summary of 
annular dimensions used. 
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26 3.25 16.4 30.7 
Control 30 4.40 19.2 34.9 
Oversized 
Annuloplasty 
34 5.72 22.0 39.1 
IMR 38 7.22 24.8 43.2 
 
 The left ventricular chamber was a rigid acrylic chamber onto which the mitral 
annular plate was mounted (Figure 4-3).  It was comprised of a left ventricular outflow 
tract that housed a 27 mm Bjork-Shiley convexo-concave mechanical valve in the aortic 
position.  The outflow tract was designed at a 135° angle with the frontal face of the 
chamber to emulate the geometrical positioning of the mitral and aortic valves [186]. The 
apical wall of the chamber contained an inlet to the bladder pump and a through-wall 




Figure 4-3 The Left Heart. 
 A mechanical  papillary muscle positioning system was used to obtain accurate 
positioning of the native papillary muscles in the left ventricle to 0.9 mm resolution, 
which was a function of the bevel gear geometry (Miter Gear A-1X-4MY06020; SDP-SI; 
New Hyde Park, NY) (Figure 4-4).  The positioning system was comprised of a main 
arm, a modified 90° pin-gear drive, and an elevator arm.  The main arm was capable of 
translating into and out of the left ventricle for apical-basal positioning.  A gear rotation 
rod coupled to the pin-gear drive induced displacement of the elevator arm.   Combined 
rotations of the main arm and gear rotation rod were used for septal-lateral and anterior-
posterior positioning.  Native papillary muscles were mounted to the mechanical 
positioning system via a Teflon connecter, which screwed into the end of the elevator 




Figure 4-4 Mechanical papillary muscle positioning rods. 
   The left heart simulator used a pressure driven compressed air bladder pump, 
which was regulated by three 3-way air solenoid valves.  One solenoid (A) was used to 
increase pressure around the bladder pump to generate a positive LVP.    The remaining 
two solenoids (B and C) were used to evacuate the air around the bladder pump, 
decreasing ventricular pressure.  The action of the solenoid valves was triggered by a 
computer controlled pulse generating system (TTL wave), which was also used to 
synchronize all data acquisition.  Table 4-2 summarizes the timing used to cyclically 







Table 4-2 Timing and effect of air solenoid valves. 
Timing Active Solenoids Effect 
0 – 220 ms A 
Bladder pump compressed, Positive LVP 
generated 
220 – 820 ms B and C Bladder pump relaxes, Ventricular Diastole 
820 – 860 ms -- Mechanical Delay 
 
 In addition to controlling the timing of the pulsatile bladder pump, pressure 
regulators, and a lumped systemic resistance and compkiance were used to tune the left 
heart simulator to adult physiological hemodynamics.  The left heart simulator was tuned 
to 70 beats per minute heart rate (860 ms total cycle time, 530 ms diastole, 330 ms 
systole), 120 mmHg peak left ventricular pressure, and 5.0 L/min average cardiac output 
(70 mL stroke volume).  Representative ensemble averaged (15 cardiac cycles) 
hemodynamic waveforms are shown in the Figure 4-5 below. 
 
 
Figure 4-5 Representative hemodynamic waveforms, ensemble average over 10 
cardiac cycles, from the left heart simulator. 
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 Waveforms were monitored in real time using custom LabView Virtual 
Instruments (National Instruments Corp; Austin, TX).  Pressures (TruWave Disposable 
Pressure Transducer; Edwards Lifesciences Corp; Irvine, CA) were acquired in the left 
atrium, left ventricle, and aortic root, while flow was acquired upstream of the mitral 
valve (In-Line Electromagnetic Flow Probe; Carolina Medical Electronics Inc.; East 
Bend, NC).  Pressure transducers were coupled to Validyne Engineering Corp. 
(Northridge, CA) signal conditioners and strain gage amplifiers (SG297A) housed in an 
8-channel module case (MC170-32).  Electromagnetic flow probes were coupled to 500 
Series flow meters (Carolina Medical Electronics Inc.).  10 cardiac cycles were acquired 
for off-line data analysis.        
4.2 Echocardiography 
A Philips iE33 real-time 3D ultrasound imaging system (Philips Healthcare; Andover, 
MA) was used to evaluate valve performance.  A 3D matrix array X7-2 pediatric 
transthoracic (TTE) probe was positioned on the left atrial window.  Ultrasound gel was 
used to create a continuous air-free medium to transmit the acoustic waves.   
 Echocardiography was used to acquire: 2D and X-plane tissue and color Doppler, 
3D tissue and color Doppler, and continuous wave (CW) Doppler.  Image acquisition was 
gated using the common TTL trigger that synchronized all data acquisition.  Images were 
transferred as .DICOM for offline analysis using Philips QLab software. 
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4.3 High Speed Imaging 
A high speed imaging system was used to acquire en face imaging of the dynamically 
functioning mitral valve in the left heart simulator.  The camera was positioned upstream 
of the left atrium, perpendicular to the mitral annulus.  Images were acquired at 250 
frames per second at 1280 x 1204 pixel resolution with a Basler a504k camera (Basler 
Vision Technologies, PA).  The camera was outfitted with a 105 mm f/2.8D AF Micro-
Nikkor lens (Nikon, USA).  The camera was coupled to an EPIX high speed frame 
grabber (PIXCI CL3SD Frame Grabber; EPIX Inc.; USA).  EPIX commercial software 
was used to acquire all images.  Image acquisition was triggered using the common TTL 
waveform.  Images were saved as .TIFF and processed offline.   
4.4 Chordal Force Transducers 
Strain gage based C-shaped transducers were used to measure the tension on individual 
chorda tendinae during dynamic valve testing (Figure 4-6).  A C-shaped brass spring 
element (L x W  x H x t: 6.5 x 2.0 x 5.0 x 0.5 mm) served as the parent geometry which 
sensed deformation.  Two strain gages (EA-06-031DE-350; Vishay Measurements 
Group; Raleigh, NC) were attached to the inner and outer surfaces of the ring.  These two 
gages were wired in a Wheatstone half-bridge configuration; the remaining half of the 
bridge was completed using a National Instruments cDAQ chassis (NI cDAQ-9174) with 
strain gauge modules (NI 9237).  The transducers were coated using M-Bond 43 (Vishay 
Measurements Group) to maintain electrical stability during saline immersion.  The 
transducers were sutured onto selected chordae; the portion of the chordae passing 
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between the measurement arms was bisected such that all chordal tensile loading was 
transferred to the brass spring element.  Real time data monitoring and acquisition was 
performed using custom LabView Virtual Instruments.  Data acquisition was 
synchronized using left ventricular pressure waveforms.   
 
 
Figure 4-6 Chordal force transducer sutured onto posterior leaflet secondary 
chordae.  After securing the transducer, the chorea are bisected to transfer all load 
to the brass spring element (not shown). 
 The sensitivity and linearity of individual transducers were tested prior to and 
after each experiment.  The minimal measureable difference in tension for these 
transducers was 0.01 N.  For all conditions tested, forces were baseline zeroed 
immediately preceding dynamic testing.  Offline analysis was performed using custom 
MatLab (MathWorks; Natick, MA) scripts.  Extensive information on c-ring design, 
manufacturing, calibration, and application can be found [187-189].   
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4.5 Modified Left Heart Simulator 
For the rigorous and comprehensive experimental validation of numerical mitral valve 
modeling (Specific Aim 3), design modifications were made to the existing left heart 
simulator to enable: (i) micro-computed tomography of the native mitral valve apparatus 
in its experimental configuration, (ii) stereoscopic particle image velocimetry of the 
native mitral flow fields, (iii) echocardiography (clinical imaging modality) of the 
dynamic mitral valve, (iv) carefully characterized boundary conditions, and (v) additional 
biomechanical evaluation of the mitral valve.     
 To meet these needs, the following key design constraints were identified: (i) 
micro-computed tomography field of view and bore size, (ii) uniform x-ray absorbance 
and scattering, (iii) minimal acoustic and optical distortions, and (iv) maintaining 
valvular geometry throughout complimentary experimental techniques.   
 The new modular design (Figure 4-7) allowed for complimentary experimental 
techniques to be performed on a singular mitral valve without perturbing the valvular 
configuration.  The left heart consisted of a thin walled cylindrical (cross section ϕ = 8.89 
cm) acrylic chamber (t = 6.35 mm).  A cylindrical design was preferred for use with the 
available micro-computed tomography system.  With the VivaCT 40 system, the x-ray 
source and detector spiral around a fixed (or axially translating) sample.  Any objects in 
the x-ray path, in this case, the left heart’s walls, would affect the detected signal.  
Therefore, to ensure the absorbance was uniform, the chamber was cylindrical, and the 
valve was centrally mounted.  The thin acrylic walls also minimized x-ray absorbance, as 




Figure 4-7 A partially exploded view of the new modular left heart simulator is 
shown.  The outflow tract with the aortic valve and the left atrium are removed for 
micro-computed tomography imaging. 
 En face imaging was possible through a thin, flat atrial (basal) wall.   Stereoscopic 
particle image velocimetry was possible through the use of an outer rectangular chamber 
with inlets continuous with the left heart simulator.  The outer chamber was filled with 36 
% glycerin solution, which was the same working fluid used in the left heart simulator for 
particle image velocimetry. The combined effect of imaging through the flat side wall of 
the outer chamber and the use of the glycerin solution minimized optical distortions.  Any 
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remaining mismatches in refractive indices were accounted for using a polynomial 
calibration mapping function in DaVis Imaging Software.      
Two designs of the left atrial chamber were used; both employed a thin basal wall 
(t = 2.5 mm).  For particle image velocimetry, a direct flow inlet on the basal wall was 
employed.  For all other experimental conditions, a side flow inlet was used.  The 
ventricular chamber had a bladder pump inlet on its apical wall and a through-wall 
connection bracket for the mechanical papillary muscle positioning rods.  An aortic flow 
outlet was machined into the left ventricle adjacent to the anterior mitral annulus.  The 
outflow orifice was machined as a continuous projection of a 25.4 mm left ventricular 
outflow tract oriented at 135°.  A removable left ventricular outflow tract and aortic valve 
chamber, which housed a 25 mm bi-leaflet mechanical heart valve (Medtronic Parallel; 
Minneapolis, MN) were designed.   
A mitral annular plate was positioned between the atrium and ventricle.  A D-
shaped orifice was machined into the mitral annular plate with dimensions similar to a 
size 30 C-E Physio annuloplasty ring (see Table 4-1).   The mitral annular orifice was 
centered on the annular plate.  A silicon cloth ring was fixed to the mitral annular plate 
(as an analog for the Physio annuloplasty ring) onto which the native mitral annulus was 
sutured.  The inner diameter of the silicon cloth ring aligned with the D-shape orifice.  An 
additional mitral annular plate was fabricated to function as an analog for the highly 
saddle shaped Profile 3D annuloplasty ring.  The core of this saddled ring was rapid 
prototyped out of ABS plastic, which was then covered in silicone and water proof cloth.  
The rapid prototyped geometry was created based on micro-computed tomography of a 
Profile 3D annuloplasty ring.  This annulus plate did not utilize the spring and wire 
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drawstring construction as the metallic components effected the quality of the micro-
computed tomography imaging acquisition.   
The mechanical papillary muscle positioning rods were simplified (Figure 4-8); 
specifically the bulky modified 90° pin-gear drive system was replaced.  The new 
papillary muscle position rods are simply a straight shaft with a papillary muscle 
attachment adapter at the end.  The apical-basal, anterior-posterior, and septal-lateral 
positioning controls were moved to the apical plate of the left ventricle using a ball and 
socket joint.  The ball and socket joint was designed as a mechanical collet.  The 
papillary muscle shaft is passed through the slotted ball port design.  To lock the position 
of the papillary muscle in place, the top is screwed down to tighten unto the ball, which 
in turn tightens onto the positioning rod.  Rubber o-rings were used at all interfaces to 
create a leak-free seal and to increase the coefficient of friction between mates to prevent 
slippage.  Accurate positioning can be obtained through simple trigonometry.  The ball 
and socket joint was designed to achieve a ~30 degree maximum rotation.  Based on the 
trigonometric relationships (25-30 mm shaft left distal to the ball and socket joint), a 14-
17 mm maximum papillary muscle displacement in the septal-lateral or anterior-posterior 
directions can be attained.  Apical-basal positioning is achieved by sliding the shaft into 




Figure 4-8 Simplified papillary muscle positioning system uses a straight shaft rod 
with the native papillary muscle adapter at its end.  The positioning mechanism was 
deferred to the ball and socket joint on the apical wall of the left ventricle.  Inlay 
shows an exploded view of the ball and socket joint. 
4.6 Particle Image Velocimetry 
Stereoscopic digital Particle Image Velocimetry was performed to resolve the three 
components of velocity of the flow through and proximal to native mitral valves.  Briefly, 
particle image velocimetry is a proven imaging technique which is able to acquire 
instantaneous measurements of velocity through a whole plane.  A working fluid is 
seeded with neutrally buoyant 1- 20 micron size particles, which are illuminated by a 
high energy sheet of laser light.  Two laser pulses separate by a short time (dt chosen 
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based on expected particle displacement) are synchronized to high resolution CCD 
(charge coupled device) camera(s) to record paired images of the illuminated flow field.  
Statistical analysis (cross-correlation of the particles from each paired image) is used to 
calculate the average displacement and subsequent velocity within a subdivided region 
(interrogation window) of each image.   
 For these studies, a pair of 532 nm pulsed (9ns pulse duration)  laser sources were 
used (Neodym:YAG, 17 mJ/pulse, ESI Inc.; Portland, OR).  The laser beam was 
redirected and adapted with appropriate optics to create a laser sheet (~ 1 mm thickness) 
that bisected the mitral valve parallel to the septal-lateral long axis plane (Figure 4-9).  
The final mirror in the laser beam path (reflected the beam 90° upward into the chamber) 
was mounted on a traverse (Model # M1-102404; Lintech; Monrovia, CA) such that the 
target imaging plane could be accurately and incrementally displaced within the left heart 





Figure 4-9 Schematic representation of the stereo-photography and laser plane 
configurations. 
 Two CCD cameras (Imager Pro, 1600 x 1200 pixels; LaVision GmbH; 
Goettingen, Germany) with a Nikon Micro-Nikkor 60 mm lens (Nikon Inc.; Melville, 
NY) were used for stereoscopic imaging.   The cameras were mounted with Schiempflug 
adapters and an orange filter to eliminate reflected laser light (cut-off λ = 560 nm; Hoya 
Optics, Santa Clara, CA).  The Schiempflug adapters ensured the particles in the field of 
view were in focus when imaged at an angle.  Neutrally buoyant polymethyl methacrylate 
(PMMA) florescent seeding particles (with Rhodium-B dye, 1-20 µm, 580 nm emission; 
Dantec Dynamics, Denmark) were suspended in the working fluid.  The CCD resolution 
was 16.6 µm/pixel with particles sizes of 2-3 pixels.  The field of view was 50 x 50 mm, 
which consisted of the flow region immediately down-stream and proximal to the mitral 
valve.  36% glycerin in water was used to match the kinematic viscosity of blood (3.5 
cSt) and to minimize distortion errors from mismatching refractive indices.  The 
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refractive index of the working fluid was 1.38, compared to 1.49 of the acrylic; this was 
corrected through calibration.  For stereoscopic image calibration, a three-dimensional 
two-leveled target was used (Figure 4-10).  The calibration target was 1 mm thick 
transparent acrylic with 1.5 mm laser printed markers aligned in a 5 mm x 5 mm grid on 
either side (dimensions L x W: 100 mm x 100mm ).  PIV data acquisition was 
synchronized using the common TTL trigger.  Data were processed off-line using DaVis 
7.2 and custom MATLAB scripts; data were visualized using TecPlot (Bellevue, WA).  
For data acquired in the left atrium, a single camera arranged orthogonal to the laser 
plane was sufficient, as there were no obstructions to imaging (as compared to the 
papillary muscles and chordae tendinae).   
 
 
Figure 4-10 Schematic representation of calibration target. 
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4.7 Micro-Computed Tomography 
Micro-computed tomography (µCT) imaging of the entire mitral valve apparatus was 
performed using a VivaCT 40 system (Scanco Medical AG; Brüttisellen, Switzerland).  
The VivaCT 40 was an in vivo small animal live specimen scanner with a 90 mm 
diameter x 500 mm length bore size.  This system provided a max scan field of view of 
38.9 mm diameter x 145 mm length.  At that diameter, 38.9 µm
3
 isotropic voxel 
resolution was achieved.  The system used a single x-ray source and detector, which 
spiraled around a stationary specimen.  To capture a volume, the specimen was secured to 
a mechanical gantry, and linearly translated to expose new sections of volume for 
imaging.    
 The modified left heart simulator was mounted to the µCT gantry using a custom 
fabricated adaptor plate.  The adaptor plate secured to the apical wall of the left ventricle.  
The adaptor did not interfere with the mechanical papillary muscle positioning rods nor 
the left ventricular pressure inlet.   
When applicable, a flexible duct hose was connected to the left ventricular 
pressure inlet, snaked through the custom adaptor plate, and out of the µCT bore through 
an access port.  The distal end of the flexible duct tubing was connected to a continuous 





4.8 Instrument Calibration 
4.8.1 Flow Probe Calibration 
Flow probe calibration was performed regularly using a simple steady flow close circuit.  
The circuit consisted of a centrifugal pump, an in-line electromagnetic flow probe, and 
sink/source reservoir.  The flow output of the pump was controlled by a rotary 
transformer.  Calibration was performed in increments (5 L/min) over a range of flow 
rates: 5 L/min to 30 L/min.  Voltage output from the flow meter was monitored in real 
time using a voltmeter.  At each flow rate, volume collected in a reservoir for specified 
time duration was recorded.  Simultaneously, voltage output from the flow meter was 
recorded.  Calibration was typically repeated three times.  Separate flow calibrations were 
performed for saline and glycerin working fluids.  Flow rates were plotted versus voltage 
output (Figure 4-11); linear regressions were fit to the data. Typical coefficients of 
regressions showed a strong correlation (R
2





Figure 4-11 Representative flow probe calibration. 
4.8.2 Pressure Calibration 
Pressure calibration was performed using a Utah Medical  Delta-Cal system (650-950; 
Utah Medical; Midvale, UT).  The Delta-Cal system is capable of simulating pressure to 
± 350 mmHg.  A range of 0 to 140 mmHg in 15 mmHg increments was used for 
calibration; calibration was repeated three times.  At each pressure value, a voltage output 
was recorded.  Pressures were plotted versus voltage output (Figure 4-12); linear 
regressions were fit to the data.  Typical coefficients of regressions showed a strong 
correlation (R
2
 = 0.98 – 1.0).  
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Figure 4-12 Representative pressure calibration. 
4.8.3 Viscosity Calibration 
Viscosity of the 36 % water glycerin solution was measured using a Cannon-Fenske size 
50 glass viscometer (Dakota Instruments; Monsey, NY).  The water glycerin solution was 
titrated to yield a kinematic viscosity similar to blood (3.5 ± 0.02 cSt).  Viscosity 
measurements were repeated three times.   
4.8.4 Papillary Muscle and Chordal Force Transducer Calibration 
Papillary muscle and chordal force transducers were calibrated using a similar technique: 
known weights were suspended from the transducers and resultant voltage output was 
noted.  The papillary muscle force transducers were affixed at their base using a table 
clamp.  To isolate each directional component of force, the orientation of the affixed 
transducers was changed between calibrations.  To calibrate for pure tension, the known 
load was applied along the central axis of the transducer.  The two out of plane bending 
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directions were calibrated by applying a load perpendicular to the central axis of the 
transducer.  One end of each arm of the c-ring chordal force transducers was suspended 
from a ring stand using 2-0 prolene sutures.  From the other end, loads were 
incrementally applied over a select range.  The papillary muscle force transducers were 
calibrated over of 0.1 to 10 N in the axial direction.  The bending directions were 
calibrated over a range of 0.1 to 5 N.  A lower range was applied in this direction because 
the resultant deformations would otherwise exceed the operating limits of the strain 
gauges.  Similarly, chordal force transducers were calibrated over a range of 0.05 to 5 N.  
This is within the range of expected chordal forces.   
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CHAPTER 5 
EXPERIMENTAL METHODS AND PROTOCOLS 
5.1 Common Experimental Techniques 
5.1.1 Mitral Valves Excision 
Fresh ovine explanted hearts were procured from a local abattoir; ovine hearts are 
structurally and functionally very similar to the human heart [184,185].  The mitral 
valves were sized using standard techniques: Carpentier-Edwards Physio annuloplasty 
ring sizer measured to the ovine mitral anterior leaflet (Figure 5-1).  Size 30 valves were 
selected for the studies herein.  Only valves with Type I or Type II papillary muscles 
were included in the studies.  Other types were difficult to mount to the left heart 
simulator due to their diffuse or multiple head geometry.  Valves were excluded if their 




Figure 5-1 Mitral valve sizing is performed with a C-E Physio annuloplasty ring 
sizer measured to the anterior leaflet. (Image adapted from Carpentier’s 
Reconstructive Valve Surgery) 
 Ovine mitral valves were excised using techniques previously described 
[34,35,39].  In short, an incision was made through the aortic valve and down the left 
anterior descending coronary artery (through the thickness of the myocardium).  This 
exposed the subvalvular apparatus for inspection.  The entire valve apparatus was 
preserved and removed from the left ventricle and stored in 0.9% physiological saline for 
later use.  1-2 mm of supra-annular and 10-15 mm of papillary muscle tissue were 




Figure 5-2 Excised mitral valve apparatus. 
5.1.2 Mitral Valve Preparation  
Excised mitral valves were mounted to the left heart simulator at the annulus and the 
papillary muscles.  The native mitral annulus was sutured to the adjustable mechanical 
annulus in a two-step process.  First, the native annulus was positioned using eight 
interrupted knot sutures carefully placed 1-2 mm above the leaflets’ natural hinge.  These 
were positioned in the following order: 
1. Left fibrous trigone 
2. Right fibrous trigone 
3. Center of the anterior annulus 
4. Posterior annulus at P1 
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5. Posterior annulus at P3 
6. Posterior annulus at P2 
7. Anterior commissure 
8. Posterior commissure 
These locations of the native annulus were sutured to their corresponding location on the 
mechanical adjustable annulus (Figure 5-3).  Care was taken to respect normal annular 
geometrical relationships: (i) intertrigonal distance, (ii) anterior leaflet occupying one 
third of the annular circumference, and (iii) the anterior and posterior commissures 
aligned at the 10 and 2 o’clock positions respectively.  A Ford interlocking stitch was run 
from the left fibrous trigone, clockwise around the mitral annulus to create a tight seal 
between the native annulus and the mechanical adjustable annulus. 
 
 
Figure 5-3 Left: Interrupted knots strategically placed to position the mitral 
annulus.  Right: Continuous Ford interlocking stitch secures the native mitral 
annulus to the silicon annulus. 
 After the annulus was secured, the papillary muscles were wrapped in Dacron 
cloth to prevent tearing.  The cloth covered 3-5 sides of the papillary muscles, only 
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leaving the tips and chordal insertions exposed.  Care was taken to ensure the cloth did 
not interfere with chordal function, i.e., the cloth and sutures were positioned away from 
the chordal insertion sites.  A Teflon connector with 2-56 stainless steel screw was 
sutured to the distal end of each papillary muscle for mounting in the left heart simulator 
(Figure 5-4).       
 
 
Figure 5-4 Mitral valve mounted onto annulus plate. 
5.1.3 Establishing a Control 
 Next, the valve was mounted into the left heart simulator and normal mitral 
annular and papillary muscle configurations were established as described below. The 
tension on the wire drawstring was adjusted such that the mitral annulus achieved its 
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control size; this corresponded to a size 30 Physio annuloplasty ring.  Annulus size was 
confirmed by taking a short axis echocardiography slice along the mitral annular plane.  
The annular area was measured with the ultrasound caliper tool; for control, this was ~ 
4.40 cm
2
.   
 Once the annulus control was established, the papillary muscles were set to their 
normal physiological position, as previously described [35]: 
1. Lateral: The papillary muscles were arranged parallel to each other and with the 
chordal insertion points directly positioned behind their respective commissure.  
The commissural chords should insert perpendicularly to the annular plane. 
2. Septal-lateral: The papillary muscles were moved septal-laterally until an even 
extension of the commissural chords inserting into the annulus was observed.   
3. Apical-basal: The papillary muscles were adjusted apical-basally until a balance 
was observed in chordal tension.  No slack should be observed, and the chords 
should be under minimal tension.   
Minor adjustments were made to the papillary muscles positions under dynamic valvular 
evaluation (70 bpm heart rate, 120 mmHg peak LVP, 5.0 L/min average cardiac output) 
to ensure normal leaflet closing characteristics were observed, mainly: (i) the anterior 
leaflet spanned approximately two-thirds of the mitral orifice, (ii) adequate coaptation 
length (5 – 6 mm) along the central long-axis plane (A2P2), and (iii) minimal tenting 
(height < 1 mm) (Figure 5-5), and (iv) minimal mitral regurgitation (< 10 mL, no 
observable jets).  More detail of how these measurements were taken can be found in 




Figure 5-5 An en-face view of the normal mitral valve closure.  Inlay: Apical-basal 
long axis view of normal mitral valve closure.  (Images adapted from Carpentier’s 
Reconstructive Valve Surgery.) 
5.2 Specific Aim 1 – Accurate Quantification of Mitral Regurgitation 
The objective of this study was to evaluate the accuracy of clinical techniques to quantify 
mitral regurgitation in a pulsatile left heart simulator using native ovine mitral valves.  
Direct flow (Gold Standard) measurements were compared to 2D PISA, Integrative 3D 
PISA, and Philips 3D FOM analyses.  Data were further subdivided based on orifice type 
(round or slit) and mitral regurgitant grade (mild, moderate, or severe) to identify 
problematic patient subsets.   
5.2.1 Experimental Protocol 
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Size 30 native ovine mitral valves were mounted into the left heart simulator with an 
adjustable annulus plate and mechanical papillary muscle positioning rods.  A calibrated 
in-line electromagnetic flow probe was positioned upstream of the mitral valve.  Normal, 
or control, mitral valve function was established using the previously described methods.  
Mitral insufficiency was created by selective adjustment of the mitral annular 
circumference and papillary muscle positioning.  Combinations of mitral annular dilation, 
anterolateral and/or posteromedial papillary muscle displacement were performed as 
necessary to achieve round and slit orifices as determined from direct visual observation 
and high speed imaging (Figure 5-6).  Each experiment (one valve) contained 4-6 
orifices.  Additionally, mild, moderate, and severe mitral regurgitation were targeted (MR 
range: 10 – 70 mL/beat); regurgitation was monitored in real-time.  For a given orifice, 
baseline mitral regurgitation was varied by adjusting peak left ventricular pressure and 
downstream aortic/systemic resistance.  Typically, this was performed to provide 3-4 
regurgitant volumes for a given geometric condition (baseline MR ± 15 mL).  In 
summation, each experiment provided 10-15 analogs of patient data.  This was performed 





Figure 5-6 Left: “Round” regurgitant mitral orifice.  Right: “Slit’ regurgitant mitral 
orifice” 
  0.9% saline (speed of sound: 1502 m/s) was used as the working fluid and blood 
analog.  En face high speed imaging (250 fps) was performed to capture each orifice’s 
geometry.  After high-speed imaging, corn starch (1% by total volume) was added to the 
working fluid as a suspended particulate to enhance color Doppler signal.  An x7-2 TTE 
probe was mounted on a traverse (1 mm linear translation) and positioned onto the basal 
left atrial wall.  The traverse was used to position the apical-basal long axis slice to best 
capture the largest regurgitant radius in the 2D plane (Figure 5-7).  2D, X-plane, and 3D 
tissue and color Doppler echocardiography, as well as continuous wave (CW) were 
acquired for all conditions.  After ultrasound data were acquired, the flow loop was 
drained, and clean saline working fluid was added.  This step was necessary as cornstarch 
the cornstarch mixture was opaque, rendering visual observation impossible.  A new 
orifice was produced and the experimental protocol repeated.      
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Figure 5-7 2D apical-basal long axis echocardiography shows a large regurgitant jet 
and proximal isovelocity surface area. 
 All baseline conditions were performed at 70 bpm heart rate, 120 mmHg peak 
LVP, and 5.0 L/min average cardiac output.  Hemodynamic data acquisition, high-speed 
imaging, and echocardiography were synchronously triggered by a central mock QRS 
signal (TTL wave).   
5.2.2 Data Analysis 
Ten cardiac cycles of direct flow data were ensemble averaged.  Mitral regurgitation was 
quantified by integrating the reverse (negative flow) during the regurgitant portion of the 
cardiac cycle; closing volume was excluded from this measurement (Figure 5-8).  
Closing volume was denoted between the first zero crossing following end diastole and 
the next local maxima.  Regurgitation was quantified by integrating flow this local 




Figure 5-8 A representative mitral flow waveform shows.  Mitral regurgitation is 
calculated by integrating over the late systolic portion of the flow curve. 
 Philips Qlab was used for 2D PISA analysis, which was performed in three main 
steps for a given experimental condition: (i) the PISA shell was identified, and a shell 
radius for a given aliasing velocity was measured, (ii) the velocity time integral (VTI) 
was measured from the CW data, and (iii) regurgitant volume was calculated based on 
PISA assumptions and conservation of mass principle. 
1. The frame with the largest PISA shell is identified in the apical-basal long-axis 
2D color Doppler sequence.   
2. Aliasing velocity is adjusted (typically ~ 40 cm/s) to achieve a clearly delineated 
corresponding thin shell (Figure 5-9). 
3. The radius of the aliasing velocity shell is measured. 
4. The velocity time integral is measured from the corresponding continuous wave 
(CW) echocardiography data (Figure 5-10). 
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EROA = Effective Regurgitant Orifice Area 
MRVOL = Mitral Regurgitant Volume 
r = PISA Shell Radius for Selected Valias 
Valias = Aliasing Velocity 
Vmax = Maximum Velocity 
VTI = Velocity Time Integral 
 
 
Figure 5-9 PISA radius and Valias are determined. 
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Figure 5-10 Vmax and VTI are measured from continuous wave echocardiography. 
A second analysis technique was performed to improve on the 2D PISA method.  In 
this integrative 3D PISA method, the assumption of a hemispherical regurgitant proximal 
isovelocity surface area was not used.  The actual isovelocity surface area was manually 
traced in several slices to reconstruct the true geometry.  This was performed through the 
following steps: 
1. The frame with the largest PISA shell is identified in the apical-basal long axis 2D 
color Doppler sequence.   
2. Aliasing velocity was adjusted to achieve a clearly delineated corresponding thin 
shell. 
3. Using the “ginput( )” MATLAB function, points along the PISA shell were 
manually selected in the apical basal long axis slice (Figure 5-11 and 5-12). 
4. Step 3 was repeated until the entire regurgitant jet was segmented (3 mm slice 
spacing, approximately 9 slices). 
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5. Point clouds were calibrated using lines of known distances drawn in Qlab using 
the caliper tool (0.217 mm/pixel). 
6. Point clouds were imported into Geomagic Studio, where a triangulated surface 
mesh was fit to the data (Figure 5-12).   
7. Erroneous facets were removed, and any holes in the mesh were filled.  Light 
smoothing was applied to remove sharp peaks. 
8. Surface area was computed using built in tools. 
9. Regurgitant volume was calculated using equations 1 and 2 above.  2πr2 was 
replaced with the true area measured in step 8.   
       
Figure 5-11 Representative long (left) and short (right) axis slices of the regurgitant 
jet.  The short axis slice was used to position the long-axis slices, from which the 




Figure 5-12 Points along the PISA for a given aliasing velocity were manually 
selected. A surface mesh was fit to the resulting point cloud using Geomagic Studio.  
Total surface of the mesh was computed to provide the effective regurgitant area.  
A third analysis technique was performed using Philips Qflow software to quantify 
mitral regurgitation through the 3D Field Optimization Method (FOM).  The FOM was 
limited to the portion of the cardiac cycle where a distinct PISA shell was observed 
(typically 4-5 frames).  The analysis was initiated in the frame where the PISA shell was 
largest.  The four quadrant view was optimized to best display the regurgitant jet.  The 
“Flow Only” setting was applied (Figure 5-13).  The regurgitant orifice origin was 
selected and the regurgitant volume was calculated using the automated FOM method.  
To better identify the regurgitant orifice, the color data could be turned off, using the 
“color suppress” toggle.  A second analysis was performed using the “Flow Only” setting 
with the “Enable Adjust Orifice and Flow Band” setting.  A final analysis was performed 
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using the “Flow + Z” setting with the “Enable Adjust Orifice and Flow Band” enabled.  
More detail on the different preferences is found in Chapter 6.   
 
 
Figure 5-13 Screen capture of the QFlow preferences.  “Flow” and “Flow + Z” 
analysis were performed with and without the “Enable Adjust Orifice and Flow 
Band” options.    
Intra-user variability was assessed for both 2D PISA and 3D FOM.  A single expert 
user trained with a subset of data to refine their technique.  User was blinded to true 
regurgitant volumes to avoid measurement bias.  Measurements were repeated five times.   
Mitral regurgitation quantified from 2D PISA, 3D PISA, and 3D FOM were plotted 
against direct flow measurements.  Linear regressions were fit to the data. A 1:1 
agreement line was overlaid on the data.  Data were grouped with all possible 
combinations of orifice type and MR grade.     
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5.3 Specific Aim 2 – Evaluating the Efficacy of Surgical Repair for Ischemic Mitral 
Regurgitation 
5.3.1 Papillary Muscle Relocation 
The objective of this study was to evaluate the efficacy of basal papillary muscle 
relocation as a targeted surgical therapy for ischemic mitral regurgitation.  The study 
intended to elucidate two key sources of procedural ambiguity: (i) what location of the 
mitral annulus is best for traction suture placement, and (ii) by how much does a papillary 
muscle need to be relocated to restore normal valvular function 
5.3.1.2 Experimental Protocol 
The experimental protocol was performed in five main steps: 
1. Control 
2. Acute Myocardial Infarction (MI) - ischemic mitral valve dysfunction 
3. Mitral Annuloplasty (Acute MI with MA) 
4. Progression of mitral valve dysfunction (Chronic MI with MA) 
5. Basal papillary muscle relocation with true sized mitral annuloplasty 
The control condition was established as previously described.  For all conditions, the left 
heart simulator was tune to 70 bpm, 120 mmHg peak left ventricular pressure, and 5.0 
L/min average cardiac output.  Ischemic mitral valve dysfunction was simulated with 
combined mitral annular dilation and papillary muscle displacement to achieve 
Carpentier type IIIb restricted leaflet motion.  The mitral annulus was dilated to 180% of 
its normal area.  The papillary muscles were symmetrically displaced 5 mm in the apical, 
posterior, and lateral directions.   This was the acute myocardial infarction (Acute MI) 
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condition.  Next, annuloplasty repair was simulated by returning the annulus back to its 
normal size, while the papillary muscles remained displaced (Acute MI with MA).  
Subsequently, further left ventricular dilation post mitral annuloplasty was simulated by 
displacing the papillary muscles an additional 3 mm in the posterior and lateral directions 
(Chronic MI with MA).  The papillary muscles were displaced to mimic the effect of 
progressive left ventricular geometric changes on the mitral leaflets following surgical 
repair [44,45,47,180]. 
 Papillary muscle relocation was performed as an adjunct to mitral annuloplasty to 
relieve mitral leaflet tethering.  The papillary muscles were relocated toward either the 
ipsilateral commissure or trigone, representing two variants of possible annular suture 
anchors (Figure 5-14).  Four targeted repair strategies were performed in conjunction 
with the simulated true-sized mitral annuloplasty: (i) both PMs were relocated toward 
their respective commissures, (ii) both PMs were relocated toward their respective 
trigones, (iii) the posteromedial PM was relocated toward its ipsilateral commissure, and 
(iv) the posteromedial PM was relocated toward its ipsilateral trigone.  Repairs were 
performed in 2 mm increments.  Mathematical unit vectors were calculated from the 
chronic MI papillary muscle positions to each annular anchor (see Appendix for further 
details) (Figure 5-15).  These vectors were resolved into their apical, posterior, and lateral 
components to define the corrective displacements for each targeted repair.  After each 
repair, the papillary muscles were returned to their pathological (progressive left 




Figure 5-14 Annular landmarks depict targets for traction suture.  Highlighted in 
red is the pathologically displaced posteriormedial papillary muscle. 
 109 
 
Figure 5-15 Basal papillary muscle relocation was performed in 2 mm increments to 
either the trigone (blue vector) or the commissure (red vector).  Pathological 
papillary muscle displacement was performed in the apical (black dashed vector), 
lateral (purple dashed vector), and the posterior (green dashed vector) directions.   
5.3.1.3 Data Analysis 
 For all conditions, three-dimensional (full volume tissue Doppler) 
echocardiography was performed; .DICOMs were evaluated offline using Philips Qlab 
software.  Clinical metrics of valvular function were analyzed at all three lines of 
coaptation, A1-P1, A2-P2, and A3-P3 (Figure 5-16).  Coaptation length (CL) was 
measured as the distance from the point of coaptation to the leaflets’ free edge.  Tenting 
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area (TA) was measured as the area entrained between the annular plane and the leaflets’ 
surfaces (Figure 5-17).   
 
 
Figure 5-16 Three lines of coaptation are shown: A1-P1, A2-P2, and A3-P3. 
 111 
 
Figure 5-17 Coaptation height and tenting area are depicted. 
 
 Statistical analysis was completed using Minitab 16 (Minitab Inc.; State College, 
PA) and data were expressed as the mean ± 1 standard deviation.  An Anderson Darling 
test was performed to assess data normality, and an F test was used to check for equality 
of variances.  Each valve served as its own control, that is, echocardiographic 
measurements (CL and TA) of disease and repaired conditions were compared with those 
made on the same valve for a given experimental sequence.  Thus, a repeated measures 
analysis of variances (ANOVA) was used as the samples were not independent.   
 If a significance of differences was present (p < 0.05), a Dunnet’s post hoc 
analysis was used to assess which experimental groups had CL or TA that varied from 
the control condition.  A Tukey’s post hoc test was used to assess differences in CL and 
TA within experimental groups.   
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 Leaflet geometric variables (CL and TA) were plotted as a response to PM 
distances.  Measured variables were normalized by anterior leaflet height to remove the 
influence of valve size.  A linear regression was used to determine the relationship 
between PM distance and closed leaflet geometry; the characteristic equations and fit 
(coefficient of determination, R
2
) were recorded.   
5.3.2 Anterior Leaflet Augmentation 
The objective of this study was to investigate the efficacy of anterior leaflet augmentation 
as a viable surgical therapy for ischemic mitral regurgitation.  Treatment efficacy was 
assessed using an integrative approach that combined: (i) clinical measurements of valve 
function, (ii) direct flow measurements of valve regurgitation, and (iii) chordal force 
measurements of leaflet tethering.  Leaflet augmentation was compared against the 
current surgical gold standard treatment for ischemic mitral regurgitation, undersized or 
restrictive mitral annuloplasty.  Surgical treatment was randomized to either a moderate 
or large size pericardial augmentation.   
5.3.2.1 Experimental Protocol 
This study involved the use of miniature chordal force transducers to capture the dynamic 
tension on four main chordae throughout the cardiac cycle: (i) anterior leaflet strut 
chordae from the anterolateral papillary muscle, (ii) anterior leaflet strut chordae from the 
posteromedial papillary muscle, (iii) posterior leaflet strut chordae from the anterolateral 
papillary muscle, and (iv) the posterior leaflet strut chordae from the posteromedial 
papillary muscle.  These chordae were chosen as they are the main load bearing chordae 
for each leaflet [187,188].   
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 Prior to each experiment, miniature force transducers were sutured to each of 
these selected chordae, without altering the chordae’s native length.  The section of 
chordae that passed between the measurements arms of the transducer was bisected to 
transfer chordal load into the transducer.  The voltage output of the transducers was 
zeroed before the start of each experimental condition (0 mmHg of transmitral pressure).           
The experimental protocol was performed in 4 main steps (Figure 5-18): 
1. Control 
2. Ischemic mitral regurgitation 
3. Undersized, or restrictive, mitral annuloplasty 
4. Leaflet augmentation 
 
 
Figure 5-18 Annular sizes and pm positions for repair protocol.  Repairs were 
randomized to either small or large patch treatments 
The control condition was established as previously described in section 5.1.2.  Ischemic 
mitral regurgitation was simulated with asymmetric annular dilation and papillary muscle 
displacement, representative of an inferior myocardial infarction.  Specifically, the mitral 
annulus was dilated to 150% of the control valve area (7.22 cm
2
).  The antero-lateral 
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papillary muscle was displaced 3 mm apically and 2 mm anteriorly, while the postero-
medial papillary muscle was displaced 4 mm apically, 4 mm posteriorly, and 8 mm 
laterally.  These changes were consistent with data previously measured in chronic 
ischemic mitral regurgitation studies [13,190,191].   
 Following IMR, undersized mitral annuloplasty was performed; the valve was 
downsized from a size 30 to a size 26 (C-E Physio).  Next, anterior leaflet augmentation 
was performed using a pericardial patch (Bovine, 0.5% in Gluteraldehyde).  
Augmentation repair was randomized to either a moderately sized (major ϕ x minor ϕ: 
1.77 x 0.65 cm) or large (major ϕ x minor ϕ: 2.68 x 1.07 cm) pericardial patch (Figure 5-
19).  An incision was made in the anterior leaflet parallel to and 1 - 2 mm from the 
anterior mitral annulus.  For the large augmentation procedure, the incision was made 
from commissure to commissure.  For the moderate augmentation, the incisions stopped 
short of either commissure by ~ 4- 5 mm.  The pericardial patch was positioned in place 
with 4 interrupted knots in the 3, 6, 9, and 12 o’clock positions.  A running mattress 
suture was used to secure the pericardium to the leaflet and create a leak free seal.  For 
each augmentation procedure, the mitral annulus was stepped through three mitral 
annuloplasty ring sizes (undersized 26, true-sized 30, and over-sized 34), in addition to 
the 150% mitral annular dilation from the IMR condition. 
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Figure 5-19 Atrial (left) and ventricular (right) views of an anterior leaflet 
augmented with a pericardial patch.  Two chordal force transducers can be seen 
attached to the anterior strut chordae.   
5.3.2.2 Data Analysis 
All hemodynamic and force data were ensemble averaged over 10 cardiac cycles.  Mitral 
regurgitation was quantified by integrating the negative (or reverse) flow over the systolic 
portion of the cardiac cycle.  The presence of MR was confirmed with Doppler 
echocardiography.  Qlab was used to quantify mitral valve leaflet coaptation as the 
distance from the point of coaptation to the leaflets’ free edge.  Chordal forces were 
measured as the difference between peak systolic and diastolic force.  Due to inherent 
drift of the transducers, absolute forces were not reported. 
 A two-way repeated measures analysis of variance (ANOVA) was used to assess 
the effects of experimental condition (Control, IMR, Repair) and patch size (moderate, 
large).  A general linear model was performed using Minitab 16.  Significance was 
determined at a 95% confidence interval (p < 0.05).  A Tukey post hoc test was used to 
determine between group significant differences.  All data were reported as mean ± 1 
standard deviation.   
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5.4 Specific Aim 3 – Developing an Experimental Database to Advance Mitral Valve 
Surgical Planning Tools 
The objective of this study was to develop an experimental workflow and potential 
database to help advance mitral valve surgical planning computational models.  For each 
experiment, multiple complimentary techniques were performed:  
5. Mitral valvular geometry was provided from: (i) state of the art micro-computed 
tomography, and (ii) clinical standard of care echocardiography 
6. Geometric and hemodynamic boundary conditions were carefully defined 
7. Stereoscopic particle image velocimetry captured native mitral flow fields 
8. Valvular mechanics (leaflet strain, and papillary muscle force) were quantified  
5.4.1 Experimental Protocol 
The work of this aim was performed in the new, modified left heart simulator.  A native 
ovine mitral valve was mounted to the left heart simulator and a control was established 
as previously described.  For all conditions, the left heart simulator was tuned to 70 bpm 
heart rate, 120 mmHg peak left ventricular pressure, and 5.0 L/min average cardiac 
output.   
5.3.1.1 Hemodynamic Boundary Conditions   
Hemodynamic boundary conditions were acquired using in-line electromagnetic flow 
probes positioned upstream of the left atrium, downstream of the bladder pump (upstream 
of the left ventricular inlet), and downstream of the aortic valve.  Pressure transducers 
were mounted to the left atrium, left ventricle, and the aortic outlet.   
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5.4.1.2 Clinical Imaging and Biomechanical Evaluation 
Full volume tissue and color Doppler echocardiography was performed using an x7-2 
TTE probe and a Philips iE33 ultrasound system.  Images were acquired over 5 cardiac 
cycles at ~ 20 Hz.  Papillary muscles forces were acquired over ten cardiac cycles.  
Baseline forces (axial, two directions of out of plane bending) were zeroed before 
pulsatile pressures were applied to the left heart simulator.  Forces were acquired over 10 
cardiac cycles.  More detail on papillary muscle force transducers and acquisition system 
can be found here [2,192].  Dual camera stereo-photogrammetry was performed to 
acquire leaflet dynamics throughout the cardiac cycle.  Tissue marker dye was applied to 
the atrialis of the anterior and posterior leaflets in a 2 mm array.  These markers were 
tracked and digitized throughout the cardiac cycle using custom MatLab scripts.  The 
pixel coordinates of each marker from the two cameras were transformed using a Direct 
Linear Transformation into 3D Cartesian space.  A 10 mm cube imaged from each 
camera was used for the calibration function.  Anterior and posterior leaflet strain were 
calculated from the marker deformation using techniques described here 
[36,118,120,193,194].   
5.4.1.3 Micro-computed Tomography 
Following clinical imaging and biomechanical evaluation, the modified left heart 
simulator was adapted for micro-computed tomography.  The mitral annulus and 
papillary muscle positions were unperturbed from their experimental configuration.  The 
left atrium and out flow tract with aortic valve housing were removed.  The aortic outlet 
was sealed with a flush mounted acrylic plate and rubber gasket.  The atrial side of the 
annulus plate was exposed to atmosphere.  All pressure transducers were removed and 
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ports sealed with flush mounted nylon set screws.  An adaptor plate was mounted to the 
apical wall of the left ventricle to secure the left heart for micro-computed tomography 
gantry.  Humidity was maintained in the left heart by a wet sponge.    
 Scanning parameters were optimized to image the mitral valve (low density soft 
tissue) in air; a control file (no. 204) was created and saved for future acquisitions (See 
Appendix for more detail).  The key parameters were: 55 keV energy, 109 µA intensity, 
and 300 ms integration time.  The field of view was set to its maximum diameter, 38.9 
mm, which resulted in 38.9 µm isotropic voxel resolution.  Typically, 600 – 1000 image 
slices were acquired in 30 – 40 min.  A Scout-View was performed to ensure the valve 
was properly positioned within the field of view.  Axial scanning boundaries were set to 
~ 1-2 mm supra-annularly and ~1-2 mm distal to the papillary muscles.  Inclusion of 
these additional geometric features was used to register the mitral valve to the surface 
mesh of the left heart simulator.   
 Two scans were typically performed to capture: (i) diastolic or open configuration 
of the mitral valve geometry, and (ii) systolic or closed configuration.  The first scanned 
was performed under ambient pressure, and ~ 0 mmHg of transmitral pressure.  
Following the first scan, a continuous compressed air pump was connected to the left 
ventricular inlet using a flexible duct hose, which was snaked through the adapter plate 
and out of the micro-computed tomography system via an access port.  The left ventricle 
was pressurized to ~ 30 mmHg; the atrial side of the valve remained exposed to ambient 
pressure.  Higher pressure could not be obtained with the continuous air pump used.  The 
scan was repeated with identical parameters.    
5.4.1.2.1 Paraformaldehyde Pressure Fixation 
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 As an alternative to pressurizing the left ventricle with a compressed air pump, the 
valve was pressure fixed using para-formaldehyde (PFA) treatment.  A 4 % PFA fixative 
was prepared ahead of time using the manufacturer’s suggested protocol (Biocare 
Medical; Concord, CA) (See Appendix for protocol detail).  Fixative was prepared fresh 
and used within two weeks (stored at 4° C). 
 Valves were fixed under static left ventricular pressure (~ 70 mmHg) to provide a 
closed configuration valve.  Pressure was dictated by maximum allowable height inside 
of a fume hood.  Static left ventricular pressure was maintained using a peristaltic pump 
(Masterflex Model # 7518-10; Cole-Parmer; East Bunker Court Vernon Hills, IL) and 
speed controller.  Speed was set to offset any leakage such that a static PFA pressure 
head was maintained.  Fixation took place overnight for ~ 10 - 12 hrs.  Valves were 
subsequently scanned in air using parameters previously described.  PFA fixation was 
performed as the terminal experimental step. 
5.4.1.2.2 Phosphotungstic Acid Contrast Enhancement 
X-ray contrast was enhanced using phosphotungstic acid (PTA).  Fresh 1% PTA solution 
was prepared using a previously outlined protocol [195] (see Appendix for protocol 
detail).  The valve was submerged in PTA solution overnight (~ 10 – 12 hrs) at 4° C.  
Valves were subsequently scanned in air as previously described. 
5.4.1.4 Stereoscopic Particle Image Velocimetry 
Stereoscopic particle image velocimetry was performed to capture flow fields through 
and proximal to the mitral valve.  The laser plane was initially set to bisect the mitral 
valve in the central apical-basal long axis slice.   Cameras were positioned equidistant on 
either side of the ventricular chamber.  Using the Schiempflug adapters, the cameras were 
 120 
angled (~ 30°) to increase optical access to the mitral flow field (avoiding the bulk of 
chordae tendinae) (Figure 5-20).      
 Data were acquired at room temperature for adult pulsatile hemodynamic 
conditions.  50 phase locked image pairs were acquired every 25 ms in the cardiac cycle 
(Figure 5-21).  The time difference (dt: 200-1000 µs) between image pairs was optimized 
for each sampled point in the cardiac cycle to capture high fidelity velocity vectors (target 
particle displacement: 5-8 pixels, or 25% of the size of the interrogation window) (Table 
5-1).  4 flow field planes were acquired in the ventricle.  The planes were spaced by 4, 8, 
and 15 mm from the central plane using the traverse.  One central plane was used in the 
left atrium.  Each plane was independently calibrated.  Calibration was performed using a 
three-dimensional two-level target positioned in the laser plane and imaged from both 
cameras.  A 3
rd
 order polynomial fit of the calibration points was utilized, which corrects 
for the velocity vectors based on the distortion observed with the calibration target.   
 
 





Figure 5-21 Representative mitral flow curve depicting time points sampled for 
particle image velocimetry. 
Table 5-1 Time difference between image pairs for various segments of the cardiac 
cycle.  
Mitral Valve State dt (µs) Flow State 
Opening 200 - 300 
Highest velocity flow 
through mitral valve 
Open 300 - 400 
Continued high velocity 
flow through mitral valve 
Closing 1000 
Low magnitude reverse 
flow 
Closed 400 - 500 





5.4.1.5 Geometric Boundary Conditions 
The geometry of the left heart simulator was modeled using SolidWorks computer aided 
design (CAD).  As a geometric boundary condition, only the surfaces that contacted the 
blood analog were modeled.  In essence, a “negative” of the left heart assembly was 
created as one solid part (Figure 5-22).  The SolidWorks part was exported as a stereo-
lithography (.STL) model for further manipulation; specifically, a surface mesh could be 
applied and optimized for computational implementation.  Additionally, inlets and outlets 
can be extended to promote fully developed for computational model stability.   
 
 





5.4.2 Data Analysis 
5.4.2.1 Geometric Reconstruction from Micro-computed Tomography 
The image data were reconstructed using multiple complimentary techniques.    A 
Gaussian filter (σ = 1.2, support = 2) was applied to improve signal to noise and edge 
enhancement.  Slice by slice user initialized contouring was performed to define the valve 
anatomy to be included in image segmentation (Figure 5-23).  Area(s) for inclusion was 
manually traced in every 40-60 slices.  A dynamic morphing algorithm interpolated the 
area(s) between slices.  The raw gray scale images were filtered and converted to binary 
images using upper and lower bound thresholds [196].  Thresholds were manually 
identified via the histogram composition of intensities and adjusted based on empirical 
observation.  An in-house MATLAB script was used to segment mitral valve anatomy 
through canny edge detection; this produced a point cloud of the valve surface.  
Geomagic Studio (company information) was used to mesh, smooth, and visualize 
resultant mitral valve geometry.  The mitral valve geometry was also registered to the 
surface mesh of the left heart using overlapping segments.  Boolean addition was used to 




Figure 5-23 Micro-CT segmentation protocol is outlined. 
5.4.2.2 Geometric Reconstruction from Echocardiography 
A validated in-house MATLAB script was used to extract the mitral leaflet geometry 
[197].  J-splines were used for semi-automatic segmentation of the posterior and anterior 
mitral leaflets during peaks systole.  15-20 long axis apical-basal slices across a valve 
were used for segmentation (slice thickness ~ 2.8 mm).  Data were interpolated using an 
algorithm which was based on the weighted positions of the surrounding points (Butterfly 
mesh refinement) [198].  Leaflet geometry was post-processed in GeoMagic Studio and 
visualized in TecPlot.         
5.4.2.3 Velocity Field Reconstruction 
After raw image pairs were acquired, a background intensity subtraction was performed 
to enhance image contrast.  Next, individual image masks were created for each time 
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point in the cardiac cycle.  A mask was created from representative images from each 
camera (for a given time point) (Figure 5-23).  A single mask was created by manually 
superimposing one masked image onto its corresponding pair.  This ensured velocity 
vectors were only calculated in regions where flow was visible from both cameras.   A 3
rd
 
order polynomial mapping function was performed in DaVis 7.2, which also corrected for 
image distortion [199].  Particle cross-correlation was performed on the calibrated 
masked images using multi-pass interrogation with decreasing window size (64 x 64 to 
32 x 32 pixels).  Erroneous vectors were rejected based on signal to noise ratio and a 
median filter which detected outliers.  Resultant vector fields were ensemble averaged 
and three-dimensional velocity fields across the cardiac cycle were obtained.  Vorticity 
(ωz) was calculated as the curl of the velocity vectors: 
 





Figure 5-23 Mask creation for PIV data processing was performed in the following 
steps: a mask was created (A) and applied (B) to the image in Camera 1; mask from 
Camera 1 was overlaid (C) and applied (D) to image from Camera 2; an additional 
mask was created for Camera 2 (E), and velocity vectors were calculated for 









SPECIFIC AIM 1: IN-VITRO VALIDATION OF THE PHILIPS 3D 
FIELD OPTIMIZATION METHOD 
6.1 Introduction 
Quantitative assessment of mitral regurgitation can help remove the uncertainty 
associated with characterizing mitral valve disease and improve on the current qualitative 
methods outlined by the ACC/AHA guidelines [24].  However, these quantitative 
methods have met clinical resistance challenging their accuracy [18,164-166].  The most 
common of these methods is the 2D color Doppler Proximal Isovelocity Surface Area 
(PISA) measurement.  Proximal isovelocity surface area is derived from the principle of 
conservation of mass: as blood approaches a regurgitant orifice, its velocity increases, 
forming concentric shells of increasing velocity and decreasing surface area [18,167].  
This surface area can be estimated during 2D color Doppler echocardiography assuming 
a hemispheric distribution of velocity vectors proximal to the regurgitant orifice.  
Unfortunately, this 2D PISA is saddled with limitations.   
The source (left ventricle) and sink (left atrium) chambers need to be sufficiently 
large to develop hemispherical axisymmetric flow convergence.  Controlled in-vitro 
experiments using a flail regurgitant mitral valve model demonstrated that proximity to 
the left ventricular wall will elongation of the shape of the isovelocity contours and cause 
overestimation of the regurgitant flow [200,201].   
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A second limitation is due to the variable shape of the regurgitant orifice and the 
non-planarity of the opposing mitral leaflets.  Hemispherical axisymmetric flow 
convergence requires single point source, which is rarely observed in clinical practice.  In 
vivo, in-vitro and in-silico studies have shown that with elongated or c-slit orifices this 
the hemispherical assumption of the flow convergence is violated and regurgitant flows 
are underestimated [164-167,202,203].  Levine et al. were the first to suggest that a 
correction factor is needed to account for leaflet non-planarity [204].  This was later 
confirmed by studies by Yamachika et al[205] and Cape et al [206], which showed 
regurgitant volume was underestimated when leaflets came together in an angle greater 
than 180 degrees.  Flow was overestimated when the leaflets came together in an angle 
less than 180 degrees.    
A final limitation, which may cause overestimation of flow is a result of 
proximity of the regurgitant flow to the outflow tract.  It is assumed that the flow 
observed proximal to the mitral orifice is directed through the insufficient mitral valve 
into the left atrium (continuity principle).  However, a combined computational and in-
vitro study found that isosurfaces at larger radii may be effected by neighboring aortic 
outflow, causing their distortion and elongation [202,203].  In that same series of study, it 
was demonstrated that, a correction for this and the previous limitations could be made 
by approximating the shape of the isosurfaces as hemi-elliptical.  A novel hemi-elliptical 
curve-fitting algorithm [207] was used to accurately quantify mitral regurgitation through 
two standard orthogonal 2D color Doppler views.             
This has led to recent improvements of the 2D methodology, which aim to 
identify the true geometry of the regurgitant isosurfaces for more accurate quantification 
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[164-167]; one such technique is the Philips 3D Field Optimization Method (FOM).  The 
Field Optimization Method utilizes a complex algorithm to correctly identify the 
proximal isosurface volume over which it integrates all the flow convergence velocities 
to calculate true mitral regurgitant volume.  Unlike other 3D PISA methods, the FOM is 
the first to correct for the Doppler angle effect, which may cause the observed magnitude 
of velocities, particularly along the lateral shoulders of the regurgitant zone, to be 
underestimated by as much as 40% [18].  However, this and other quantitative 
measurements still need rigorous validation to ensure their clinical accuracy.   
To this end, in this thesis, a regurgitant mitral valve model was developed for 
which multiple regurgitant orifices and flow rates were simulated.  Transmitral flow was 
measured directly upstream of the left atrium using an electromagnetic flow probe 
sampled at 1kHz, as a true gold standard.  Regurgitant volume was measured using three 
echocardiography methods: (i) 2D PISA, (ii) 3D FOM, and (iii) an Integrative 3D PISA.  
The algorithm of the 3D FOM was iterated three times based on empirical insights.     
6.2 Results  
6.2.1 Mitral Regurgitation Model 
Mitral regurgitation was created using isolated and combined annular dilation and 
papillary muscle displacements.  Mitral regurgitation was created empirically under 
pulsatile conditions through live monitoring of the hemodynamics and direct visual 
observation of the systolic mitral closure.  In total, 42 regurgitant orifices were created 
yielding 18 round orifices and 24 slit orifices.  Orifice shape was binned into round and 
slit based on en face high speed imaging of mitral leaflets during systole and the shape of 
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the PISA shell through echocardiography (Figure 6-1).  PISA shell shape was determined 
in the C-plane 1-3 mm sub-annularly.  Mitral regurgitation per beat ranged from 13.8 mL 
to 71.2 mL (median: 37.9 mL) (Figure 6-2).  Similarly, mitral regurgitation was graded 
into mild, moderate, and severe based on direct flow measurements acquired with the 
electromagnetic flow probe (Table 6-1).  Grades were determined in accordance with 
guidelines on valvular disease [24].   
 
 
Figure 6-1 Representative images of round (Left) and slit (Right) regurgitant 
orifices.  Inlays shows corresponding C-plane echocardiography of proximal 




Figure 6-2 Scatter plot of mitral regurgitation shows a range of volumes from 10 to 
70 mL. 








Mild 15 (35.7) < 30 
Moderate 21 (50) 30 – 59 
Severe 6 (14.3) > 60 
  
6.1.2 2D PISA Analysis 
2D PISA analysis was performed as it is the currently used quantitative clinical 
measurement.  2D PISA analysis was performed on all data sets with corresponding 
Continuous Wave Doppler echocardiography (N = 30).  CW data was not available for all 
42 data sets acquired.  For each condition, the CW data analysis was repeated 5 times and 
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averaged to measure maximum velocity (Vmax) and the velocity time integral (VTI).  
Similarly, the 2D PISA radius measurement was repeated five times and averaged from 
the 2D Color Doppler images.  For each independent observation (N = 5), 15 cardiac 
cycles were available for analysis.  Subsequently, mitral regurgitation was calculated as 
described above (Chapter 5.2.2).  The intra-observer variability was captured using the 
coefficient of variation, which is the non-dimensional ratio of the standard deviation to 
the mean.  The average standard deviation between regurgitant volume measurements 
was relatively large (9.1 mL), and the coefficient of variation was 0.26 (a value less than 
0.05 is desirable).   
Regurgitant volume calculated from 2D PISA was plotted against regurgitant 
volume measured through direct flow analysis (Flow Probe Gold Standard) (Figure 6-3).  
2D PISA analysis underestimated mitral regurgitation over all data sets, regardless of 
leakage severity and orifice type.  On average, 2D PISA underestimated true 
regurgitation by 9.8 mL ± 9.3 mL; however this was not statistically significant (p = 
0.014).  A measurement bias of -5.84 (underestimation) was calculated using Bland-






Figure 6-3 Mitral regurgitation volume quantified through 2D PISA underestimated 
true mitral regurgitation.  Dashed line represents 1:1. 
 
Figure 6-4 Mitral regurgitation volume quantified through 2D PISA underestimated 
true mitral regurgitation.  Dashed lines show mean ± 2 standard deviations. 
Data were further analyzed by orifice type as it was expected that 2D PISA 
analysis would be accurate for round orifices, but otherwise inaccurate (systematic 
underestimation) for slit orifices (Figure 6-5).  For the round orifice, the average error by 
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2D PISA analysis was reduced to 2.7 ± 2.3 mL; regurgitant volume measured by both 
techniques was not significantly different (p = 0.668).  Similarly, the measurement bias 
was reduced to 0.63 mL.  However, for the slit orifice, systematic underestimation was 
observed, and the measurement bias was -7.81 mL.  The average error was 12.0 ± 9.6 
mL; this was nearly statistically significant and is clinically impactful.  These results 
confirm that the hemispherical assumption of the 2D PISA analysis was violated for the 
slit orifices.  Mitral regurgitation was underestimated for 69.6% percent of the slit orifice 
data (N  = 16/23).  Intra-observer repeatability was equally poor for both orifice 
conditions (coefficient of variation: round 0.27; slit 0.25).     
 
 
Figure 6-5 Data were grouped for round and slit orifice.  2D PISA was accurate for 
the round data, but systematically underestimated regurgitant volume for the slit 
orifice data.   
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Average error was further subdivided by regurgitation severity (Table 6-2).  
Average error for the round orifice types remained low (< 5 mL) for mild and moderate 
grades.  No data were available for severe regurgitant through a round orifice.  Average 
error for the slit orifice increased with regurgitation severity.    
 





Total Round Slit 
Mild 6.1 ± 4.8 4.8 ± 2.1 3.4 ± 6.0 
Moderate 10.9 ± 9.1 3.1 ± 1.7 12.8 ± 9.1 
Severe 14.1 ± 13.5 -- 14.1 ± 13.5 
Total 9.8 ± 9.3 2.3 ± 2.3 12.0 ± 9.6 
 
 
Misdiagnosis incidence was reported as the frequency of erroneous regurgitation 
grading by 2D PISA (Table 6-3).  Hard cutoffs were applied to regurgitation grades as 
measured through the direct flow gold standard.  In total, there were 10 events of 
misdiagnosis; the majority of these were underestimation of regurgitation severity (N = 7, 
70% of total misdiagnosis).  The most frequent misdiagnoses were in the moderate mitral 
regurgitation grade.  As these techniques aim to move away from qualitative guidelines, 
it may be better to bin the data by their percent error from truth (Figure 6-6).  60 percent 
of the 2D PISA analysis resulted in less than 10% error from truth.  The largest errors 
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were all a result of the slit conditions; this can be noticed in the histogram distributions.  
The round orifice data have a tight clustering for low errors, whereas the data are more 
equally distributed for the slit orifices. 
 





Mild 2 (↑) 
Moderate 1 (↑) 6(↓) 
Severe 1(↓) 





Figure 6-6 Histogram distribution of percent errors were grouped for round and slit 
orifice data.   
6.2.3 Philips 3D Field Optimization Method 
Three iterations of the 3D FOM were assessed.  In the first iteration, velocities in the flow 
convergence zone were integrated over fixed, pre-defined radii across all conditions and 
frames in the cardiac cycle.  In the second and third iteration, the radii of velocity 
integration were actively adjusted by the automated algorithm for each frame of the 
cardiac cycle, as well as, for each regurgitant condition.  In addition to adaptively 
adjusting the radii for velocity integration, in the third iteration, the z-height of a 
regurgitant orifice was actively adjusted from frame to frame.  For all three iterations, 3D 
FOM was performed on all data sets (N = 42).  For each condition, 3D FOM was 
repeated 5 times.   
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6.2.3.1 Iteration 1: Fixed Radii of Velocity Integration 
The average standard deviation between measurements was a robust 1.4 mL.  The 
coefficient of variability was an acceptable (0.06).  The average error, however, was a 
relatively large 12.6 ± 13.3 mL; the difference between measured values and truth were 
statistically significant (p < 0.005).  On average, 3D FOM underestimated true 
regurgitant volume, and a -9.4 mL measurement bias was observed.  As identified in the 
scatter (Figure 6-7) and Bland Altman (Figure 6-8) plots, the errors were largest for 
regurgitant volumes greater than 30 mL per beat, which were typically associated with 
the slit offices.  Therefore, the data were further grouped by round and slit orifice.   
 
 
Figure 6-7 Mitral regurgitation volume quantified through 3D FOM 
underestimated true mitral regurgitation.  Dashed line represents 1:1. 
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Figure 6-8 Mitral regurgitation volume quantified through 3D FOM 
underestimated true mitral regurgitation.  Dashed lines show mean ± 2 standard 
deviations 
Three data points were identified as outliers (red points on scatter plot in Figure 6-
9).  The error associated with these three points (17.3, 35.5, and 47.0 mL) was greater 
than 1.5 times the interquartile range (4.3) added to the third quartile (5.91); outlier cut 
off value was 13.6 mL.  Error was defined as the regurgitant volume difference between 
direct flow measurement and 3D FOM calculation.  Each of the three data points 
originated from the same mitral orifice condition.  These points were excluded from 





iteration of the 3D FOM.  3D FOM accurately measured regurgitant volume for the round 
orifices (average error: 2.6 ± 1.9 mL) (Figure 6-9); the difference between measured 
values and truth were not statistically significant (p = 0.186).  Tight scattering was 
observed in the Bland-Altman plot, and measurement bias was -1.1 mL.  Large average 
errors (16.2 ± 12.6) were observed for the slit orifices; the difference between measured 
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values and truth were statistically significant (p < 0.005).  Systematic underestimation 
was observed for the slit orifices (measurement bias: -11.6 mL). 
  
 
Figure 6-9 Data were grouped for round and slit orifice.  3D FOM was accurate for 
the round data, but systematically underestimated regurgitant volume for the slit 
orifice data.   
Average error was further subdivided by regurgitation grade (Table 6-4).  
Average error for the round orifices remained low (< 5 mL) regardless of regurgitation 
severity.  No data were available for severe regurgitation through a round orifice.  










Total Round Slit 
Mild 3.1 ± 2.0 2.7 ± 1.9 4.7 ± 1.4 
Moderate 11.0 ± 10.6 3.1 ± 2.3 13.8 ± 11.0 
Severe 24.7 ± 14.7 -- 24.7 ± 14.7 
Total 12.6 ± 13.3 2.6 ± 1.9 16.2 ± 12.6 
 
 
Misdiagnosis incidence was reported as the frequency of erroneous regurgitation 
grading by 3D FOM (Table 6-5).  There were 19 total events of misdiagnosis; the 
majority of these were underestimation of regurgitation severity (N = 15, 79% of total 
misdiagnosis).  The most frequent misdiagnoses were in the moderate mitral regurgitation 
grade.  Histogram analysis further reveals that the largest errors are associated with the 
slit orifice conditions (Figure 6-10).  Errors were acceptably low for the round office 













Mild 2 (↑) 
Moderate 2 (↑) 10(↓) 
Severe 5(↓) 




Figure 6-10 Histogram distribution of percent errors were grouped for round and 
slit orifice data.   
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6.2.3.2 Iteration 2: Adaptive Adjustment of Radii for Velocity Integration 
Previously, this was pre-defined, and the radii chosen were applied to all frames of the 
cardiac cycle (Figure 6-11).  This is a non-trivial undertaking as the minimum selected 
radius is known to have a large effect on the calculated regurgitant volume.    
 
Figure 6-11 The top panels show the radius is adjusted between frames of the 
cardiac cycle.  This is most clearly observed as the minimum radius increases than 
decreases from frame 1 to 2 and then from frame 2 to 3.  In the bottom panel, the 
radius is predefined and constrained.  (Green dot is the origin of the flow 
convergence.  The two curved bands are the minimum and maximum radius over 
which the velocities are integrated). 
The analysis was first performed on the 3 data points identified previously as    
outliers for the round orifice data.  In all three cases, the new measurement was more 
accurate, as can be seen in Table 6-6.  Previously, the FOM analysis severely 
underestimated the regurgitant volume.  With the adaptive radii implementation, two of 
the three measured regurgitant volumes were accurate to within 3 mL.  The third case 
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overestimated the true regurgitant volume.  While the new method was more accurate, 
the results were slightly more variable.  The average measurement standard deviation for 
these three cases increased from 1.2 to 3.5 mL per beat from the initial method to the new 
adaptive radii measurement.  Similarly, the coefficient of variability slightly increased 
from 0.053 to 0.065.  This underscores the difficulty of accurately and repeatedly 
identifying the necessary radii over which the velocity vectors should be integrated to 
calculate the regurgitant volume. 
 
Table 6-6 Reanalysis of round orifice outliers. 
Case Initial FOM Adaptive R True 
1 17.4 ± 1.5 51.2 ± 5.8 52.9 
2 19.4 ± 1.3 52.8 ± 2.3 36.6 
3 20.5 ± 0.2 62.8 ± 2.4 59.4 
 
 
All slit orifice conditions were reanalyzed (Figure 6-12).  Measured regurgitant 
volumes using the new adaptive radii algorithm were on average more accurate than 
previously measured over all flow rates (adaptive radii: 7.6 ± 7.8 mL; old FOM: 16.8 ± 
13.1 mL), a statistically significant improvement.  The difference between measured 
values between the new adaptive radii FOM and truth were not statistically significant (p 
= 0.081).  Mitral regurgitation was no longer systematically underestimated as most data 
points lay onto or above the 1:1 line (regurgitant volume measured through ultrasound : 
regurgitation volume measured through flow probe).  Contrarily, at higher regurgitant 
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volumes (60+) mitral regurgitation was overestimated. The average error was relatively 
low for both mild (2.8 ± 2.0 mL) and moderate (6.2 ± 6.2 mL) mitral regurgitation 
severity.  Average error increased with severe mitral regurgitation to 13.5 ± 10.3 mL.  
Overall, there was a slight overestimation measurement bias of 3.8 mL observed by 
Bland Altman analysis.   
 
 
Figure 6-12 Mitral regurgitation volume quantified through adaptive radii 3D FOM 
slightly overestimates the data.  Dashed line represents 1:1. 
Additionally, as seen in Table 6-7 incidence of misdiagnosis was relatively low; 
only a total of 5 cases were identified.  Of these five, there were two observed cases of 
underestimation of moderate mitral regurgitation, and one observed case of 
overestimation of mild mitral regurgitation.  A histogram distribution shows 79% of the 
measured mitral regurgitation volumes were in an acceptable range (< 10%) (Figure 6-
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13).  This is a reversal from previously slit orifice analysis which contained equal 
distribution of errors. 
 






Moderate 1 (↑) 2(↓) 
Severe 1(↓) 
Total 2(↑) 3(↓) 
 
 
Figure 6-13 Histogram distribution of percent errors between measured and truth 
regurgitant volumes for slit orifices. 
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Finally, the algorithm proved relatively robust. For each condition, the 
measurement was repeated five times; the average and median standard deviation were 
4.9 and 3.0 mL, respectively.  The coefficient of variability increased slightly to 0.094 
from 0.060 (comparison of adaptive radii to constrained radii), but this is still within an 
acceptable range. Collectively, these data show the updated 3D FOM can accurately 
measure mitral regurgitation over a wide range of regurgitant mitral orifices and flow 
rates.   
6.2.3.3 Iteration 3: Adaptive Adjustment of Regurgitant Orifice Z-height 
All slit orifice conditions were reanalyzed (Figure 6-14).  Measured regurgitant volumes 
using the new adaptive algorithm were on average more accurate than previously 
measured by the original FOM over all flow rates (adaptive z: 8.2 ± 7.2 mL; old FOM: 





Figure 6-14 Mitral regurgitation volume quantified through adaptive z-height 3D 
FOM slightly overestimates the data.  Dashed line represents 1:1. 
However, this method had slightly reduced accuracy (p = 0.036) as compared to 
the adaptive radii method without automated z-height adjustment (adaptive z: 8.2 ± 7.2 
mL; adaptive radii without adaptive z: 7.6 ± 7.8).  The overall trend in data were similar 
as well as observed by the linear regressions (adaptive z: 1.22x – 4.5, R
2
 = 0.79; adaptive 
radii without adaptive z:1.25x – 7.79, R
2
 = 0.78).  Surprisingly, these two adaptive 
algorithms were comparatively robust.  The median and mean measurement standard 
deviation for the adaptive z-height method were 3.9 and 4.7, respectively (compared to 
3.9 and 4.9 for the constrained z-height).  The coefficients of variability were not 
statistically different (CV adaptive r: 0.094; CV adaptive z: 0.090; p = 0.805).   
The difference between measured values between the new adaptive z-height FOM 
and truth were statistically significant (p = 0.009).  This was mostly a result of the 
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relatively large errors at the higher regurgitant volumes.  The average error was relatively 
low for both mild (5.9 ± 4.2 mL) and moderate (6.6 ± 5.9 mL) mitral regurgitation 
severity.  These were both negligibly larger than the previous iteration of the Field 
Optimization Method.   Average error increased with severe mitral regurgitation to 13.5 ± 
9.8 mL, which was comparable to the second iteration and better than the measurements 
from the initial algorithm.  However, because this error was due to overestimation, 
clinically this would have minimal effect on patient diagnosis.  Overall, there was a slight 
overestimation measurement bias of 5.6 mL observed by Bland Altman analysis. Mitral 
regurgitation was rarely underestimated as most data points lay on or above the 1:1 line 
(regurgitant volume measured through ultrasound : regurgitation volume measured 
through flow probe).  Contrarily, at higher regurgitant volumes (60+) mitral regurgitation 
was overestimated. 
As seen in Table 6-8 incidence of misdiagnosis was relatively low; only a total of 
6 cases were identified. Of these six, there were two observed cases of underestimation of 
moderate mitral regurgitation, and two observed case of overestimation of mild mitral 
regurgitation.  A histogram distribution shows 67% of the measured mitral regurgitation 
volumes were in an acceptable range (< 10%) (Figure 6-15).  This is an improvement 












Mild 2 (↑) 
Moderate 1 (↑) 2(↓) 
Severe 1(↓) 
Total 3(↑) 3(↓) 
 
 
Figure 6-15 Histogram distribution of percent errors between measured and truth 
regurgitant volumes for slit orifices. 
Collectively, these data show the updated 3D FOM can more accurately measure 
mitral regurgitation over a wide range of regurgitant mitral orifices and flow rates as 
compared to the initial algorithm.  However, the updated algorithm did not perform as 
well as the adaptive radii only algorithm.   
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6.3 3D Integrative PISA 
3D Integrative PISA was performed on all data sets with available Continuous 
Wave Doppler echocardiography (N = 30) (Figure 6-16).  As previously noted in 6.1.2, 
CW data was not available for all 42 data sets.  Previously measured Vmax and VTI from 
the 2D PISA analysis were retained for the 3D Integrative PISA analysis.  Average error 
across all data points was low (5.9 ± 3.3 mL).  The difference between measured values 
by the integrative 3D PISA method and truth were not statistically significant (p = 0.625).  
Measurement bias was similarly low (-0.6 mL) (Figure 6-17).   
 
 
Figure 6-16 Mitral regurgitation volume quantified through the integrative 3D PISA 
method correlates closely to the truth data.  Dashed line represents 1:1. 
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Figure 6-17 Mitral regurgitation volume quantified through the integrative 3D PISA 
method has a minimal measurement bias.  Dashed lines show mean ± 2 standard 
deviations 
These trends were consistent across both round and slit orifices (Figure 6-18).  
Average error for the round orifice was 6.0 ± 4.1 mL with a measurement bias of -4.1 mL 
(Table 6-9).  Average error for the slit orifice was 5.9 ± 3.1 mL with a measurement bias 
of 0.4 mL.  Average error across all regurgitant grades was low for both orifice types.  No 




Figure 6-18 Data were grouped for round and slit orifice.  The Integrative 3D PISA 
method was comparably accurate for the round and slit orifice data.   
 
 
Table 6-9 Reported errors for the Integrative 3D PISA method grouped by orifice 




Total Round Slit 
Mild 7.3 ± 2.8 6.6 ± 3.4 7.9 ± 2.5 
Moderate 5.5 ± 3.6 5.5 ± 3.4 5.5 ± 3.4 
Severe 6.5 ± 3.0 -- 6.5 ± 3.0 
Total 5.9 ± 3.3 6.0 ± 4.1 5.9 ± 3.1 
 
 155 
Misdiagnosis incidence was reported as the frequency of erroneous regurgitation grading 
by 3D Integrative PISA (Table 6-10).  There were four total events of misdiagnosis; over- 
and underestimation occurred at the same frequency.  The most frequent misdiagnoses 
were in the moderate mitral regurgitation grade.  83% of the data (N = 26/30) have an 
acceptable percent error from the truth (Figure 6-19).  All of the errors fall below 15% on 
a histogram distribution.    
 






Moderate 1(↑) 1(↓) 
Severe 1(↓) 
Total 2(↑) 2(↓) 
 
 
Figure 6-19 Histogram distribution of percent errors between measured and truth 
regurgitant volumes for slit orifices. 
 156 
6.4 Discussion 
An in-vitro pulsatile mitral valve regurgitation model using native ovine heart valves was 
successfully developed. A wide range of mitral regurgitation conditions were created for 
maximal clinical relevance.  The higher flow rates were all associated with the 
comparatively larger slit orifices. Geometric orifice area of a round orifice was the 
limiting factor.  To produce large orifices, the mitral annulus was dilated; however, 
because annular dilation was performed globally throughout the circumference of the 
annulus, leaflet coaptation was equally lost throughout the line of closure.  This resulted 
in a slit orifice, making it impossible to create severe regurgitation through a round 
orifice.      Mild (35.7%) and moderate (50%) severity was created with greater frequency 
as they are associated lower quantification accuracy [167].  Moreover, accurately 
determining mild and moderate regurgitation severity may affect surgical indication.  
Surgical intervention may be delayed for asymptomatic patients presenting with mild 
regurgitation, whereas patients with moderate to severe regurgitation would be more 
readily referred for surgery.      
 Mitral regurgitation was quantified using three general methods.  2D PISA 
analysis was performed as it is the currently used quantitative clinical measurement.  2D 
PISA is a simple well established method and its limitations are also well understood.  
Consequently, more complicated 3D PISA techniques should be comparable to or more 
accurate and robust than the 2D PISA method to establish clinical efficacy.  
 As expected, there was very little error in measured regurgitant volume by 2D 
PISA for round orifices.  This is consistent with previous validation studies [164].  
However, there was a systematic underestimation of regurgitant volume for the slit 
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orifices.  This underestimation is consistent with previous studies, and is a result of the 
hemispherical assumption of the isovelocity surface areas.  The violation of this 
assumption was later confirmed through the integrative 3D PISA method which extracted 
the isovelocity surface area at a given aliasing velocity. 
 In addition to characterizing the accuracy of 2D PISA, measurement robustness 
was explored.  It was found that intra-observer repeatability was equally poor for both 
orifice conditions.  This is a known issue associated with the difficulty of manually 
identifying the regurgitant orifice (Figure 6-20) [18,167].  Subsequently, the radial 
measurement made from the orifice to the isovelocity surface area is affected.  As the 
calculated regurgitant volume from the 2D PISA method is proportional to R
2
, small 
errors in radius measurements may have large effects.  This lack of measurement 
robustness is a key challenge in the development of the Philips FOM, as well as other 3D 
PISA methods.   
 
 
Figure 6-20 There is an uncertainty associated with identifying the origin of flow 
convergence and the subsequent radial measurement to the velocity isosurface. 
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The Philips 3D Field Optimization Method has been previously validated in an 
idealized in-vitro setting against nominal planar pin hole and c-slit regurgitant orifices 
created in acrylic plates [167].  However, this simplistic model is limited; native mitral 
regurgitant orifices are three-dimensional and non-planar (the z-height of the orifice may 
change across its lateral spread and the leaflets rarely oppose each other at a 180° angle) 
and dynamic throughout the cardiac cycle.  Identifying the location of the regurgitant 
orifice in each frame is non-trivial, particularly by automated techniques.  For these 
reasons, in collaboration with Philips Healthcare, the accuracy of the 3D FOM was 
assessed in a pulsatile native mitral valve left heart simulator.   
Three successive iterations of the 3D FOM were investigated.  In the first 
iteration, velocities in the flow convergence zone were integrated over a fixed, pre-
determined radius.  Subsequently, in an effort to improve the accuracy of the Field 
Optimization Method, the algorithm was adjusted to automatically identify the correct 
radii over which to integrate velocities of the flow convergence zone.  A final adjustment 
to the Field Optimization Method was to implement an algorithm to adaptively locate the 
orifice in each frame of the cardiac cycle.  In the two previous iterations, the orifice was 
constrained to the location initialized by the user in the chosen ultrasound frame 
(typically selected as the frame with the largest proximal isovelocity surface area).   
The fixed radii 3D FOM was as accurate as the 2D PISA method for round 
orifices.  Three cases were identified as outliers in the round orifice data and excluded 
from this statistical comparison.  These three data points corresponded to three of the four 
largest regurgitant flow rates created for the round orifice and warranted further 
investigation.  Additionally, there was a decrease in accuracy for the slit orifices, 
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particularly those at higher regurgitant volumes.  Reanalysis of these conditions identified 
that the calculated regurgitant volume was strongly sensitive to the pre-defined radii 
chosen and applied to all frames of the cardiac cycle.  Specifically, for these data, the 
calculated regurgitant volume was most sensitive to the minimum defined radius.   
This is because flow closest to the orifice has the highest velocities and enters 
what is known as the “decorrelation zone” [167].  In the decorrelation zone, flow is 
unpredictably turbulent and the velocity profile is no longer inversely proportional to the 
radius squared (V ∝1/R2) (Figure 6-21).  The decorrelation zone is larger at greater flow 
rates adding to the complexity of empirically pre-defining the minimum radius.  This will 
be a point of emphasis in future studies utilizing highly-resolved velocity data from 
particle imaging velocimetry (see future studies, 9.3.1).    
 
 
Figure 6-21 (Left) Near to the mitral orifice, highly turbulent and chaotic flow 
defines the decorrelation zone.  (Right) In the decorrelation zone, the velocity profile 
no longer follows the expected relationship (V∝ 1/R2) [167]. 
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It is easier, however, to identify the maximum radius as the calculated regurgitant 
volume is not as sensitive to small changes in this dimension.  This is because of the 
inverse relationship described above; velocities at larger radii are smallest.  Therefore, the 
exclusion of this low velocity flow does not impact the total regurgitant volume 
calculated.  However, it should be noted that large noise near the outer border of the 
isovelocity surface area may erroneously increase the regurgitant volume calculated.  
Additionally, proximity of the left ventricular outflow to the regurgitant flow may cause 
these velocities to be incorrectly included for analysis.   
Implementation of the adaptive radii algorithm increased the overall accuracy of 
the 3D FOM to calculate regurgitant volume for both round and slit orifices.  For the 
round orifice conditions, the adaptive radii 3D FOM was comparably accurate to the 2D 
PISA method. However, there was a marked improvement in analysis accuracy for the 
slit orifice conditions, particularly for the mild and moderate regurgitant severities.  Most 
of the observed large errors corresponded to severe mitral regurgitation.  Fortunately, for 
these cases, the adaptive radii 3D FOM overestimated total regurgitant volume.  
Clinically, this would have minimal effect on patient diagnosis; surgery would be 
correctly indicated. 
A final iteration to the 3D FOM was implemented to account for the dynamics of 
the heart and mitral apparatus throughout the cardiac cycle.  These motions may cause 
apical-basal translation of the regurgitant orifice from frame to frame.  If the location of 
the orifice were restrained in a case when migration was present, mitral regurgitation 
would be erroneously calculated due to the under- or over-estimation of the isosurface 




Figure 6-22 Erroneous migration of the apical-basal position of the mitral orifice is 
seen between two frames in the cardiac cycle.   
    The adaptive z-height 3D FOM algorithm was observed to be comparably 
accurate as the adaptive radii 3D FOM. Additionally, as with the adaptive radii iteration, 
the adaptive z-height method was more accurate for slit orifice conditions than 2D PISA.  
Similar to the previous iteration of the 3D FOM, the large errors were predominantly 
localized to over-estimation of severe mitral regurgitation.  Again, this would have 
minimal clinical impact, as surgical would remain correctly indicated. 
Of note, however, each of the 3D FOM iterations demonstrated intra-observer 
measurement repeatability.  Each of these three techniques was more robust than the 2D 
PISA measurements.  Between 3D FOM techniques, the initial constrained radii 
algorithm was the most robust, but this was associated with unacceptable accuracy.  Both 
of the adaptive algorithms were comparably and acceptably robust. 
It should be noted however, that data corresponding to very large discrepancy 
(greater than 3 mm) between automated z-height orifice location and true orifice location 
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were rejected during initial observations; these measurements were repeated.  This 
artificially improved the robustness of the adaptive z-height algorithm.  This erroneous 
migration of the adaptive z-height orifice location was easily identifiable.  Such a 
selection criteria could be readily applied in the clinic to advise a trained user.  However, 
it is recommended that further studies should be performed on the intra-observer 
variability in a more dynamic system.  In the present left heart simulator, there is minimal 
apical-basal translation of the regurgitant orifice.  Specifically, the left heart simulator 
does not mimic annular motion or the apical-basal contraction of the heart.  Moreover, 
the position of the ultrasound probe to the mitral annular plane was fixed.  These 
limitations could underscore the similarity in the accuracy and robustness of the two 
iterations. 
 A final source of error was explored for the 3D Field Optimization Method 
following empirical observation of the limited temporal frequency of the 
echocardiography acquisition.  For all 3D FOM analysis, only 3-5 frames of the cardiac 
cycle (250 msec regurgitation period) were available during systole; typical acquisition 
frame rate was 20 Hz (1/50 msec).  Due to discrete sampling, the regurgitation period 
may have been under-sampled by 1-2 frames (or 50- 100 msec).  Regurgitation period as 
measured by 3D FOM and through direct flow measurements were compared.  On 
average, 3D FOM underestimated regurgitation period by 9.3 ± 27.2 msec.  A simple 
case study shows the effect of offsetting the initial and final time frame due to discrete 
sampling, which could cause up to a 20 mL underestimation of tree regurgitant volume 
(Table 6-11).  This may be worse for clinical data were acquisition frequency can be as 
low as 11 Hz and only 1-2 frames comprise the regurgitant period.   
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Table 6-11 Discrete temporal sampling by the ultrasound system may affect 
regurgitation quantification by up to 20 mL per beat.  These values were extracted 








0 0 54.3 
+50 0 38.2 
0 -50 44.7 
+50 -50 28.7 
 
One source of error not investigated in these studies is the effect of the initial 
hemispherical guess performed in the FOM analysis (as mentioned in section 2.5).  As 
previously explained, the FOM uses an initial hemispherical estimation of the proximal 
flow; this is an estimation of the true velocity field.  Next, the FOM applies ultrasounds 
physics to calculate an “observed” velocity field.  This corrects for the cosine angle 
projection of the true velocity vectors projected onto the ultrasound scan lines.  
Subsequently, the true velocity vectors are iterated until the error field between the 
calculated and true observed velocities is minimized.  Once the error is minimized, the 
velocity vectors are integrated to calculate the regurgitant volume.  However, this process 
is limited by the initial estimation applies a hemispherical velocity field. 
Pioneering work by Hopmeyer et al. suggests a hemi-elliptical model of the 
isovelocity surface areas may be better suited for this initial estimation [202,203]. In their 
studies, Hopmeyer et al. used hemi-elliptical curve fitting applied to digitized isovelocity 
flow data from two perpendicular long-axis color Doppler planes.  From each plane, the 
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height and widths of the isovelocity contour were extracted.  Next, the total surface area 
was computed using elliptical integrals as described in [208]. This method demonstrated 
promise in accurately quantifying regurgitant volumes over a range of flow rates, and was 
more accurate than a hemispherical assumption in their in-vitro studies.  With the 
advances of three-dimensional echocardiography, this hemi-elliptical curve fitting may be 
applied to additional lateral planes of the proximal convergent flow.  This will improve 
the estimation of the isovelocity surface area.  Such a technique may be implemented in 
future iterations of the FOM to more accurately represent the isovelocity surface areas.  
This may be performed in place of the initial hemispherical assumption currently used.        
A final analysis technique was performed using a manual method.  The intention 
of this was to confirm the utility of the experimental three dimensional echocardiography 
data as a gold standard by which similar analyses could be developed and validated.  This 
was performed in parallel with the Philips collaborative studies.   
3D Integrative PISA method was based on several previously published studies 
which sought to specifically improve on the hemispherical assumption of 2D PISA [165].  
In this technique, a single frame with the largest isosurface was identified; subsequently, 
the isosurface was manually segmented through several lateral slices.   A surface mesh 
was fit to the generated point cloud and the total surface area was calculated.  A key 
benefit of this technique is that the location of the regurgitant orifice does not have to be 
identified (nor is a radius measurement explicitly taken).  This removes errors associated 
with this uncertainty.  It must be noted, however, that this technique was manually 
intensive and time consuming (~ 30 min), which makes it unsuitable for clinical use. 
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3D Integrative PISA was observed to very accurate over the range of regurgitation 
flow rates and orifices.  Overall, the 3D Integrative PISA method was the most accurate 
of the analyses performed; this was somewhat unexpected.  This technique did not correct 
for the Doppler angle effect.  Therefore, in theory, a systematic underestimation 
(potentially up to 40%) should have been observed.  It’s quite possible that the expected 
underestimation was offset by measuring only the single largest PISA instead of 
integrating over multiple frames in the cardiac cycle.  Potentially, this can be confirmed 
through a more thorough manual analysis, but is currently unnecessary for the intent of 
developing and validating the Philips FOM. 
 There are three insights which were gained from the 3D Integrative PISA method 
which could be applied to future iterations of the Field Optimization Method.  First, it is 
comparatively easier to identify the isoveolocity surface area (isosurface at a defined 
aliasing velocity) than it is to identify the origin of the regurgitant orifice.  This also 
removes uncertainty associated with the subsequent radius measurements from said 
orifice.  Second, it is not necessary to integrate the regurgitant volume over several 
frames.  It is sufficient to analyze the regurgitant isosurface in a single frame (preferably 
the frame with the largest identifiable PISA) and utilize information for Continuous 
Wave Doppler to complete the measurement.  This removes limitations associated with 
temporal frequency, which can manifest in clinical data where only 1-2 frames may 
represent the entre regurgitant period.  Finally, by performing the PISA analysis using a 
single frame, uncertainty associated with a dynamic or migrating regurgitant orifice is 
removed.      
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 These insights are consistent with the pioneering observations by Hopmeyer et al.  
In each method, the focus was to identify the isovelocity surface area, regardless of the 
location of the regurgitant orifice.  As explained above this reduces errors associated with 
identifying the dynamic orifice.  Both techniques were accurate in resolving regurgitant 
flows using only one frame of the cardiac cycle, which identified the single largest 
regurgitant jet.  While not investigated in this study, it is expected that the proximity of 
the flow convergence zone to the left ventricular myocardium and outflow tract would 
not affect the accuracy of the 3D Integrative PISA.  This was a motivating factor the 
hemi-elliptical assumption.  It is now known however, if the FOM would be susceptible 
to such flows due to its current use of the hemispherical model.  Finally, the generated 
surface meshes of the 3D Integrative PISA method can be used to refine the 
approximation of the hemi-elliptical model, which may then be implemented in the FOM.    
6.5 Conclusions 
A mitral regurgitation model using native (ovine) heart valves in a pulsatile left heart 
simulator was established.  This model was able to create several regurgitant orifices and 
flow rates representing a wide range of valvular insufficiencies.  For all conditions, a true 
gold standard measurement was acquired, which may be used for analysis development 
and validation.  The accuracy and repeatability of the Philips FOM was assessed over 
three algorithm iterations, and were compared to truth as well as the current clinical 
quantitative standard, 2D PISA.  The Philips FOM using an adaptive radii algorithm was 
accurate and robust over a wide range of regurgitant offices and flow rates.  However, the 
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FOM algorithm performed worse when the z-height was automatically adjusted from 
frame to frame, suggesting further development may be needed. 
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CHAPTER 7 
SPECIFIC AIM 2: SURGICAL MANAGEMENT OF ISCHEMIC 
MITRAL REGURGITATION 
7.1 Introduction 
In the previous chapter, improved patient diagnosis was explored through novel 
quantitative methods; this is the first step in optimizing patient surgical management.  In 
this chapter, two adjunctive surgical repairs are evaluated for their functional benefit and 
their effect on leaflet-subvalvular tethering.  Through evaluating these surgical repairs in 
an in-vitro and carefully controlled experimental environment, a mechanistic 
understanding of their efficacy can be gained.  This, in turn, will add to the surgical 
toolbox from which patient specific surgical repairs may be performed based on 
preoperative diagnosis. 
 Ischemic mitral valve disease is one particular landscape for which new and 
targeted surgical repair is believed to be needed.  Ischemic mitral regurgitation is a 
complex disease process stemming from a multifactorial pathology [13,180,191,209].  
Myocardial infarction or chronic ischemia results in left ventricular remodeling, dilation 
and dysfunction.  These combined effects disrupt mitral valve geometric relations leading 
to mitral annular flattening and dilation and papillary muscle displacement.  Collectively, 
this causes Carpentier’s type IIIb valvular dysfunction, or restricted systolic leaflet 
motion, and insufficiency, or mitral regurgitation.  If left untreated, ischemic mitral 
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regurgitation is associated with a two-fold increase in patient mortality [12].  Moreover, 
ischemic mitral regurgitation severity has a graded relationship with reduced survival and 
increased heart failure [12].       
 While significant knowledge of ischemic mitral regurgitation and its 
physiological impact exists, its surgical management remains controversial 
[55,56,58,160,210-212].  Amid this controversy, restrictive mitral annuloplasty, 
performed with a complete rigid ring has been regarded as the preferred surgical repair 
[160,162].  While typically effective, approximately 10-15 % patients, specifically those 
presenting with severe left ventricular dilation, suffer from recurrent or persistent mitral 
regurgitation, have low rates of reverse left ventricular remodeling, and exhibit poor 
survival [13-17].  
Several studies have identified pre-operative characteristics which are predictive 
of simple annuloplasty failure, including: mitral regurgitation grade [49] and jet 
characteristics [46], coaptation length [51,52], interpapillary muscle distance [53], and 
left ventricular dilation [48,50].  These studies have identified excessive leaflet restriction 
through tethered chordae and pathologically displaced papillary muscles as a key 
contributor to repair failure.  Additionally, it is believed that further tethering may be 
produced through the unnatural downsizing of the mitral annulus by restrictive mitral 
annuloplasty .  Downsizing annuloplasty hoists the posterior annulus directionally away 
from pathologically displaced papillary muscle (Figure 7-1).  In turn, valvular function 
effectively becomes unicuspid, as the posterior leaflet is “chordalized” and immobile 
[38].  The anterior leaflet becomes solely responsible for maintaining valvular 
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competency and overall coaptation redundancy is reduced.  Ultimately, the valve is 
susceptible to any further left ventricular remodeling [44-47,213].   
 
 
Figure 7-1 Restrictive mitral annuloplasty is performed by systematically 
downsizing the mitral annulus by two sizes using a rigid ring.  As a result, mitral 
coaptation is dominated by the anterior leaflet; the posterior leaflet is chordalized. 
Consequently, new adjunct surgical strategies have been attempted to compensate 
for severely dilated left ventricles [17,54-58].  When completed with mitral annuloplasty, 
these adjunct strategies are hypothesized to further alleviate chordal-leaflet tethering, 
improve leaflet mobility, and maximize leaflet coaptation.  Of note, anterior leaflet 
augmentation [57,58] and basal papillary muscle relocation (Kron Procedure) [17,56] 
have been recently demonstrated to restore leaflet coaptation and mobility without the 
need to unnaturally undersize the mitral annulus .  While preliminary studies have 
demonstrated the potential benefits of these two adjunct procedures, little knowledge 
exists of what mechanistic improvements in valve function can be expected. 
In this chapter, the functional benefit and effect on leaflet-subvalvular tethering of 
anterior leaflet augmentation and basal papillary muscle relocation as adjunctive 
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procedures to true-size mitral annuloplasty for the repair of ischemic mitral regurgitation 
will be presented.  As it is hypothesized that surgical repair should aim to restore normal 
physiology, each surgical repair will be compared to control (or healthy mitral valve) 
function.  Additionally, improvements in mitral valve function as compared to the 
preferred surgical technique, isolated mitral annuloplasty, are explained.                    
7.2 Anterior Leaflet Augmentation 
Anterior leaflet augmentation is an adjunctive procedure to mitral annuloplasty, in which 
pericardial tissue is used to increase the surface area of the anterior leaflet.  The increased 
anterior leaflet area is expected to provide greater leaflet redundancy to promote valve 
competency.   
Anterior leaflet augmentation was performed with either a small or large 
pericardial patch to further elucidate the potential effects of procedural technique, i.e. 
does the size of the pericardial patch determine its efficacy.  It is hypothesized that 
anterior leaflet augmentation will achieve comparable leaflet coaptation to restrictive 
mitral annuloplasty, while yielding significant improvements in leaflet tethering as 
measured by chordal forces.   
7.2.1 Results 
The results of this section are subdivided into (i) development of the ischemic mitral 
regurgitation model, and (ii) surgical repair.  Surgical repair was performed as undersized 
mitral annuloplasty, and anterior leaflet augmentation with true-sized annuloplasty.  The 
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main experimental endpoints are mitral regurgitation grade, leaflet coaptation length, and 
chordal forces   
7.2.1.1 Ischemic Mitral Regurgitation 
Ischemic mitral regurgitation was successfully simulated with asymmetric annular 
dilation and papillary muscle displacement for all experimental conditions (3+ MR grade: 
N = 4; 4+ MR Grade: N = 11) (Table 7-1).   
 









< 3+ 0 < 29 % 
3+ 4 30 – 59 % 
4+ 11 > 60 % 
 
 
Mitral regurgitation was graded based on the volume fraction of regurgitation to 
forward flow (stroke volume ~ 70 mL) [24].  This normalized any potential differences in 
total regurgitation volume due to possible variations in pulsatile hemodynamics.  A 
volume fraction of 30-59% is graded as 3+ mitral regurgitation; a volume fraction greater 
than 60% is characterized as 4+ [24].  The combined annular and papillary muscle 
alterations did not produce mitral regurgitation lower than 3+.  
Further, mitral regurgitation was confirmed through color Doppler 
echocardiography.  Large, asymmetric regurgitant jets were observed in combination 
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with severely tethered mitral leaflets (Figure 7-2).  It should be noted that mitral 
regurgitation was not quantified through echocardiography, but solely through the direct 
flow measurements taken immediately upstream of the left atrium through the 
electromagnetic flow probe.   
 
 
Figure 7-2 Large asymmetric regurgitant jet.  White arrow indicates flow direction. 
Noticeable leaflet tethering was observed in both the anterior and posterior 
leaflets, consistent with severe papillary muscle displacement [157].  This can be seen in 
Figure 7-3.  The overlaid red lines trace the centerline of the mitral leaflets.  Localized 
tethering points by the restricted mitral chordae are indicated by the white arrows.  The 
green line denotes the mitral annular plane at which physiological coaptation takes place.  
As seen in Table 7-2, the anterior leaflet coaptation length was significantly decreased 
from the control condition (Control: 4.8 ± 0.5 mm; IMR: 3.2 ± 0.5 mm; p< 0.005) at the 
central A2-P2 coaptation plane.  It should be noted that all coaptation data were analyzed 
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at the central coaptation plane as chordal force transducers cause acoustic shadowing 
which prohibited accurate measurements in the off-center planes (A1-P1, A3-P3).     
 
 
Figure 7-3 Minimal coaptation is observed at the A2-P2 coaptation line.  Anterior 
and posterior leaflets are tethered apically into the ventricle.  A notable kink in each 
leaflet is observed due to chordal tethering. 





Sample Size 15 15 -- 
Coaptation 
Length [mm] 
4.8 ±0.5 3.2 ± 0.5 0.001 
 
 
Chordal force data are summarized in Figure 7-4 and Table 7-3.  Significant 
increases in tethering forces compared to the control group were observed for both the 
anterior strut and posterior intermediate chordae originating from the posteromedial 
papillary muscle.  While modest increases where observed, no statistically significant 
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differences were observed for the anterior strut and posterior intermediate chordae 
originating from the anterolateral papillary muscle.   
 
 
Figure 7-4 Chordal forces were increased from the healthy to the IMR conditions. * 











Table 7-3 Chordal forces for all four instrumented chordae in the control and 












0.71 ± 0.31 1.23 ± 0.44 0.001 
Posterior 
Intermediate 




0.62 ± 0.44 0.80 ± 0.52 0.304 
Posterior 
Intermediate 
0.49 ± 0.34 0.71 ± 0.51 0.181 
 
7.2.1.2 Undersized Annuloplasty versus Anterior Leaflet Augmentation with True-Size 
Annuloplasty 
Surgical repairs were performed as undersized mitral annuloplasty (N = 15) and anterior 
leaflet augmentation with true sized mitral annuloplasty.  Anterior leaflet augmentation 
was randomized to small (N = 8) and large (N = 7) pericardial patch procedures.  The 













N = 8 
Large Patch 
N = 7 
p value 
Length [cm] 1.77 ± 0.10 2.68 ± 0.25 0.001 
Height [cm] 0.65 ± 0.14 1.07 ± 0.10 0.001 
Area [cm2] 0.86 ± 0.29 2.26 ± 0.36 0.001 
 
All surgical repairs alleviated mitral regurgitation; no regurgitant jets were 
observed postoperatively through Color Doppler echocardiography.  Additionally, all 
repairs significantly (p < 0.005) increased coaptation length from ischemic mitral 
regurgitation (MR) back to or greater than control levels (Table 7-5).  The large patch 
procedure resulted in an additional 1 mm gain in coaptation length, as the large patch 
significantly increased the anterior leaflet surface area available for coaptation.   
 
Table 7-5 Coaptation length was significantly increased by all three repairs 
compared to the IMR condition. * Denotes significance (p < 0.05) between large 
patch and both RMA and small patch. 
 
 RMA Small Patch Large Patch 
Sample Size 15 8 7 
Coaptation 
Length [mm] 
4.7 ±0.6 4.8 ± 0.5 5.8 ± 1.0 * 
  
For heightened clinical relevancy, coaptation length is also shown as a percent 
increase from the ischemic mitral regurgitation condition to each repair (Figure 7-5).  By 
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evaluating repair efficacy as a percent increase from the pathological condition, this data 
can be most readily translated to the clinic, where patient healthy levels are not known.  
Additionally, repair efficacy can be viewed in this normalized perspective to remove 
effects of variable valve size and geometry.   
The large patch procedure with true-sized mitral annuloplasty resulted in the 
greatest improvement in coaptation length (98.3 ± 31.0% increase) as compared to 
ischemic mitral regurgitation.  Restrictive mitral annuloplasty (51.0 ± 21.3 % increase) 
and the small patch with true-sized annuloplasty (43.2 ± 16.5 % increase) treatments 
resulted in similar improvements in coaptation length as compared to ischemic mitral 
regurgitation.  Further, postoperative coaptation length for the large patch procedure was 
significantly greater than the restrictive mitral annuloplasty (p = 0.006) and the small (p = 
0.003) patch repairs.   
 
Figure 7-5 % improvement in coaptation length of each repair as compared to IMR. 
* Denotes significance between repairs. † Indicates significance as compared to IMR 
condition. 
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Forces in all four chordae for all of the surgical repairs are found in Table 7-6.  
Figure 7-6 shows the percent improvement in chordal forces for all chordae for each 
repair as compared to the ischemic mitral regurgitation condition. 
 
Table 7-6 Chordal forces for all four instrumented for the surgical repair conditions. 
* denotes significance (p < 0.05) as compared to IMR.  † indicates significance 










0.89 ± 0.33 * 0.91 ± 0.37 * 0.74 ± 0.31 * 
Posterior 
Intermediate 




0.66 ± 0.39 0.78 ± 0.43 0.94 ± 0.60 
Posterior 
Intermediate 
0.54 ± 0.33 0.46 ± 0.24 0.63 ± 0.45 
 
 
Compared to the ischemic mitral regurgitation condition, the large patch 
procedure significantly reduced  the force in the anterior strut chordae (20.5 ± 20.0 %), 
and the posterior intermediate chordal chordae (25.2 ± 18.0 %) originating from the 
posteromedial papillary muscle.  Similar improvements were observed for the small patch 
procedure as compared to the ischemic mitral regurgitation condition: 34.8 ± 33.5 % 
reduction in anterior strut chordae and 15.8 ± 23.9 % reduction in posterior intermediate 
chordae originating from the posteromedial papillary muscle.  Restrictive mitral 
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annuloplasty only resulted in significant reduction (27.0 ± 16.6%) in chordal force in the 
anterior strut chordae originating from the posteromedial papillary muscle.  Forces in the 
posterior intermediate chordae originating from the posteromedial papillary muscle 
remained elevated (3.7 ± 23.9% reduction). 
Conversely, there was a slight increase in the tethering force for both the small 
(20.5 ± 69.4%) and large (11.8 ± 27.2%) patch treatments as compared to ischemic mitral 
regurgitation for the anterior strut chordae originating from the anterolateral papillary 
muscle.  Restrictive mitral annuloplasty resulted in a slight reduction in chordal force for 
the anterior strut origination from the anterolateral papillary muscle.  
None of the repairs had an effect on posterior intermediate chordae originating 
from the anterior papillary muscle as compared to ischemic mitral regurgitation (RMA: 
4.7 ± 48.4% reduction; Small Patch: 1.5 ± 48.4 % increase; Large Patch: 0.7 ± 88.1% 




Figure 7-6 % improvements in chordal forces for all repairs as compared to IMR.  
†denotes significance (p < 0.05) as compared to IMR.  * indicates significance 
between groups.   
7.2.2 Discussion 
Ischemic mitral regurgitation was successfully simulated with pathological 
annular dilation and papillary muscle displacement that consistent with well-established 
large animal models and patient data [13,209,214].  Inferior myocardial infarction was 
chosen as the basis for simulating ischemic mitral valve disease as this is associated with 
greater mitral valve regurgitation severity and incidence, and valvular geometric 
distortion [11,157,159].  Mitral regurgitation severity was consistent with previously 
published data for inferior myocardial infarction [13,39,209,214].   
Leaflet-chordal tethering was quantified using miniature force transducers 
instrumented onto the major load bearing chordae (anterior strut, posterior intermediate) 
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from both the anterior and posterior leaflets [138,153,215].  The anterior strut and 
posterior intermediate chordae are also known to be the most sensitive to changes in 
papillary muscle displacement [215]. 
In the inferior myocardial model, asymmetric papillary muscle displacement was 
performed.  Specifically, greater papillary muscle displacement was performed for the 
posteromedial papillary muscle, particularly in the lateral direction.  Overall, the 
posteromedial papillary muscle was displaced a total of 9.8 mm as compared to 3.6 mm 
from the anterolateral papillary muscle.  This is nearly a 3 fold increase in extension the 
chordae need to account for to maintain normal coaptation.  This explains why significant 
increases in chordal forces were observed for the chordae originating from the 
posteromedial papillary muscle, but not for the anterolateral papillary muscle.   
Between repairs, anterior leaflet augmentation with a large pericardial patch 
resulted in the best improvement in length; anterior leaflet augmentation also resulted in 
the best improvement in coaptation length compared to ischemic mitral valve disease.  
Overall, this creates additional redundancy in coaptation to maintain proper valvular 
competency, which may have the potential to withstand late ventricular remodeling.  
These data demonstrate that large patch procedure has the greatest impact on mitral valve 
functional efficacy, whereas both the restrictive mitral annuloplasty and small patch 
procedures have comparable improvements in clinical valve performance.  To further 
delineate between these repairs, leaflet-chordal tethering was investigated.         
The large patch procedure, which resulted in the greatest improvements in leaflet 
coaptation length, was expected to be associated with deleterious increases in cyclic 
chordal forces.  This relationship was expected due to the significantly larger exposed 
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leaflet surface area (Force = Pressure X Exposed Leaflet Surface Area) created by the 
pericardial augmentation; the anterior leaflet bellowed above the annulus plane, similar to 
a sail.  However, this was not observed for the anterior strut and posterior intermediate 
chordae originating from the pathologically displaced posteromedial papillary muscle.  
The opposite was observed as both the anterior strut and posterior intermediate chordae 
originating from the posteromedial papillary muscle experienced lower force after repair 
as compared to disease.   
The reduction in anterior strut chordal force is most likely due to two mechanisms 
(Figure 7-7): (i) leaflet insertion points of the anterior strut chordae were displaced 
apically, towards the papillary muscles, by use of the patch.  This effectively shortened 
the distance between the leaflet insertion point and the papillary muscles, which reduced 
the overall extension needed from the chordae to maintain proper coaptation.  (ii) 
Echocardiography showed that the anterior strut chordae were moved into or near to the 
coaptation zone (Figure 7-8) [216].  This site is known to experience relatively low 
chordal force as it is not actively engaged in resisting transmitral pressure 




Figure 7-7 Schematic representation of the effects Ischemic Mitral Regurgitation 
(IMR), Restrictive Mitral Annuloplasty (RMA) and, Anterior Leaflet Augmentation 
(ALA) has on chordal tethering.  PMPM: posteromedial papillary muscle. 
 
Figure 7-8 Echocardiography shows that the anterior strut chordae have been 
translocated apically with the insertion of an anterior leaflet patch.  This moved the 
chordae into the coaptation zone and away from the belly of the leaflet. 
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Three mechanisms are suspected for the reduction of posterior intermediate 
chordal force.  First, the increased anterior leaflet mobility reduced the overall loading of 
the posterior leaflet, such that the posterior leaflet did not traverse as far to oppose the 
anterior leaflet.  This effectively limits the elongation of the chordae from diastole to 
systole.   Second, more of the posterior leaflet was involved with coaptation, effectively 
displacing the posterior intermediate chordae near to, or into the coaptation zone; a site 
known to experience lower chordal forces.  Finally, the posterior annulus was not hoisted 
directionally away from the pathologically displaced papillary muscles as is done with 
restrictive, or undersized, mitral annuloplasty [41].  This effectively shortened the 
distance between the leaflet insertion point and the restraining papillary muscle, limiting 
the extension of the chordae. 
These mechanisms are likewise applicable to the significant reduction in anterior 
strut chordal force and moderate reduction in posterior intermediate chordal force 
observed for the small patch procedure.  It is believed that the larger reduction in anterior 
strut chordal force in the small patch procedure compared to the large patch procedure is 
a result of smaller exposed surface area in the small patch procedure.  Both repairs are 
performed in conjunction with true-sized annuloplasty, i.e. their mitral annular area is the 
same. However, for the large patch procedure, the anterior leaflet more greatly dominates 
coaptation and results in mild billowing (leaflet area above the mitral annular plane).  
This results in greater exposed surface area.  However, these same mechanisms yield 
better reductions in posterior intermediate chordal force for the large patch repair as 
compared to the small patch repair as the posterior leaflet is not as involved in coaptation.   
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Restrictive mitral annuloplasty also results in a significant reduction in chordal 
force in the anterior strut chordae originating from the posteromedial papillary muscle.  
This was expected as restrictive mitral annuloplasty undersizes the mitral annular area. 
While the anterior leaflet still dominates coaptation, the mitral orifice it spans is the 
smallest of all conditions.   
Conversely, there was no measured change in posterior intermediate tethering 
forces for the restrictive mitral annuloplasty repair treatment.  An increase of force was 
expected due to the hoisting of the posterior annulus.  However, it is likely this was offset 
by the creation of a functionally unicuspid valve, which resulted in minimal posterior 
leaflet area exposed to a transmitral pressure gradient.  Nonetheless, posterior chordal 
forces remained elevated at pathological levels.  Because of this elevated tension, the 
posterior leaflet remains susceptible to further perturbations in papillary muscle 
positioning.  This is an often cited mode of failure for restrictive mitral annuloplasty 
which may be explained by these data [41,163].     
Anterior strut chordae originating from the anterior papillary muscle did not 
benefit from anterior leaflet augmentation.  Contrarily, there was a slight increase in 
tethering force for both the small and large patch treatments as compared to ischemic 
mitral regurgitation.  Restrictive mitral annuloplasty showed a moderate improvement in 
chordal force as compared to ischemic mitral regurgitation.   
These data suggest that significant papillary muscle displacement (as seen with 
the posteromedial papillary muscle) has a compensatory effect on the tethering forces in 
the presence of leaflet augmentation.  Without papillary muscle displacement, the 
anterior leaflet freely billowed into the left atrium, which further exposed surface area to 
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transmitral pressure.  In this setting, restrictive mitral annuloplasty resulted in modest 
improvement in tethering force, which is attributed to the smaller mitral orifice.  These 
data support the notion that these complex and adjunctive leaflet augmentation 
procedures should be targeted in cases of enlarged left ventricles associated with severely 
displaced papillary muscles.   
 None of the repairs had an effect on posterior intermediate chordae originating 
from the anterior papillary muscle as compared to ischemic mitral regurgitation.  Without 
significant papillary muscle displacement, hoisting of the posterior annulus did not 
exacerbate posterior leaflet tethering.  The leaflet remained mobile and spanned more of 
the mitral orifice to oppose the anterior leaflet.   
 In this work, it is assumed a reduction in chordal forces, specifically from the 
ischemic condition, towards normal, control levels is beneficial.  It may be possible that a 
significant reduction in chordal forces below physiological levels may lead to decreased 
ventricular function, as seen with non-chordal sparring mitral valve replacement [218].  
However, with these repairs, it is not expected that the intricate valvular-ventricular 
balance will be disrupted. 
7.2.3 Conclusions 
 This study demonstrated that in the setting of ischemic mitral regurgitation due to 
severe left ventricular geometric distortion, anterior leaflet augmentation is a viable 
surgical option.  The data from each patch size suggest that augmentation dimensions do 
not need to be precisely tailored as sufficient repair is achievable within a range.  An 
oversized patch can be targeted as it provided the best gains in coaptation length and 
reduction in chordal tethering.  Although all repairs abolished mitral regurgitation 
 188 
acutely, repairs that create the greatest coaptation may conceivably produce a more 
robust and lasting repair in the chronic stage.  However, there is still a clinical need to 
best identify which patients with altered mitral valve geometry would most benefit from 
an adjunct procedure over a simple restrictive mitral annuloplasty (refer to section 9.3.2 
for more detail).   
7.3 Basal Papillary Muscle Relocation 
Basal papillary muscle relocation was first pioneered by Dr. Kron and colleagues to 
surgically relocate the papillary muscles towards the mitral annular plane to combat left 
ventricular dilation [17,56].    In this technique, as an adjunct to mitral annuloplasty, 
prolene sutures are passed through the fibrous portion of the posteromedial papillary 
muscle and looped through the mitral annulus at the right fibrous trigone.  The 
posteromedial papillary muscle is subsequently pulled basally until a surgeon-desired 
level of leaflet coaptation is thought to be achieved.  This is typically done on a non-
beating, flaccid heart during bypass, and subsequently confirmed with saline testing.  
Therefore there is some procedural uncertainty associated with translating the geometric 
relationships between an arrested heart during bypass and the beating heart 
postoperatively.   
 Using this procedure, improved leaflet coaptation, alleviated subvalvular 
tethering, and a reinforcement of the left ventricle have been demonstrated [17,56].  
While the potential benefits of this technique have been described, several challenges 
remain in demonstrating papillary muscle relocation as an effective and reproducible 
adjunct to mitral annuloplasty.  Mainly, where on the mitral annulus should the papillary 
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muscle(s) be relocated, and how much basal relocation is necessary to promote valve 
competency. 
In this study, basal papillary muscle relocation was performed to two locations on 
the mitral annulus.  For each annular anchor, the posteromedial papillary muscle was 
relocated in isolation, or both papillary muscles were relocated symmetrically.  Finally, 
basal papillary muscle relocation was performed with 2, 4, and 6 mm displacements, for 
each repair group.        
7.3.1 Results 
The results of this section are subdivided into: (i) development of the ischemic mitral 
regurgitation model and subsequent annuloplasty repair, and (ii) basal papillary muscle 
relocation.  The experimental conditions are (refer to section 5.2.1 for more detail):  
1. Control 
2. Acute myocardial infarction (MI) 
3. Acute MI with mitral annuloplasty (MA) 
4. Chronic MI with MA 
5. Posteromedial papillary muscle (PM) repair to either the commissure (Comm) 
or trigone (Trig) 
6. Both PMs to either the Commissure or Trigione.   
The main end points are Coaptation Length (CL), Tenting Area (TA), and Tenting Height 
(TH) as measured through three-dimensional echocardiography, and are presented as 
mean ± 1 standard deviation.  Statistical significance was determined at p < 0.05.  For all 
conditions, a total of N = 6 experiments were performed.       
7.3.1.1 Disease Progression and Ring Annuloplasty 
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Annular dilation and papillary muscle displacement (Acute MI) resulted in significant 
decreases in coaptation length and tenting area compared to control (Table 7-7, Figure 7-
9).  Mitral annuloplasty improved leaflet geometry, but did not restore coaptation, nor 
relieve leaflet tethering compared to Control.  Further papillary muscle displacement 
following mitral annuloplasty (Chronic MI with MA), as seen with late left ventricular 
remodeling [41,42,163], resulted in moderately worsened coaptation, and leaflet 
tethering.  Coaptation and tenting deleteriously returned to Acute Myocardial Infarction 
levels, indicating long-term repair failure.  These data are consistent with clinical 
observations, which identify continued left ventricular dilation as a mechanism of ring 
annuloplasty failure [41,42,163].  
 
Table 7-7 Coaptation length and tenting area for the disease progression and mitral 
annuloplasty repair. 
 
N = 6 Control Acute MI 






5.58 ± 1.42 3.96 ± 0.98 4.74 ± 1.22 3.98 ± 0.71 
p value to 
control 
 0.002 0.024 0.001 
p value to 
previous 
condition 
  0.453 0.069 
Tenting Area 
[mm2] 
18.3 ± 12.0 30.9 ± 9.3 26.9 ± 12.3 41.6 ± 19.8 
p value to 
control 
 0.001 0.046 0.001 
p value to 
previous 
condition 




Figure 7-9 Coaptation length and tenting area are shown for the disease progression 
and mitral annuloplasty conditions.  * denotes significance to control (p < 0.05). † 
indicates significance between conditions (p < 0.05). 
7.3.1.2 Basal Papillary Muscle Relocation 
For the 6 mm basal papillary muscle relocation, all repairs significantly improved 
coaptation and relieved leaflet tethering compared to isolated mitral annuloplasty 
(Chronic MI with MA) (Table 7-9, Figure 7-10).  No significant differences in coaptation 
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length and tenting area were observed between any of the 6mm repair groups and the 
control group, suggesting papillary muscle relocation was able to restore natural 
physiological function of the mitral valve.  Additionally, no statistical significance was 
observed when comparing coaptation length and tenting area within any of the 6 mm 
repair groups.     
 
Table 7-9 Coaptation length and tenting area for all four repairs at the 4mm and 6 
mm increments. The 2mm repair increment is not shown as this level of repair did 
not improve leaflet closure. 
 
N = 6 
 Posteromedial Papillary 
Muscle 
Both Papillary Muscles 
Repair 




6 mm 5.96 ± 1.46 6.23 ± 1.84 6.23 ± 1.58 6.26 ± 1.80 
4 mm 4.96 ± 1.25 5.31 ± 1.27 5.58 ± 1.39 5.75 ± 1.82 
Tenting 
Area [mm2] 
6 mm 19.7 ± 11.6 21.7 ± 10.7 20.4 ± 12.0 19.8 ± 10.2 





Figure 7-10 Coaptation length and tenting area for all four repairs at the 4mm and 
6 mm increments. * denotes significance from Control, while † denotes significance 
from Chronic MI with MA.  2mm repair increment is not shown as this level of 




 For a 4 mm basal papillary muscle relocation, displacing both papillary muscles 
towards either annulus anchor significantly improved coaptation length and relieved 
leaflet tenting compared to isolated mitral annuloplasty (Chronic MI with MA).  The 
resulting coaptation length and tenting area were not statistically significant from 
Control.  Additionally, there was no statistical significance between the two annular 
anchor groups.  Relocating only the posteromedial papillary muscle did not significantly 
improve coaptation length or tenting area from the Chronic MI with MA grouping.  
Leaflet tenting area was significant from control for either of the annular anchor groups.  
Again, there was no statistical significance observed between the repair groups.  2mm 
repair increment data were not shown as there were no improvements from pathology. 
 Leaflet coaptation geometry was plotted as a function of papillary muscle distance 
(Figure 7-11) for the Control to the IMR conditions.  Papillary muscle distance was 
measured as the absolute distance from the tip of the papillary muscle to the adjacent 
commissure on the mitral annular plane.  This is a different measurement than papillary 
muscle displacement which was a relative magnitude from the control geometry.   Leaflet 
geometry was normalized against anterior leaflet length to eliminate effects of valve size 
variability.  A scatter points were used to show the data for all six experiments for the 
plotted conditions; similar trends were observed between all experiments. 
With disease progression, normalized coaptation length was observed to have a 
linearly proportional (inverse) relationship with papillary muscle distance.  Conversely, 
normalized tenting area linearly increased with papillary muscle distance.  Characteristic 




Figure 7-11 Normalized coaptation length has an inverse relationship with papillary 
muscle distance.  Tenting area is linearly proportional to papillary muscle distance.  
Papillary muscle distance is measured from the tip of the papillary muscle to the 












Characteristic Equation Fit [R2] 
Coaptation Length -0.15*PM + 0.74 0.88 
Tenting Area 0.18*PM – 0.33 0.78 
 
Similarly, a strongly linear relationship existed between normalized coaptation 
geometry and papillary muscle distance for the individual papillary muscle repair groups.  
This can be observed in Figure 7-12.  From right to left, papillary muscle position is 
basally improved from the Chronic Myocardial Infraction condition by 2, 4, and 6 mm 
(x-axis shows absolute papillary muscle distance decreased by 2 mm for each increment 
of repair).  Normalized coaptation length was linearly and inversely proportional to 
papillary muscle distance.  Characteristic equations and fits for all linear regressions were 




Figure 7-12 Normalized coaptation length has an inverse relationship with papillary 
muscle distance.  Tenting area is linearly proportional to papillary muscle distance. 
Papillary muscle distance is measured from the tip of the papillary muscle to the 





Table 7-10 Relationships between leaflet parameters and papillary muscle 
distance are tabulated.  Coefficients are comparable between repair groups. 
 
 



























Coaptation Length -0.26*PM + 1.10 0.97 







 Coaptation Length -0.30*PM + 1.20 0.98 






















Coaptation Length -0.23*PM + 1.97 0.93 







 Coaptation Length -0.30*PM + 1.71 0.96 
Tenting Area 0.34*PM – 0.75 0.75 
 
It was observed that isolated postero-medial papillary muscle repair in the anterior 
myocardial infarction model failed to alleviate tethering at the contralateral, A1-P1, 
coaptation line (Table 7-11, Figure 7-13).  Tenting area was significantly different from 
control for both commissural and trigonal repairs.  The ipsilateral A3-P3 coaptation line 
showed no significant tethering for either annular anchors compared to control.   
 
 199 






























7.3.2.1 Efficacy of Basal Papillary Muscle Repair 
Within this study, the 4 and 6 mm basal papillary muscle relocations restored leaflet 
coaptation and alleviated leaflet subvalvular tethering when performed as an adjunct to 
true-sized mitral annuloplasty.  This adjunctive repair was more efficacious than isolated 
mitral annuloplasty, which showed a regression in valvular competency in the presence 
of chronic left ventricular dilation.   
Moreover, these data suggest that there is a viable range to which the papillary 
muscles can be relocated which yield physiological valvular function.  This is important 
as a patient’s normal papillary muscle position is not known, thus making it difficult to 
pre-operatively determine the exact papillary muscle relocation required for a competent 
long-term repair.  Fortunately, the results herein indicate this may not be necessary as 
normal coaptation can be obtained within  a given range of papillary muscle relocation 
positions .  This redundancy is due to the natural functional reserve of the mitral valve, 
which has been previously characterized in in-vitro studies of annular dilation and 
papillary muscle displacement [14,34]. 
By exploiting this redundancy a surgeon can restore leaflet function with a more 
durable repair.  Specifically, forces on traction sutures and consequently the papillary 
muscles have recently been shown to be proportional to the applied repair distance [219].  
Logically, it follows that lesser stress on the papillary muscles would be beneficial for 
optimizing repair durability and avoiding potential long term papillary muscle distension 
or rupture.   
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The data also suggest that undersized mitral annuloplasty, or the unnatural 
downsizing of the mitral annulus, is not necessary when adjunctive papillary muscle 
repair is performed.  This is consistent with recent work published by Fattouch et al. in 
which patients receiving papillary muscle relocation with concomitant true-sized 
annuloplasty demonstrated favorable outcomes compared with isolated undersized 
annuloplasty at 5 year follow up [54].  However, it is unclear where there is an added 
benefit of combining undersized annuloplasty with papillary muscle relocation.  
7.3.2.2 Effect of Annular Anchor Selection 
Basal papillary muscle relocation was performed to two annular landmarks based on their 
physiological structure and function: the commissures and the fibrous trigones.  In 
normal physiology, each papillary muscle lays behind its corresponding commissure 
(Figure 7-14).  Therefore, it is believed that relocating the papillary muscle towards its 
respective commissure will restore natural physiology.  The fibrous trigones, due to their 
dense collagenous structure, are believed to serve as more secure anchors from which the 
papillary muscles can be suspended.  Also, relocating the papillary muscles towards the 
trigones is expected to result in additional corrective lateral displacement of the papillary 
muscles.  This would further resist  the outward tethering of the left ventricle.   
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Figure 7-14 Papillary muscles and annular landmarks are shown. 
The anchor position of the traction suture did not affect valve function as 
determined by leaflet coaptation.  No statistically significant differences in mitral leaflet 
coaptation and tethering were observed between repairs.  At 6 mm displacement, 
coaptation was entirely restored and tenting was alleviated as compared to control for 
either the trigonal or commissural repair group.   
The similarity between trigonal and commissural repair efficacies was attributed 
to the relatively small spatial differences between the two annular landmarks.  Annular 
dimensions were defined by annuloplasty geometry.  For size 28 to 32 annuloplasty rings, 
this corresponds to approximately 5 to 7 mm in the lateral direction (Figure 7-15).  
However, when this is projected onto the direction of the surgical repair, there is a 
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minimal affect.  For each repair, the main direction of papillary muscle relocation is an 
apical-basal correction.  This can be seen in Table 7-8 below, which shows the residual 
papillary muscle displacement for each repair throughout the 2 mm increments.  With 
either annular location, the apical component of papillary muscle displacement was 
entirely corrected.  Posterior and lateral components of the pathological displacement 
largely remained with either annular anchor repair.  This is consistent with previous in-
vitro investigations, which found apical papillary muscle displacement can be primarily 
responsible for mitral insufficiency, and exacerbates regurgitation in the presence of 
posterior and lateral displacement [14,220].  Clinically, these results are favorable as the 
data suggest that the procedures are robust to variations along the mitral annulus.     
 
 

























































Lateral 0 8 7.3 6.6 5.9 
Posterior 0 8 7.4 6.7 6.1 






































Lateral 0 8 7.2 6.5 5.7 
Posterior 0 8 6.9 5.7 4.6 
Apical 0 5 3.5 2.1 0.6 
 
7.2.2 Clinical Parameters to Inform Papillary Muscle Relocation Distance  
Simple clinical correlates between papillary muscle position and leaflet geometry were 
identified, which may be used to pre-operatively determine a favorable basal papillary 
muscle relocation range.   
The formulae derived from the linear regressions may be used clinically to 
determine papillary muscle distance as measured through an easily obtained surrogate 
leaflet parameter (e.g. coaptation length); papillary muscle position is difficult to capture 
with current clinical imaging modalities.  These relationships can be exploited to pre-
operatively plan papillary muscle relocation.  That is, given the diseased and the desired 
repaired coaptation length, the difference in papillary muscle distance can be determined.  
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Subsequently, that distance can be surgically applied to the papillary muscle relocation.  
Follow up studies are necessary to quantify the predictive value of these parameters more 
comprehensively (refer to section 9.3.3 for more detail).   
7.3.2.3 Effect of Papillary Muscle Selection 
By analyzing the changes in leaflet closure geometry at the off-center coaptation lines 
(A1-P1, and A3-P3), the localized effect of papillary muscle relocation was investigated.  
Isolated repair of the posteromedial papillary muscle only improved leaflet closure at the 
ipsilateral (A3-P3) and the adjacent (A2P2) coaptation line.  As the anterolateral papillary 
muscle remained displaced, localized tethering was observed at the A1P1 coaptation line.  
This indicates that basal papillary muscle relocation should be targeted to the displaced 
papillary muscle, which can be identified by local leaflet tethering measured through full 
volume echocardiography. 
In this study, symmetric papillary muscle displacement was performed, which 
most closely simulated anterior myocardial infarction [11,157,213].  For this model, both 
papillary muscles require correction to improve leaflet function.  However, the data are 
readily extrapolated to single papillary muscle repairs in a posterior myocardial infarction 
model.  For such a case, left ventricular dilation and papillary muscle displacement is 
asymmetric, resulting in mostly isolated posterior papillary muscle displacement.  Based 
on the improvement in leaflet closure observed by correcting both papillary muscles in 
the symmetrically displaced anterior myocardial infarction model, it is expected that 
repairing only the posteromedial papillary muscle in an asymmetric inferior myocardial 
infarction model will be sufficient.  In an inferior myocardial infarction model, the 
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anterolateral papillary muscle only experiences mild displacement.  Furthermore, this 
displacement is not in the apical direction.   
7.3.3 Conclusions 
 In this systematic controlled in-vitro study, basal papillary muscle relocation was 
found to be insensitive to the choice of annular suture location and exploits natural leaflet 
redundancy, demonstrating great surgical repeatability and robustness.  Papillary muscle 
distance was linearly proportional to changes in leaflet geometry as measured by 
coaptation length and leaflet tenting.  This relationship indicated that leaflet geometry 
could be used as a surrogate for papillary muscle positioning to inform surgical repair.     
 These published findings [38] were recently appreciated in an invited commentary 
Dr. Ulrik Hvass, “These essential findings should make surgeons more confident by the 
various imperfections they fear to produce, and that controlling the mitral regurgitation 
by intervening on the subvalvular anatomy does not require a high degree of precision.”  
The simplicity of basal papillary muscle relocation (as opposed to anterior leaflet 
augmentation) combined with its demonstrated robustness suggests this adjunctive repair 
may be performed by lesser experienced cardiovascular surgeons.   
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CHAPTER 8 
SPECIFIC AIM 3: NOVEL LEFT HEART SIMULATOR FOR THE 
DEVELOPMENT AND VALIDATION OF COMPUTATIONAL 
MITRAL VLAVE SIMULATIONS 
8.1 Introduction 
In the past ten years, numerical models of the heart’s mitral valve have evolved from 
simple, two-dimensional mathematical approximations to three-dimensional patient 
specific models with couple fluid-structure interaction [221].  These evolving methods 
can provide unique and non-invasive analysis of mitral valve function and biomechanics 
while evaluating fluid flow characteristics pre- and post-operatively [221,222].  More 
recently, medical imaging has been employed to extract patient specific annuloplasty ring 
design, MitraClip implantation and closure, and predict virtual modification of the mitral 
annulus and chordae [223-230].     
However, as numerical mitral valve models have grown in complexity, most still 
lack direct one-to-one experimental validation.  Typically, the computed endpoints of the 
numerical solvers are compared to previously published data, for which only mean values 
are available, and often result in mismatches in valve geometry and boundary conditions.  
As computational solvers can vary considerably, experimental benchmark data are 
important to ensure model accuracy [231].  Without such validation against benchmark 
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data, the computation model is of “questionable” value in its clinical utility.  As rightly 
pointed out by Einstein et al. “…three-dimensional in-vitro flow, deformation and strain 
data with a native mitral valve are sorely needed” [232].  
Herein, a novel left heart simulator designed specifically for the validation of 
mitral valve finite element and fluid structure interaction models is presented.  Several 
distinct and complementary techniques were collectively performed to resolve mitral 
valve geometry and biomechanics.  In particular, micro-computed tomography and three-
dimensional echocardiography were used to obtain high-resolution valvular anatomy and 
systolic leaflet geometry, while stereoscopic digital particle image velocimetry provided 
detailed characterization of the mitral flow field.  In addition, physiologic hemodynamic 
boundary conditions were defined and all data were synchronously acquired through a 
central trigger.   
The results presented below are a demonstration of the capabilities of the novel 
left heart simulator and further subdivided by experimental technique: (i) hemodynamic 
data (ii) echocardiography, (iii) micro-computed tomography, (iv) stereoscopic particle 
image velocimetry, and (v) valve and subvalvular biomechanics.  Finally, current uses of 
the experimental data are explored. 
8.2 Results 
8.2.1 Hemodynamic Boundary Conditions 
Hemodynamic boundary conditions (pressure and flow) were obtained in the left atrium, 
left ventricle, and aortic outflow tract.  Data were acquired at 1 kHz over ten cardiac 
cycles and subsequently ensemble averaged to remove cycle to cycle variability.  
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Representative adult physiological hemodynamics are presented below (Figures 8-1, 8-2, 
and 8-3).   The ensemble averaged mitral flow was 4.8 ± 0.1 L/min, corresponding to a 
stroke volume of 69.9 ± 2.1 mL; the closing volume was 6.5 ± 0.6 mL.  Peak mitral flow 
rate was 13.2 L/min.  Left ventricular pressure peaked at 125.6 ± 1.7 mmHg, and the rate 
of LVP (dLVP/dt) increase was 1506 ± 52.8 mmHg/sec.  Aortic pressure was 122 ± 
1.8/52 ± 0.9 mmHg (systole/diastole).  Diastole lasted approximately 560 msec (as 
denoted by positive flow through the mitral valve); the remaining 300 msec comprised 
systole.  The mitral valve closed in approximately 100 msec (as observed in the 
retrograde flow) and remained closed for the final 200 msec (zero flow) of the cardiac 
cycle.  
The atrial, ventricular, and aortic pressures and the mitral flow were stable (as 
noticed by the low standard deviation) and well simulated [233].  Additionally, the 
waveforms are easily tunable to simulate various pathologies such as tachycardia 
(elevated heart rate), hypertension (elevated systemic pressure), or congestive heart 
failure (depressed cardiac output).  Pressures and flows at all inlets and outlets were 
acquired as various computational techniques require different boundary conditions as an 
input.  For example, finite element solvers may require transmitral pressure [19,234], 
whereas fluid-structure interaction models, such as smooth particle hydrodynamic may 




Figure 8-1 Representative pressure waveforms in the Atrium, Ventricle, and Aorta 
as acquired from the modified heart simulator.  
 
Figure 8-2 Representative mitral flow has low cycle to cycle variability as denoted 
by ± 1 standard deviation. 
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Figure 8-3 Representative aortic outflow and bladder pump inlet flow. 
8.2.2 Geometric Characterization 
Peak systolic anterior and posterior leaflet geometries segmented from three-dimensional 
echocardiography are shown in Figure 8-4.  Echocardiography images were analyzed 
using a previously validated in-house MATLAB tool [197].  The leaflets demonstrated 
good closure curvature and functional redundancy creating a competent seal.  Annular 
area was 4.5 cm
2
.  Coaptation length at the center of the valve was 5.0 mm; this decreases 
to 2.0 mm near the commissures.  The point of coaptation was 9.3 mm from the anterior 
annulus and occurred 2.3 mm from the annular plane.  Different time points in the cardiac 
cycle may be similarly segmented for distinct comparison of leaflet-motion with 
numerical simulation across the cardiac cycle.  This has previously been accurately 
performed for the opening and closing phases, where the leaflets are most dynamic [197].  
As the ultrasound acquisition had a temporal frequency of ~ 20 Hz, 16-17 frames may be 
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analyzed.  This technique has been previously shown to be accurate for segmenting the 
highly dynamic motion of valve closure and opening [197].   
  
 
Figure 8-4 Segmented mitral valve leaflets reconstructed from full volume 
echocardiography. 
    As echocardiography is the clinical standard of care imaging modality, it was 
important for the experimental platform to provide clear acoustic windows which capture 
dynamic mitral leaflet geometry.  The in-house segmentation tool demonstrated the mitral 
leaflets can be clearly and easily extracted from the data [197].  The anterior and 
posterior leaflets and annulus were extracted from 18 apical-basal long axis slices in the 
peak systolic echocardiography frame.  A butterfly mesh interpolation scheme was used 
to create smooth surface topology.  Ongoing development is aimed at providing 
improved acoustic windows to capture subvalvular geometry.  Representative 
echocardiography images through the new acoustic window show the subvalvular 
apparatus can be captured throughout the cardiac cycle (Figure 8-5).   
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Figure 8-5 Full volume echocardiography images acquired through new acoustic 
imaging windows capture subvalvular apparatus.  The green lines indicate a long 
axis slice taken through the central A2-P2 zone.  The red line indicates a short axis 
slice taken at the mitral annulus.   
8.2.3 Micro-Computed Tomography 
In the novel left heart simulator, high resolution micro-computed tomography was 
performed to acquire experimental mitral valve geometry.  That is, valvular anatomy, 
particularly the mitral annulus and papillary muscles, were unperturbed form their 
experimental configuration.  This ensures that experimentally measured endpoints 
directly correspond to acquired mitral valve apparatus geometry; this is a key distinction 
between data generated herein as compared to previously published data. 
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Micro-computed tomography derived geometry is shown in Figure 8-6.  Imaging 
the valve in air provided excellent contrast for reconstruction.  Due to the low-density of 
the biological tissue and its high water content, scanning in solution provided low 
contrast.  The left ventricular chamber had minimal interference, which allowed a high 
quality segmentation to be performed.  Two defined leaflets with small commissural 
scallops were observed.  Chordae tendinae, derived from each papillary muscle, insert 
into the mitral leaflets.  The chordal structures are well defined and show continuous 
insertions into the free edge, belly, and base of the mitral leaflets.  Leaflets and chordal 
structure are asymmetric and have varying lengths and thicknesses.  Comparatively, 
numerical simulations often assume symmetric and homogenous thickness in mitral 
anatomy.  Additionally, unlike present numerical approximations, the chordae do not 
originate from a singular point on the papillary muscles; chordal insertions vary along the 
body of each papillary muscle.  Chordae also appear to branch or diffuse radially into the 
mitral leaflet, which is typically not represented in computer simulated models.  The 
reconstructed annulus and papillary muscles can be registered to the CAD model of the 
left heart simulator using Boolean algebra for use in computational modeling (see 




Figure 8-6 Mitral valve apparatus as reconstructed from micro-computed 
tomography imaging. 
The high spatial resolution (39 µm) micro-computed tomography data were 
necessary to accurately resolve the detailed and intricate chordal branching.  In particular, 
no other modality is currently capable of reliably imaging the marginal chordae, which 
control leaflet coaptation, and are thus critical to numerical modeling accuracy.  Recent 
studies have shown the effect of modeling mitral valve closure with approximated 
chordal structure as compared to more realistic image derived geometry [19].  
Specifically, in models of approximate chordal structure, the mitral leaflets bellow 
unnaturally above the mitral annular plane.   
Mitral valve anatomy was also acquired in closure, representing ventricular 
systole.  This was done at two pressures.  Using a continuous air pressure pump 
connected to the left ventricle, approximately 30 mmHg of pressure was obtained.  This 
was suitable to maintain valve closure.  Further, based on its collagenous microstructure,   
leaflet strain plateaus during closure suggesting this is suitable to capture accurate 
systolic mitral valve geometry [118].  Greater pressure may be obtained with a more 
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powerful air pump; however, with this technique, the valve may dry out making further 
experimentation difficult.  Pressure fixation was also performed using dilute aqueous 
Paraformaldyhe (PFA).  PFA fixation was limited to 70 mmHg; this was determined by 
the largest pressure column possible in the fume hood.  Mitral valve anatomy obtained by 
each complementary imaging modality (micro-computed tomography: off-white; full 
volume echocardiography: cyan) at peak systole is compared in Figure 8-7.  Strong 
agreement in leaflet geometry was observed.  Similarly, diastolic, or open, leaflet 
geometry may be compared.  With the mitral valve scanned in air, the mitral leaflets 
appear shorter after micro-computed tomography reconstruction as compared to 
echocardiography (Figure 8-8).  This suggests a method is needed to unfurl the mitral 
leaflets during scanning (water tension may be causing retraction of the leaflets).  This 
can be circumvented by using the systolic geometry (already shown to agree well 
between echocardiography and micro-computed tomography) or by scanning the leaflets 
in solution.  For the latter, the Phosphotungstic Acid staining (contrast agent) should be 
performed overnight, and the valve should be scanned in ethanol (see Chapter 5.4.1.4.2).     
Micro-computed tomography imaging was limited to these two time points.  Transient 
valvular anatomy during opening or closing was only obtained through 





Figure 8-7 Comparison of mitral valve anatomy obtained through micro-computed 
tomography imaging (off-white) and full volume echocardiography (cyan). 
 
 
Figure 8-8 Comparison of open mitral leaflets reconstructed from echocardiography 
(left) and micro-computed tomography (right). 
Ongoing developments are aimed at improving micro-computed tomography 
image acquisition.  Recent availability of a Siemens Inveon (Siemens Medical Solutions 
USA, Inc.; Malvern, PA) micro-computed tomography system will provide higher 
resolution data (up to 21 µm vs. 39 µm) , faster image acquisition (<20 min vs. ~45 min), 
and larger field of view (56 mm diameter vs. 39 mm) (Figure 8-9).  With higher 
resolution images, smaller marginal chordae can be captured.  Faster data acquisition can 
help ensure the valve does not dry out, making further experimentation possible if 
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necessary.  The larger field of view makes data analysis more streamlined, as the limited 
field of view of the Scanco system caused a high intensity ring artifact at the borders the 
valve anatomy.  This had several drawbacks: (i) valve size was limited by the field of 
view and made simulating annular dilation impossible, (ii) the ring artifact was of similar 
intensity as the valve structure prohibiting simple thresholding from being effective, and 
(iii) automated segmentation techniques required manual user manipulation to be 
effective.  Additionally, there is a large field of view in the axial direction, which allows 
the valve to be scanned from the annulus to the papillary muscles in one pass.  
Previously, the Scanco system required translation of the sample into the bore, which 
resulted in motion artifacts.   
 
Figure 8-9 Comparable image slices from Siemens Inveon and Scanco micro-
computed tomography systems.  Data from the Siemens system have lower signal to 
noise and a larger field of viewing.  A simple band-pass threshold is sufficient 
(applied in images as green) for the Siemens data sets. 
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8.2.4 Stereoscopic Particle Image Velocimetry 
For the first time, stereoscopic digital particle image velocimetry was performed on a 
native mitral valve with intact subvalvular apparatus to quantify the fluid fields through 
and proximal to the mitral valve.  This well-established technique is capable of measuring 
velocity vectors with high spatial resolution at any point in the cardiac cycle, which is 
necessary for the direct quantitative validation of computational fluid dynamics.  
Stereoscopic particle image velocimetry was performed at 27 time points in the cardiac 
cycle.  Four flow fields were captured in the left ventricle at 4, 8, and 15 mm lateral 
spacing from the central plane.  An additional central plane in the left atrium was 
captured using a single camera orthogonal to the flow field.   
 Because of the complex subvalvular apparatus, stereoscopic particle image 
velocimetry was necessary to acquire the best field of view in the left ventricle.  The 
mitral chordae and the papillary muscles obscured the optical access of a single 
orthogonal camera as would be performed with typical 2D PIV.  To improve this, first the 
native papillary were closely trimmed to minimize their thickness without affecting their 
function.  Next, the camera was angled with the use of a Schiempflug filter to minimize 
optical distortion (Figure 8-10).  However, the use of a single camera in a 2D 
configuration led to the underestimation of the velocity vectors; observed velocities were 
a projection of the true velocity vectors onto the imaging plane.  To compensate for this, 
a second camera in a stereo configuration was added.  This also provided the added 





Figure 8-10 Comparison of PIV optical access from orthogonal and angled camera 
configurations.  Dotted red line highlights increased field of view, which captures 
flow through and proximal to the mitral valve. 
Flow fields at key points in the cardiac cycle are presented below.  During early 
systole, the flow field was mostly quiescent when both the mitral and aortic valves were 
closed (Figure 8-11).  During early diastole, the mitral valve opens and flow beings to 
accelerate through the mitral valve.  This is indicated by the velocity vectors into the 
ventricle originating from the mitral orifice.  Flow is primarily orientated perpendicular 
to the mitral annular plane.  Some entrainment of fluid from the quiescent portions of the 
ventricle, particularly near the top and bottom of the image (Figure 8-12), was observed.  
The peak velocity of flow through the vale is about 0.4 m/s in the center of the filling jet.   
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Figure 8-11 Flow field during early systole is mostly quiescent.  Mitral annular 
plane is to the right in the image.  Inlay shows the point on the cardiac cycle 
demarked on the mitral flow curve.   
 
Figure 8-12 Flow field during early diastole shows the onset of left ventricular filling 
through the mitral valve.  Mitral annular plane is to the right in the image.  Inlay 
shows the point on the cardiac cycle demarked on the mitral flow curve.   
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At peak diastole, a strong central filling jet was observed (Figure 8-13).  The peak 
velocity observed in this jet was ~ 0.6 m/s, which is similar to the velocities observed in 
flow through the mitral valve in clinical studies using echocardiography and in in-vitro 
studies on native mitral valves [235-237].  The mitral filling jet appears anteriorly 
oriented, as indicated by the velocity vectors overlaid on the contour plot.  This is a result 
of the anterior leaflet having slightly higher mobility (and opening).  This is similar to 
jets observed in clinical studies using Phase Contras Magnetic Resonance Image and 
echo-PIV [238-240].  As suggested by Kilner et al. [238], the dominant direction of flow 
through the mitral valve is observed to be towards the anterior mitral leaflet free edge.  
The diastolic jet also causes some entrainment of fluid from the quiescent region near the 
aortic outflow, indicated by the redirection of flow towards the central jet.  The peak 
Reynolds number of the flow through the mitral valve, based on the flow at peak diastole 
(15 L/min) and mitral annular area (4.5 cm
2






Figure 8-13 Flow field during peak diastole shows a strong, anteriorly oriented 
central filling jet through the mitral valve.  Mitral annular plane is to the right in 
the image.  Inlay shows the point on the cardiac cycle demarked on the mitral flow 
curve.   
During end diastole, ventricular pressure increases, slowing and reversing flow 
through the mitral valve and ultimately forcing it shut.  This is indicated by the velocity 
vectors oriented towards the mitral annulus (Figure 8-14).  There is minimal flow in the 
remaining portions of the ventricular chamber during this time point in the cardiac cycle.  
No flow was observed when the mitral valve was closed since the valve was competent. 
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Figure 8-14 Flow field during end systole shows mostly quiescent flow with low 
velocity flow reversal, which helps drive the valve closed.  Mitral annular plane is to 
the right in the image.  Inlay shows the point on the cardiac cycle demarked on the 
mitral flow curve.   
Figure 8-15 shows contours of the out-of-plane velocity (W) at peak diastole.  The 
low magnitude of W throughout the entire field of view indicates that the flow is 
predominately two dimensional through the native valve, which can be expected in the 
cylindrical axisymmetric left ventricular chamber.  Similar low out-of-plane velocities 
were observed at all points in the cardiac cycle that were studied (not shown).  Figure 8-
16 shows the out-of-plane vorticity during peak diastolic filling through the mitral valve.  
As expected, the highest magnitudes of vorticity are observed at the edges of the central 
filling jet.  The region of clockwise fluid rotation, indicated by the negative vorticity 
values, appear stronger and more coherent compared to the positive vorticity observed 





Figure 8-15 Contour plot of out of plane velocity during peak diastole confirms flow 
through mitral valve is mostly two-dimensional.  Mitral annular plane is to the right 
in the image.  Inlay shows the point on the cardiac cycle demarked on the mitral 
flow curve.   
 
Figure 8-16 Out of plane vorticity is strongest at edges of central filling jet during 
peak diastole.  Mitral annular plane is to the right in the image.  Inlay shows the 
point on the cardiac cycle demarked on the mitral flow curve.   
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An additional central plane in the left atrium was captured using a single camera 
orthogonal to the flow field.  Stereoscopic particle image velocimetry was not performed 
as the flow was expected to be mostly two-dimensional in the axisymmetric cylindrical 
atrium.  Further, direct optical access to the desired field of view could be obtained with a 
single orthogonal imaging plane.  Figure 8-17 shows a strong central jet filling the left 
atrium through the pulmonary venous return; velocity vectors are directed towards the 
mitral orifice.  Figure 8-18 shows a low velocity retrograde jet.  As the valve was 
competent, this was the closing volume advecting away from the mitral annular.  This 
suggests a regurgitant jet could be accurately resolved in the left atrium in cases of 
simulated mitral valve insufficiency 
 
 




Figure 8-17 Flow in the left atrium during diastole shows a strong pulmonary 
venous return jet.  Velocity vectors are directed towards the mitral orifice.  Mitral 
annular plane is to the left in the image.   
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Figure 8-18 Flow in the left atrium early systole shows a low velocity retrograde 
jet; as this valve was competent, this was the closing volume.  Mitral annular 
plane is to the left in the image 
 
8.2.5 Valve Biomechanics 
Finally, experimental measurements of valve biomechanics can be used to tune material 
properties prescribed to computational mitral valve models.  Of paramount importance, 
complex mitral leaflet deformation needs to be characterized.  Mitral leaflets are non-
linear anisotropic membranes that experience large deformation due to their intricate 
microstructure [4,106,110,134].  To this end, mitral leaflet strain was calculated 
throughout the cardiac cycle through a well-established experimental technique 
[118,194]. 
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 Surface markers on the anterior and posterior leaflets were digitized from dual 
camera photogrammetry in a reference and systolic configuration (Figure 8-19).  The 
reference configuration was chosen at the lowest left ventricular pressure when surface 
markers were easily visible.  Peak systolic closure was determined by selecting the frame 
which corresponded to peak left ventricular pressure (image and pressure acquisition 
were synchronously triggered).  51 nodes were tracked for the anterior leaflet; 23 for the 
posterior leaflet.  Markers were tracked over the entire anterior leaflet and the P2 
(central) scallop of the posterior leaflet.  A triangulated shape function was applied to the 
nodes (71 elements for the anterior leaflet; 28 for the posterior leaflet).  Green areal, 
circumferential and radial strains were calculated based on methods described in 








Figure 8-19 Surface markers on the anterior (green circles) and posterior (blue 
circles) leaflets were digitized from dual camera photogrammetry in a reference and 
systolic configuration. 
Spatially averaged anterior and posterior strains were consistent with previous in-vitro 
studies (Figure 8-20) [36,118,193,194].  Anterior leaflet areal strain (0.577 ± 0.288) was 
greater than posterior leaflet areal strain (0.404 ± 0.360).  Radial strain was the largest 
contributor (anterior leaflet: 0.118 ± 0.107; posterior leaflet: 0.311 ± 0.208).  
Circumferential strain was comparatively low for both leaflets (anterior leaflet: 0.123 ± 
0.103; posterior leaflet: 0.040 ± 0.150).  This is expected as the native mitral leaflets 
extend radially to create competent valvular closure.  Additionally, it is well known that 
the load bearing collagenous fibers preferentially orient in the circumferential direction 




Figure 8-20 Anterior and posterior areal, circumferential and radial strains. 
Local areal (Figure 8-21), circumferential (Figure 8-22), and radial (Figure 8-23) 
strains were additionally characterized to identify regional gradients of leaflet 
deformation.  This is necessary to understand the complex mitral leaflet deformation 
because of the unique scallops and closures geometries.  The anterior leaflet shows 
preferentially larger strains closer to the anterior commissure.  In this region, the 
coaptation line appears to skew towards the posterior annulus, suggesting the anterior 
leaflet undergoes larger deformation as necessary to maintain valve competency.  
Posterior leaflet strain is largest at the central region of the P2 scallop.  Both the posterior 




Figure 8-21 Anterior and posterior areal strain. 
 
Figure 8-22 Anterior and posterior circumferential strain. 
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Figure 8-23 Anterior and posterior radial strain. 
In addition to mitral leaflet strain, forces can be resolved at each papillary muscle 
using in-house built strain gauge transducers [2].  These transducers are the last link 
between the mechanical positioning rods and the native papillary muscles.  Forces can be 
resolved in the tensile and bending components throughout the cardiac cycle.  The largest 
component of force in the normal valvular configuration is in the tensile direction (Figure 
8-24).  Understanding the resultant forces at each papillary muscle provides an additional 
metric to validate subvalvular computational modeling.  Resultant papillary muscle 
forces will be affected by the implementation of chordal anatomy.  While it’s not possible 
to experimentally measure forces on all potential chordae, it is comparatively easy to 




Figure 8-24 Forces at each papillary muscle can be resolved in the tensile and 
bending directions throughout the cardiac cycle.  Force profiles follow the 
transmitral pressure waveform.  The largest force component is in the tensile 
direction. 
8.3 Discussion 
These representative data, along with additional data acquired through further 
experimentation, have become available to the scientific community through a central 
online repository.  This repository is accessible through a password protected secure shell 
client.  The currently available data are tabulated below (Table 8-1).  Micro-computed 
tomography imaging for open (N = 6; MV_1-6) and closed (N = 2; MV_5-6) mitral 
valves are available.  Two of these data sets have corresponding full volume 
echocardiography (N = 2; MV_1-2).  Of these, there are papillary muscle forces (N = 1; 
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MV_1) and leaflet strains (N = 1; MV_1) for one geometry.  For this geometry, 
hemodynamic (120 mmHg peak LVP, 70 bpm heart rate, 5.0 L/min cardiac output, N = 
1; MV_1) and particle image velocimetry (4 flow fields in the left ventricle, 1 flow field 
in the atrium, each sampled every 25 ms in the cardiac cycle, N = 1; MV_1) data are also 
available.  Additional steady flow particle image velocimetry data are available at four 
flow rates for all conditions.   A single valve (N = 1; MV_7) was tested with normal 
papillary muscle positioning and papillary muscle displacement.  Papillary muscle 
displacement was performed in the apical, lateral, and posterior directions for the 
anterolateral papillary muscle, the posteromedial papillary muscle, and both papillary 
muscles simultaneously.  A second iteration of papillary muscle displacement was 














Table 8-1 Currently available data.  Repository population is ongoing. 
Experimental 
Technique 
Sample Size Notes Serial # 
Micro-Computed 
Tomography 
Open (N = 6) 
Closed (N = 2) 
Closed geometry 
obtained at > 30 mmHg. 
MV_1-6 
MV_5-6 
Echocardiography N = 2 Dynamic. MV_1-2 
Papillary Muscle 
Forces 
N = 1 Dynamic. MV_1 
Leaflet Strains N = 1 





N = 1 
Sampled every 25 ms in 
the cardiac cycle.  4 LV 
planes, 1 LA plane. 
MV_1 
Steady Flow Particle 
Image Velocimetry 
N = 1 




Data can be selectively mined based on the methods and objectives of the 
implemented computational solver.  Three such examples of independent research groups 
having made use of the experimental data for their computational model development and 
validation are described below.  Each of these research institutions has a unique approach 
to leverage their particular expertise.   
Siemens Healthcare is placing a priority in the development of anatomically 
accurate models that can be virtually rendered in real time using advanced machine 
learning algorithms [20,21,225].  Because their model generation is exceptionally fast, 
there is an associated loss in patient specific geometric features.  Their mitral valve 
models are developed from a large statistical database, which causes smoothing of unique 
features, such as the indentations between leaflet scallops.  Additionally, their database is 
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populated solely from clinical imaging modalities, which are not capable of accurately 
resolving the complex chordal structure.  As a result, chordae are assumed based on 
representative literature data.  
 The data generated from the novel left heart simulator have been paramount to 
improving their model accuracy.  In particular, Siemens Healthcare is utilizing high-
resolution micro-computed tomography data, full-volume echocardiography, and 
pressure boundary conditions for their model development.  Computational simulations 
of mitral valve closure from high-resolution micro-computed tomography imaging were 
compared to similar such models generated from lower resolution clinical imaging 
(echocardiography) (Figure 8-25).  For each model, experimental pressure boundary 
condition was applied as the driving force to leaflet motion and valve closure.  The 
discrepancy in resultant valve closure geometry was used to parametrically tune the 
anatomical model generated from the lower resolution medical imaging to ultimately 
develop a strategy for simulating patient specific geometry (Figure 8-26).   
 
 
Figure 8-25 Mitral valve anatomy reconstructed from micro-computed tomography 
imaging (Left) and full volume echocardiography (Right).  Notice the idealized 




Figure 8-26 Simulated mitral valve closure is compared for models generated from 
micro-computed tomography and echocardiography imaging. [21] 
 In particular, by combining the state of the art imaging with the standard of care 
imaging, Siemens healthcare is attempting to develop a new empirically derived strategy 
to computationally model the mitral chordae.  A simple workflow is proposed in Figure 
8-27.  As an initial guess, the computational model should assume chordal architecture 
derived from literature.  Subsequently, the chordal anatomy can then be iterated until the 
simulated and experimental endpoints are agreeable.  This may first be performed for the 
control valve; however, these generated models should be further tested under a range of 
hemodynamic and geometric conditions.  Hemodynamic changes may be applied as 
altered heart rate (brachy/tachy-cardia), left ventricular pressure (hyper/hypo-tension), 
and cardiac output (heart failure/exercise). Detailed comparisons between valvular 
mechanics can be performed using leaflet strain and subvalvular force measurements.  
Geometric conditions may be applied as annular dilation and papillary muscle 
displacement (neither of these perturbations affects leaflet or chordal structure).  These 




Figure 8-27 Proposed flow chart to iteratively tune mitral valve anatomy. 
A second example of the unique utilization of these experimental is provided by 
the Center for Cardiovascular Simulation at the University of Texas.  Dr. Sacks et al. are 
developing a microstructurally accurate mitral valve model to understand the precise 
interplay between global mechanical stimuli and underlying cellular response [241].  In 
the short term, Dr. Sacks et al. aims to identify the mechanisms by which global 
mechanics induce cellular response, which in turn mitigates bulk valvular function.  Their 
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ultimate vision is to utilize these models to understand adaptive mitral valve remodeling 
following mitral valve repair to understand and predict long-term repair failure. 
In the first step in this arduous process, Dr. Sacks et al. have developed a novel 
method to map the collagenous microstructure of the mitral leaflets through combined 
micro-computed tomography imaging and Small Angle Light Scattering.  This is done by 
using miniature Ebony glass beads affixed to the atrialis of each mitral leaflet, which then 
serve as landmarks for both experimental modalities.  Microstructural fiber orientation is 
then mapped to the reconstructed micro-computed tomography valve model (Figure 8-
28).  To this end, the micro-computed tomography acquisition protocol was amended to 
include the application of these radio-opaque beads. Scans were performed in the open 
and closed configuration.  Experimental leaflet strain could also be acquired throughout 
each mitral leaflet using the 3D location of these radio-opaque beads.  Static pressure 
boundary conditions were prescribed for these studies, which can be ultimately applied to 
the computational simulations.  Currently, model development is in place.  Preliminary 
studies replace the complex chordal structure with simple tensile elements, which 
originate from the papillary muscles and insert into the leaflets as indicated by micro-
computed tomography.  In the future, stress development in the mitral leaflets will be 
investigated for pathological and surgical repaired mitral valves.  As demonstrated in this 
thesis, simple annuloplasty and complex adjunctive repairs can be performed with these 
experimental techniques to provide the necessary data to assess the models predictive 




Figure 8-28 Radio opaque glass beads are used to register microstructure fiber 
orientation to micro-computed tomography reconstructed mitral leaflet geometry. 
 Finally, in collaboration with the University of Maine, Pacific Northwest National 
Laboratory, and the Cardiovascular Fluid Mechanics Laboratory at Georgia Tech, an 
atomically accurate mitral valve fully three-dimensional fluid structure interaction model 
is being developed.  Previous models utilize pressure boundary conditions to drive leaflet 
dynamics; these models fail to appreciate the intimate relationship between fluid 
dynamics and mitral valve and ventricular function.  Several studies have implicated 
mitral inflow in deleteriously affecting ventricular vortex dynamics and systolic 
ventricular function [235-237,242].  Additionally, initial flow reversal and ventricular 
vortex dynamics have been suggested to impact mitral valve closure [243-245].  Systolic 
valvular function (Systolic Anterior Motion) has also been shown to be effected by 
acceleration of left ventricular outflow (Venturi effect) in obstructive hypertrophic 
cardiomyopathy.  Systolic Anterior Motion may also occur following poorly executed 
surgical repair which displaces the coaptation line anteriorly [246,247]  
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This model will be the first to fully incorporate the intimate mechanical feedback 
between mitral valve dynamics and the surrounding fluid flow.  The anatomic mitral 
valve geometry is developed directly from the micro-computed tomography data; no 
assumptions are made concerning leaflet shape or thickness, and chordal architecture 
(Figure 8-29).  Fluid dynamics through and proximal to the mitral valve will be 
quantitatively compared to the highly resolved stereoscopic particle image velocimetry 
data.  Because this computational model uses a Smooth Particle Hydrodynamics 
computational solver, flow boundary conditions were utilized at all inlets and outlets.  In 
this case, pressure conditions experimentally acquired at these locations were used for 
validation.  This model has the potential to accurately simulate mitral regurgitation and 
predict valve competency following virtual surgical repair procedures.   
 
 
Figure 8-29 Highly resolved mesh of the anatomically accurate mitral valve model 
generated from micro-computed tomography. 
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The three examples presented above are a short list of possibilities tailored specifically to 
the individual expertise of each research institution.  Through an initiative towards an 
open access repository, it is believed these and future data will be strategically mined for 
continued mitral valve model development and validation.   
8.4 Conclusions 
Recent advances in computational mitral valve modeling aim to provide an ideal platform 
for mitral valve surgical planning.  These models have ability to mimic complex repair 
procedures preoperatively and non-invasively [223-230]. However, high-fidelity 
experimental data are necessary to validate these finite element and fluid-structure 
interaction models to ensure their clinical accuracy and utility.  The current study 
presents a novel platform to provide these data for direct one-to-one validation of the 
complex geometry and biomechanical responses of the mitral valve.  Multiple state of the 
art experimental techniques can be combined to create comprehensive benchmark data 









Table 8-1 Comprehensive experimental benchmark data are generated through 
multiple complementary experimental techniques. 
 































CLINICAL SIGNIFICANCE, LIMITATIONS, AND FUTURE WORK 
9.1 Clinical Significance 
In this thesis, significant progress was made in developing a new planning paradigm for 
the surgical treatment of mitral valve disease.  This planning paradigm explored three key 
steps in the surgical management of mitral valve disease, including: (i) clinical diagnosis, 
(ii) targeted surgical repair efficacy, and (iii) development and validation of novel 
computational predictive mitral valve models (Figure 9-1).   
 
 
Figure 9-1 Patient specific treatment planning is a multi-factorial process that 
combines clinical diagnosis, understanding treatment options and efficacy, and 
utilizing novel computational methods for predicative virtual modeling.   
The first step in the clinical management of mitral valve disease is to accurately 
identify patients for surgical referral.  Currently, this decision making process relies on an 
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integrative approach that factors qualitative grading of mitral regurgitation severity, 
presentation of symptoms, left ventricular function, and likelihood of successful repair 
[24].  As an example, isolated mitral valve surgery is not indicated for patients with mild 
or moderate mitral regurgitation, but surgery is beneficial for asymptomatic patients with 
chronic severe regurgitation and mild to moderate left ventricular dysfunction.  These key 
distinctions underscore the need to accurately quantify mitral regurgitation severity.  In 
particular, clear quantitative delineation between moderate and severe mitral 
regurgitation would promote timely and beneficial surgical intervention. 
Unfortunately, current clinical characterization of mitral regurgitation in of itself 
can be a complicated, integrative assessment.  Qualitative measurements include 
angiographic grading (invasive), regurgitant jet area and direction, and vena contractra 
width.  Quantitative measurements include regurgitant volume, fraction, and orifice area.  
These latter measurements, however, are known to underestimate mitral regurgitation and 
suffer from poor intra- and inter-observer variability.  Additionally, these measurements 
have their largest errors at moderate to severe regurgitation, particularly where mitral 
regurgitant orifice geometry violates a critical assumption in the methodology.   
These issues were recently recognized in an editorial in the Journal of the 
American Society of Echocardiography where Dr. Stephen H. Little noted, “Ideally what 
the imaging clinician needs is a single tool to accurately quantify a broad range of MR 
severity, and to be able to apply that same tool over time to make informed decisions 
about valve function, and patient prognosis” [18].  In that same editorial, a call for “an 
irrefutable reference standard – a gold standard – for the quantification of regurgitant 
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flow volume” was initiated.  Clinical studies are limited by this principle lack of a gold 
standard by which new measurement techniques can be compared.   
For this reason, the Georgia Tech Left Heart simulator was used for the 
development and validation of a novel regurgitant flow quantification tool.  The Philips 
3D Field Optimization Method presents a great possibly to impact future clinical 
diagnosis of mitral valve disease.  In the studies presented herein, this simple to use 
technique was demonstrated to have superior accuracy and intra-observer robustness than 
the current clinical standard, 2D PISA.  Through use of these experimental gold standard 
data, further refinement of the 3D FOM is possible, as is similar development by other 
researchers.   
These quantifiable tools will lead to better delineation of treatment and 
progression of mitral valve disease and the critical timing of surgical indication.  As a 
result, surgical treatment options may be tailored based on the clinical characterization of 
the valvular disease.  A specific example where targeted treatment is needed is ischemic 
mitral regurgitation where the current preferred surgical repair option results in 
unacceptably high rates of recurrent regurgitation within the first 5 years of intervention.  
Using quantitative metrics of regurgitant flow and functional assessment of the mitral 
valve and left ventricle, surgical repair may be optimized to ensure long-term repair 
durability.  In particular, patients presenting with ischemic mitral regurgitation that may 
not benefit from isolated restrictive annuloplasty and require adjunctive surgical 
treatments may be identified.   
 Consequently, it is important to understand the efficacy of these targeted 
adjunctive surgical repairs.  Additionally, as these repairs may increase surgical 
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complexity, it is important to understand the effect of repair variability on resultant 
valvular function.  In this thesis, two such adjunctive surgical repairs were investigated 
together with ring annuloplasty: (i) anterior leaflet augmentation, and (ii) basal papillary 
muscle relocation.  Both of these repairs were found to restore leaflet coaptation and 
valve function while reducing tethering through the subvalvular apparatus in the 
treatment of ischemic mitral regurgitation.  Specifically, these results were demonstrated 
in a setting of extreme papillary muscle displacement often associated with severe left 
ventricular dilation.  Adjunctive surgical repair compared favorably against the surgical 
preferred treatment, which suggests there may currently be a mismatch between patient 
valvular dysfunction and applied surgical repair.   
The results herein may provide the “average” cardiac surgeon with the confidence 
to perform such complex adjunctive surgical repairs, which may otherwise be eschewed 
in favor of simple annuloplasty.  Anterior leaflet augmentation was found to be 
efficacious with two significantly different patch sizes.  There were no deleterious effects 
on valvular function caused by oversizing the pericardial patch.  These data show a large 
range of pericardial augmentation sizes can be performed, or more simply an oversized 
patch can be targeted to maximize leaflet coaptation.   
Similarly, basal papillary muscle relocation did not require a high degree of 
anatomical precision to restore valvular function and alleviate leaflet-subvalvular 
tethering.  Specifically, two key sources of potential surgical variability were explored.  
First, the location of the mitral annulus to which the papillary muscles will be suspended 
from did not affect resultant valvular function.  Regardless of the how the repair was 
performed, apical-basal displacement of the papillary muscle was largely corrected.  This 
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isolated directional improvement was sufficient despite residual displacement in the 
posterior and lateral directions.  Second, a range of apical-basal relocation magnitude was 
capable of restoring valvular function.  As pre- and peri-operatively determining how far 
the papillary muscles should be relocated is challenging, these findings should be 
encouraging to the surgical community.  Finally, surrogate measurements were identified 
which could inform the surgical repair by approximating the relationship between 
systolic leaflet closure and papillary muscle position. 
While these studies were able to demonstrate the efficacy and robustness of these 
adjunctive surgical repairs, they remain limited as patient to patient variability creates an 
additional aspect of complexity, which may not be reasonably studied in an experimental 
framework.  The pathological conditions created herein were informed from  
averaged clinical statistical data.  As with any statistical measurement, individual nuances 
are overlooked.  For this reason, novel computational tools are being developed for the 
patient-specific predictive surgical evaluation for mitral valve repair.   
  These models have evolved from simple and idealist annular, leaflet, and chordal 
profiles to patient specific models derived from medical imaging.  Computational models 
have the potential to provide unique non-invasive evaluation of mitral valve mechanics 
and function pre- and post-operatively.  These models vary considerably in their 
execution owing to differences in anatomical construction, material properties, boundary 
conditions, and preferred numerical solver methods.  The mitral valve apparatus has a 
complex structure, for which any of the components can be modeled through direct image 
reconstruction or with idealized simplifications.  Most notably, the leaflets are often 
modeled with homogeneous thickness and without commissural scallops [168].   The 
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chordae are approximated as simple traction only elements without any thickness and 
minimal anatomical branching, and the papillary muscles are never modeled.  Figure 9-2 
highlights some of the subtle but important differences that are observed between mitral 
valve models.  Material properties are applied differently between models, despite the 
well characterized non-linear anisotropic, inhomogeneous tissue response.  Boundary 
conditions may be applied as a dynamic annulus or papillary muscles, the valve may be 
modeled in isolation or within the anatomy of the left heart, and pressure or flow 
hemodynamics may be applied.  Finally, numerical solvers may utilize finite element 
analysis, mass-spring modeling, or fluid-structure analysis.   These limitations currently 
affect the clinical accuracy and applicability of such computational simulations. 
 
 
Figure 9-2 Three separate mitral valves are reconstructed from micro-computed 
tomography (Top: posterior view; Bottom: anterior commissure view).  There are 
noted differences in leaflet lengths, scallop indentations, chordal branching, and 
papillary muscle tips.  
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Therefore, in this thesis, an experimental framework was developed for the direct 
one-to-one validation of computational methods against comprehensive, time-resolved 
experimental data with multiple measured endpoints and well defined boundary 
conditions (Figure 9-3).  Additionally, such systematic data can be used to understand 
whether increasing model fidelity and complexity provides marked gains in clinically 
assessing mitral valve function and structural mechanics, particularly as a patient specific 
surgical planning tool.  After these tools have been comprehensively validated, they may 
be used in pre-operative surgical planning, where surgical options can be assessed 
virtually on patient specific valvular anatomy.  Figure 9-4 shows a simple flow chart, 
which outlines how a predictive surgical planning tool may be used.  Anatomical mitral 
valve geometry can be created from standard of care echocardiography.  The lessons 
learned from these in-vitro studies will be applied to resolve the differences between 
observed valvular geometry through clinical imaging with true anatomy.  The material 
properties of the computational model can be initialized based on data from the in vitro 
studies and subsequently tuned for the patient’s native mitral valve by comparing the 
simulated and observed valve dynamics.  Virtual surgical options may then be simulated 
and assessed for efficacy.  Difficult to measure tissue responses such as stress and strain 
may also be compared to optimize for long-term repair durability.  Such a paradigm has 
been pioneered by the Cardiovascular Fluid Mechanics Laboratory and implemented 
through a novel virtual interface for countless patient-specific predictive surgical 




Figure 9-3 Patient specific treatment planning is a multi-factorial process that 
combines clinical diagnosis, understanding treatment options and efficacy, and 
utilizing novel computational methods for predicative virtual modeling.  
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As with all experimental methods, the studies presented in this thesis are not 
without limitations.  Although the in vitro model used in these studies simulate the 
physiologic function, hemodynamics, and mechanics of the normal and diseased mitral 
valve, certain limitations remain.  An initial limitation of this study is associated with the 
interspecies variability between ovine and human mitral valves.  Ovine mitral valves 
were used in this study because of the limited availability of human tissue.  Fortunately, 
ovine mitral valves bear close anatomical and functional resemblance to human mitral 
valves [184,185].  Ovine mitral leaflets have similar dimensions to human valves, which 
makes creating normal and pathological dysfunction possible.  While ovine mitral valve s 
contain less chordae than human valves, both valve types exhibit comparable chordal 
distribution and structure.  For these reasons, large animal studies also employ ovine 
models to investigate mitral valve dysfunction and surgical repair.     
The rigid ventricle used in this thesis did not mimic native dynamic annular and 
ventricular dynamics: (i) the native mitral annulus changes in size and shape during the 
cardiac cycle [100,249-251], (ii) the left ventricle undergoes helical apical-basal 
contraction, and (iii) the papillary muscles contract throughout the cardiac cycle 
[172,252].  During exercise, these dynamics are known to further exacerbate mitral 
regurgitation [253], a phenomenon, which cannot be simulated with these methods.  
Although these dynamics were not simulated, the distance between the papillary muscles 
and the annular plane have been shown to remain relatively constant throughout the 
cardiac cycle [252]; the papillary muscle can be considered as shock absorbers to for the 
mitral apparatus.  Furthermore, these dynamics are retarded in functional mitral valve 
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disease [13,191,209].  All the repairs in this thesis were supported with mitral 
annuloplasty, which further obliterates native mitral annular dynamics [254].   
These recognized limitations can be improved upon by future iterations of the left 
heart simulator. Preliminary research has been performed to create a dynamic papillary 
muscle system.  In this system, the apical-basal position of the papillary muscles can be 
controlled through servo motors using custom motion profiles programmed through 
LabView [255].  A similar approach can be taken to create mitral annular dynamics.  The 
drawstring mechanism which currently allows the mitral annulus to dilate may be 
motorized to create the sphincteric motion observed in normal physiology.  A separate 
motorized mechanism would be needed to create active non-planarity of the mitral 
annulus.  This out of plane motion may not be critical, however, as the saddle shape of 
mitral annulus does not affect valvular competency [188].  Despite these limitations, this 
thesis makes significant contributions to the clinical and academic community through 
elucidating mitral valve function and mechanics in disease and surgical repair, while 
improving clinical diagnosis and advancing predictive computational modeling.     
While the experimental techniques performed were designed to limit their 
invasiveness on mitral valve mechanics, the miniature chordal force transducers may 
effect chordal strain and subsequently valve closure.  The brass spring element replaces a 
small portion of the native chordae.  This spring element is designed to limit strain to 3% 
(the operating range of the strain gage); in comparison, the native strut chordae may 
strain up to 20% [256].  This more rigid brass element may therefore affect the closure of 
the valve.  Additionally, as the strut chordae vary from valve to valve, the brass element 
may comprise a larger proportion of the chordae (for smaller strut chordae).  This may 
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affect the total force measured at each chordae, which is a potential source of the large 
standard deviations observed in the chordal force data.  
9.3 Future Studies 
9.3.1 Specific Aim 1 
Several future studies have been identified to continually benefit the clinical and 
scientific communities.  Additional data are needed to further assess the efficacy and 
robustness of the Philips 3D Field Optimization Method with the adaptive z-height 
algorithm.  Specifically, the experimental model needs to be adjusted to simulate apical-
basal migration of the regurgitant orifice.  This may be challenging to accomplish, but 
there are 3 possible solutions.  First, the echo transducer can be mounted onto a 
mechanical traverse to artificially create the relative motion between the probe and the 
dynamic heart as observed clinically. Second, a dynamic mitral annulus plate may be 
used to create apical-basal translation of the mitral annular plane.  This can be done by 
replacing the rigid acrylic plate with a rubber membrane that can deflect with elevated 
left ventricular pressure.  This was previously done in in vitro studies to understand the 
effect mitral annular non-planarity on subvalvular force distribution [188,217].  A third 
approach may be possible as described above through a dynamic mitral annulus.  
Programmable servomotors may be utilized to produce mitral annular contraction and 
non-planar motion.  With the use of one of these options, a range of mitral regurgitation 
conditions should be performed.  As was done in this thesis, mitral annular dilation and 
papillary muscle displacement could be utilized to create round and slit orifices at mild, 
moderate, and severe mitral regurgitation grades.  These data will help differentiate 
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between the adaptive radii and adaptive z-height iterations of the 3D Field Optimization 
Method.  They may also be used for the development other similar methods.   
 Particle image velocimetry may be performed to acquire highly resolved 
velocities in the flow convergence zone.  Because of the difficult viewing angles, 
stereoscopic-PIV may not be possible, but 2D-PIV should be sufficient.  As it may be 
difficult to identify the location of the regurgitant jet, a traverse system will be needed.  
Preliminary acquisitions will need to be acquired to assess if the necessary flow fields 
were captured and the position of the laser plane and imaging window can be optimized.  
As the regurgitant jet is a three dimensional volume, several planes will need to be 
acquired.  A strategy for acquiring imaging planes and calibration will need to be 
considered.  It is not recommended to acquire data and calibration a single plane at a 
time, as the dynamics of a regurgitant orifice may be complicated.  If full-volume PIV is 
possible, this is recommended as the entire jet can be captured through a single 
acquisition.   
 A final future study is suggested to understand the effect of the hemispherical 
assumption on the accuracy of the FOM technique.  No new data is required for this.  A 
hemi-elliptical approximation to the flow convergence zone is recommended based on 
the observations by Hopmeyer at al [202,203] (Figure 9-5).  This may be calculated using 
the approximation for the surface area of a hemi-ellipsoid with height A and widths B 












Figure 9-5 Hemi-ellipsoidal isovelocity contour in two perpendicular planes. 
9.3.2 Specific Aim 2 
Anterior leaflet augmentation and basal papillary muscle relocation were demonstrated to 
be efficacious for the repair of ischemic mitral regurgitation in the pulsatile left heart 
simulator.  These repairs should be investigated in randomized clinical trials to best 
identify which patients should have targeted adjunctive surgical repairs.  The clinical 
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studies should involve a comparison to restrictive mitral annuloplasty.  Clinical endpoints 
of efficacy should include mortality, mitral regurgitation grade, and New York Heart 
Association (NYHA) functional classification of the stages of heart failure.  Preoperative 
patient characteristics including leaflet coaptation and tethering, papillary muscle 
position, and ventricular dimensions should be measured.   
 Animal studies may be performed to investigate the predicative capability of 
using surrogate leaflet measurements to pre-operatively determine the amount of basal 
papillary muscle relocation needed to promote leaflet coaptation.  These studies should 
utilize full volume echocardiography to carefully measure leaflet coaptation, annular 
diameter, and papillary muscle position pre-operatively.  The linear relationship between 
leaflet closure geometry and papillary muscle positioning can be utilized to inform the 
basal papillary muscle relocation.  The expected leaflet coaptation following this applied 
papillary muscle relocation can then be compared to the postoperative geometry 
observed.  These experiments can be used to refine the previously observed in vitro 
relationships between leaflet geometry and papillary muscle position. 
 The pinnacle prospective study would involve randomized patient treatment 
comparing the efficacy of undersized ring annuloplasty to these adjunctive repairs; a ratio 
of 1:1:1 is suggested.  The study should recruit patients with severe mitral regurgitation 
(carefully graded through a 3D PISA method).  End points should include postoperative 
regurgitation, left ventricular reverse remodeling (end-systolic diameter), mortality, and 
adverse cardiac events measured acutely and at a 12 month follow up.  Patients should 
also be classified by their degree of preoperative left ventricular diameter.  It’s expected 
that the largest benefit of these adjunctive repairs may be found in patients with severe 
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left ventricular dilation, where isolated ring annuloplasty may not be an appropriate 
treatment.   
9.3.3 Specific Aim 3 
The development and comprehensive validation of computational mitral valve models 
will be further aided by additional acquisition of experimental data.  If possible, human 
mitral valves should be procured for these studies.  This will limit any errors associated 
with mapping material properties from the ovine models to human mitral valves.  
Experimental studies should also aim to produce pathological mitral valve conditions as 
well as surgical repairs.  Functional mitral valve disease can be performed using 
combinations of mitral annular dilation and papillary muscle displacement.  Simulated 
and experimental mitral valve function and mechanics should be compared.  Simulated 
mitral valve anatomy (specifically leaflet structure and chordal anatomy), and material 
parameters should not be adapted between conditions. These should be tuned to the 
physiological conditions, and once established should not be refined.    This will allow 
the predicative capabilities of the simulations to be assessed.  Following pathology, a 
myriad of surgical options can be performed experimentally as well as in silico, including 
those previously mention in this thesis.  Again, the computed and experimental end 
points should be compared. 
 As previously mentioned the in vitro model can be improved with the addition of 
mitral annular and papillary muscle dynamics.  This adds another level of complexity for 
which computational models should be assessed.  The motion profiles of the annulus and 
papillary muscles should be carefully prescribed, such that they can be applied 
computationally.   
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 Following the development of these computational models through these studies, 
preliminary clinical evaluation of the computational tools should be assessed.  This may 
be performed through the use of retrospective medical imaging data.  Pre- and post-
operative echocardiography (or computed tomography) with detailed notes on the 
implemented surgical strategy will allow a patient specific mitral valve computational 
model to be created and evaluated.  The preoperative data can be used to create and tune 
the virtual model, while the detailed notes will be used to virtually recreate the 
implemented surgical strategy.  Postoperative computed and actual valve function can be 
compared to assess the predictive capability of the computational models.  A variety of 
surgical repairs should be targeted, specifically, ring annuloplasty, papillary muscle 




 A new treatment planning paradigm for mitral valve disease was developed on the 
strength of recent advances in medical imaging technology, targeted etiology 
specific repairs, and computational mitral valve repair models.  Specifically, an 
integrative experimental framework was utilized with the intent of improving 
mitral valve surgical repair outcome through multiple complementary approaches.   
 The Philips 3D Field Optimization Method, a clinical tool for the quantitative 
analysis of mitral regurgitation, was developed and validated against gold-
standard experimental data for a range of mitral valve disease conditions (mild to 
severe mitral regurgitation).  This tool was found to be as efficacious and more 
robust compared to the current clinical standard, 2D PISA.  The experimental data 
may be likewise utilized for development of similar tools in the future.   
 Adjunctive repairs for the surgical treatment of ischemic mitral regurgitation were 
found to be as efficacious as the current surgical preferred treatment, restrictive 
mitral annuloplasty.  These repairs, anterior leaflet augmentation and basal 
papillary muscle relocation, restored valvular function while reducing the leaflet-
subvalvular tethering associated with ischemic left ventricular remodeling.  These 
adjunctive repairs have the potential to withstand late ventricular remolding, a 
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common mode of isolated annuloplasty ring failure.  Finally, the studies herein 
discovered the repairs are robust to variability in surgical implementation, which 
may encourage a more widespread clinical adaptation.  Additional studies are 
needed to best identify which patients will benefit from adjunctive repairs as 
compared to restrictive mitral annuloplasty.   
 An integrative experimental framework was developed for the comprehensive 
validation and advancement of novel computational surgical planning platforms 
for mitral valve disease.  The experimental framework combines high-resolution 
state of the art imaging with clinical imaging to provide the most realistic 
anatomical reconstructions possible, including leaflet heterogeneity and chordal 
architecture.  For the first time, ventricular flow fields through and proximal to 
the native mitral valve, including its subvalvular structure, were acquired 
throughout the cardiac cycle using stereoscopic particle imaging velocity.  These 
data are combined with highly resolved geometric and boundary conditions with 
measurements of leaflet dynamics and subvalvular forces to create the most 




A.1 Paraformaldehyde Fixation 
Paraformaldehyde fixative (PFA) can be used to pressure fix the mitral valve into the 
closed or systolic geometry.  PFA is preferred to gluteraldehyde fixation if small angle 
light scattering (SALS) will be performed.  4% Paraformaldehyde fixative can be 
prepared fresh following the below protocol (the protocol was adapted from Biocare 
Medical; Concord, CA).  To yield 100 mL of 4% PFA fixative: 
1. Dissolve 4 g of paraformaldehyde in 90 mL of 1X Phosphate Buffered Saline 
(PBS) 
2. Heat gently to 58 - 60° C under a hood.  Do not heat over 60°C 
(paraformaldehyde disassociates at 60°C) 
3. Add 10N NaOH to clear the solution (pH 10 dissolves the paraformaldehyde). 
Usually 5 – 10 drops 
4. Remove from heat and pH 
5. Carefully titrate to pH 7.0 – 7.5 
6. Bring to volume (100 mL) PBS (for a final concentration of 4 g in 100 mL of 1x 
PBS) 
7. Filter sterilize through a .22 micron filter 
8. Use at room temperature 
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It is best to prepare fixative fresh.  However, the fixative can be stored at 4°C for up to 2 
weeks.  Fixative should be scaled up as needed for proper pressure fixation.  Pressure 
fixation should be performed in a fume hood.   
A.2 Phosphotungstic Acid  
Phosphotungstic acid (PTA) is a contrast agent which may be used to enhance micro-
computed tomography image quality.  To prepare 1% (w/v) Phosphotungstic acid in 
water (protocol was adapted from [195]): 
1. Mix 30 mL 1% PTA solution with 70 mL absolute ethanol to make 0.3% PTA in 
70% ethanol; this keeps indefinitely 
2. Take samples to 70% ethanol 
3. Stain overnight or longer 
4. Staining is stable for months 
5. Samples may be scanned in 70-100% ethanol; samples may also be scanned in 
saline 
A.3 Particle Image Velocimetry 
The following operations were performed in Davis 7.2 to process the stereoscopic 
particle image velocimetry data: 
1. Particle Image Velocimetry 
a. Group: Stereo Vector Field Computation 
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b. Operation: Particle Image Velocimetry 
2. Image Preprocessing 
a. Sliding background subtraction, scale length: 10 pixels 
3. Vector Calculation Parameter 
a. Data range = use masked area: create user defined mask 
b. Correlation mode: stereo cross-correlation 
c. Iterations: Multi pass (decreasing window size) 
i. 64 x 64, square weight (1x1), 50% overlap, 2 passes 
ii. 32 x 32, square weight (1x1), 50% overlap, 2 passes 
d. Usage of masked out pixels 
i. Disable vector if at center of interrogation window there is no valid 
pixel 
ii. Allowed ratio of masked out to all pixels before disabling the 
vector: 0.3 for the first pass, 0.6 for all subsequent passes 
iii. Allowed ratio of masked out to all pixels before switching to direct 
correlation: 1 for first pass, 0.1 for all subsequent passes 
e. Initial reference vector field 
i. Constant initial interrogation window shift 
ii. Restrictions implied by (adaptive multipass / initial) reference 
vector fields 
1. Relative vector range restriction = reference +/- all 
(window size/2) AND absolute vector range restriction = 
reference +/- 10 pixels 
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iii. Symmetrical vector position: in the middle between interrogation 
windows/images 
f. Correlation function 
i. Initial Pass(es): standard l1x2 (via FFT, no zero padding) 
ii. Final Pass(es): standard l1Xl2 (via FFT, no zero-padding) with 
high-accuracy mode for final vector result (Whitaker 
reconstruction) 
g. Correlation peak validation 
i. 3D vector valid only if error < 5 pixels 
ii. Quantity stored in peak ratio of vector field: correlation ratio ½ 
peak 
h. Multi-pass post processing 
i. Median filter: strongly remove and iteratively replace 
1. Remove if difference to average > 2*R.M.S of neighbors 
2. (re)insert if difference to average < 3*R.M.S of neighbors 
ii. Remove groups with < 5 vectors 
iii. 1x Smooth 3x3 
 
Three components of velocity were averaged over the 50 image pairs and exported as 




In this section, the raw experimental data from specific Aims 1-3 are presented.  These 
data were used to compile the tables and create the graphs, and compute the statistics 
seen throughout this thesis.   
B.1. Specific Aim 1 
B.1.1 Enface Images of Mitral Regurgitant Orifices 
  
Figure B-1 PISA B, Orifices 1 and 2. 
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Figure B-2 PISA B, Orifices 3 and 4. 
  
Figure B-3 PISA C, Orifices 1 and 2. 
  




Figure B-5 PISA E, Orifices 1 and 2. 
  
Figure B-6 PISA E, Orifices 3 and 4. 
 
B.1.2 Enface Reconstruction of Proximal Flow Volume through Manual 3D 
Integrative PISA 
  
Figure B-7 PISA A, Orifice 2, Flow 1 and Orifice 3, Flow 2. 
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Figure B-8 PISA A, Orifice 4, Flow 1 and Flow 2. 
  
Figure B-9 PISA B, Orifice 4, Flow 2 and Flow 3. 
  
Figure B-10 PISA C, Orifice 1, Flow 1 and Flow 2. 
  
Figure B-11 PISA C, Orifice 1, Flow 3 and Orifice 2, Flow 1. 
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Figure B-12 PISA C, Orifice 2, Flow 2 and Flow 3. 
  
Figure B-13 PISA C, Orifice 3, Flow 1 and Flow 2. 
  
Figure B-14 PISA C, Orifice 3, Flow 3 and Orifice 4, Flow 1. 
  
Figure B-15 PISA C, Orifice 4, Flow 2 and Flow 3. 
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Figure B-16 PISA E, Orifice 1, Flow 1 and Flow 2. 
  
Figure B-17 PISA E, Orifice 1, Flow 3 and Orifice 2, Flow 2. 
  
Figure B-18 PISA E, Orifice 2, Flow 3 and Flow 5. 
  
Figure B-19 PISA E, Orifice 3, Flow 1 and Flow 2. 
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Figure B-20 PISA E, Orifice 3, Flow 3 and Orifice 4, Flow 1. 
  
Figure B-21 PISA E, Orifice 4, Flow2 and Flow 3. 
 
B.1.3 Summary of Average PISA data for all Analysis Techniques  
 
Table B-1 Summary of Average PISA data for all analysis techniques. 


















1 A 2 1 42 round 21.9 -- 23.5 -- -- -- 
2 A 2 2 51 round 28.5 -- 31.4 -- -- -- 
3 A 3 1 68 round 22.7 29.5 23.4 -- -- 29.2 
4 A 3 2 92 round 31.8 30.0 30.2 -- -- 27.9 
5 A 4 1 107 slit 21.5 37.1 16.0 17.0 16.5 13.5 
6 A 4 2 126 slit 31.2 32.0 36.1 42.4 40.8 33.4 
7 A 5 1 176 round 18.2 -- 17.1 -- -- -- 
8 A 5 2 188 round 22.8 -- 22.1 -- -- -- 
9 2 1 1 7 round 13.8 -- 10.2 -- -- -- 
10 2 1 2 14 round 21.2 -- 16.9 -- -- -- 
11 2 2 1 24 round 19.8 -- 24.4 -- -- -- 
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12 2 2 2 31 round 19.3 -- 20.8 -- -- -- 
13 2 3 1 38 round 33.8 -- 32.7 -- -- -- 
14 2 3 2 42 round 45.0 -- 40.3 -- -- -- 
15 2 4 1 52 round 52.9 -- 17.4 51.2 -- -- 
16 2 4 2 65 round 36.6 34.2 19.4 52.8 -- 36.5 
17 2 4 3 74 round 59.4 64.4 12.5 62.8 -- 48.2 
18 3 1 1 7 slit 59.5 37.6 48.4 56.7 59.9 64.1 
19 3 1 2 18 slit 67.8 60.5 46.3 65.7 73.8 61.4 
20 3 1 3 25 slit 34.3 21.0 36.7 20.7 25.7 30.1 
21 3 2 1 32 slit 37.2 34.6 62.1 42.2 49.1 40.7 
22 3 2 2 43 slit 71.2 96.3 37.3 99.5 100.2 74.5 
23 3 2 3 59 slit 29.7 30.4 32.8 29.1 31.9 23.9 
24 3 3 1 56 slit 52.6 52.7 60.8 58.3 63.2 46.9 
25 3 3 2 66 slit 69.5 63.4 55.3 88.0 84.5 64.0 
26 3 3 3 76 slit 40.9 37.2 47.1 41.6 44.0 47.1 
27 3 4 1 82 slit 48.7 44.3 46.7 43.9 44.0 53.7 
28 3 4 2 88 slit 63.1 62.8 61.0 83.2 83.2 69.2 
29 3 4 3 97 slit 49.9 55.5 55.9 49.5 51.0 46.2 
30 4 1 1 10 slit 30.0 18.4 15.9 23.9 25.6 41.7 
31 4 1 2 19 slit 37.9 25.9 26.6 61.6 58.9 47.2 
32 4 1 3 28 slit 27.3 20.2 21.8 30.6 37.8 33.9 
33 4 2 2 47 slit 61.0 29.2 21.6 53.4 57.9 49.6 
34 4 2 3 54 slit 44.1 30.1 20.9 41.6 46.4 47.6 
35 4 2 4 63 slit 61.4 -- 24.2 65.8 69.0 -- 
36 4 2 5 69 slit 56.2 34.2 21.4 59.5 51.3 57.0 
37 4 3 1 81 round 14.3 12.7 12.5 -- -- 11.4 
38 4 3 2 90 round 22.5 22.0 20.5 -- -- 11.4 
39 4 3 3 99 round 20.5 19.3 13.5 -- -- 14.4 
40 4 4 1 108 slit 39.8 16.0 23.2 48.6 52.2 48.1 
41 4 4 2 118 slit 48.1 25.3 22.1 49.3 50.6 50.2 
42 4 4 3 127 slit 50.7 27.9 16.1 53.2 49.5 38.4 
 




B.2.1 Anterior Leaflet Augmentation 
Table B-2 Mitral regurgitation for all anterior leaflet augmentation conditions. 
  Mitral Regurgitation [mL] 
  Small Patch Large Patch Combined 
  Avg Stdev Avg Stdev Avg Stdev 
Healthy 23.5 2.0 32.2 3.8 27.6 5.3 
IMR 43.4 7.1 51.2 9.0 47.0 8.7 
Undersized MA 21.7 3.6 28.6 2.6 27.5 4.6 
Anterior Leaflet Patch w. No 
MA 
38.9 8.0 50.5 7.0 24.9 4.7 
Anterior Leaflet Patch w. 
Oversized MA 
30.2 5.4 43.6 6.7 44.3 9.4 
Anterior Leaflet Patch w. True 
Sized MA 
25.4 4.0 37.2 6.0 36.4 9.0 
Anterior Leaflet Patch w. RMA 22.3 2.4 34.2 6.0 30.9 7.8 
 
Table B-3 Coaptation length for all anterior leaflet augmentation conditions. 
  Coaptation Length [cm] 
  Small Patch Large Patch Combined 
  Avg Stdev Avg Stdev Avg Stdev 
Healthy 0.50 0.05 0.47 0.05 0.48 0.05 
IMR 0.34 0.03 0.30 0.07 0.32 0.05 
Undersized MA 0.48 0.05 0.47 0.07 0.47 0.06 
Anterior Leaflet Patch w. No 
MA 
0.39 0.08 0.40 0.09 0.39 0.08 
Anterior Leaflet Patch w. 
Oversized MA 
0.42 0.06 0.48 0.04 0.44 0.05 
Anterior Leaflet Patch w. True 
Sized MA 
0.48 0.05 0.58 0.10 0.53 0.09 
Anterior Leaflet Patch w. RMA 0.59 0.07 0.63 0.06 0.61 0.06 
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Table B-4 Anterior strut chordal force data for all anterior leaflet augmentation 
conditions from the posteromedial PM. 
  Posteromedial PM - Anterior Strut Force [N] 
  Small Patch Large Patch Combined 
  Avg Stdev Avg Stdev Avg Stdev 
Healthy 0.87 0.24 0.53 0.28 0.71 0.31 
IMR 1.50 0.33 0.93 0.36 1.23 0.44 
Undersized MA 1.04 0.28 0.71 0.30 0.89 0.33 
Anterior Leaflet Patch w. No 
MA 
0.99 0.34 0.84 0.35 0.92 0.34 
Anterior Leaflet Patch w. 
Oversized MA 
0.94 0.35 0.78 0.32 0.87 0.33 
Anterior Leaflet Patch w. True 
Sized MA 
0.91 0.37 0.74 0.31 0.93 0.34 
Anterior Leaflet Patch w. RMA 0.91 0.45 0.68 0.31 0.80 0.39 
 
Table B-5 Posterior strut chordal force data for all anterior leaflet augmentation 
conditions from the posteromedial PM. 
  Posteromedial PM - Posterior Strut Force [N] 
  Small Patch Large Patch Combined 
  Avg Stdev Avg Stdev Avg Stdev 
Healthy 0.28 0.08 0.28 0.17 0.28 0.13 
IMR 0.45 0.16 0.65 0.37 0.55 0.29 
Undersized MA 0.45 0.19 0.56 0.33 0.51 0.26 
Anterior Leaflet Patch w. No 
MA 
0.39 0.20 0.52 0.31 0.46 0.26 
Anterior Leaflet Patch w. 
Oversized MA 
0.38 0.17 0.52 0.30 0.45 0.25 
Anterior Leaflet Patch w. True 
Sized MA 
0.39 0.18 0.45 0.25 0.42 0.21 




Table B-6 Anterior strut chordal force data for all anterior leaflet augmentation 
conditions from the anterolateral PM. 
  Anterolateral PM - Anterior Strut Force [N] 
  Small Patch Large Patch Combined 
  Avg Stdev Avg Stdev Avg Stdev 
Healthy 0.71 0.54 0.51 0.28 0.62 0.44 
IMR 0.79 0.64 0.81 0.40 0.80 0.52 
Undersized MA 0.65 0.41 0.66 0.39 0.66 0.39 
Anterior Leaflet Patch w. No 
MA 
0.85 0.47 1.13 0.60 0.97 0.53 
Anterior Leaflet Patch w. 
Oversized MA 
0.79 0.43 1.09 0.58 0.92 0.50 
Anterior Leaflet Patch w. True 
Sized MA 
0.78 0.43 0.94 0.60 0.85 0.50 
Anterior Leaflet Patch w. RMA 0.77 0.36 1.01 0.56 0.87 0.45 
 
Table B-7 Posterior strut chordal force data for all anterior leaflet augmentation 
conditions from the anterolateral PM. 
  Anterolateral PM - Posterior Strut Force [N] 
  Small Patch Large Patch Combined 
  Avg Stdev Avg Stdev Avg Stdev 
Healthy 0.39 0.28 0.60 0.38 0.49 0.34 
IMR 0.51 0.30 0.93 0.62 0.71 0.51 
Undersized MA 0.44 0.22 0.65 0.42 0.54 0.33 
Anterior Leaflet Patch w. No 
MA 
0.50 0.23 0.81 0.53 0.65 0.41 
Anterior Leaflet Patch w. 
Oversized MA 
0.45 0.20 0.76 0.49 0.59 0.39 
Anterior Leaflet Patch w. True 
Sized MA 
0.46 0.24 0.63 0.45 0.54 0.35 




B.2.3 Papillary Muscle Relocation 
Table B-8 Leaflet coaptation length and tenting area data for all papillary 
muscle relocation experimental conditions. 





CL (cm) 0.53 0.37 0.47 0.41 
TH (cm) 0.23 0.34 0.32 0.40 
TA (cm^2) 0.17 0.32 0.28 0.40 
ATA (cm^2) 0.09 0.17 0.16 0.23 
PTA (cm^2) 0.07 0.11 0.11 0.13 
Commissure 
Anterolateral PM 2mm 4mm 6mm 8mm 
CL (cm) 0.43 0.51 0.60 0.55 
TH (cm) 0.38 0.34 0.26 0.23 
TA (cm^2) 0.36 0.30 0.20 0.17 
ATA (cm^2) 0.22 0.19 0.11 0.10 
PTA (cm^2) 0.13 0.09 0.07 0.05 
Trigone 
Anterolateral PM 2mm 4mm 6mm 8mm 
CL (cm) 0.47 0.55 0.64 0.64 
TH (cm) 0.41 0.36 0.30 0.25 
TA (cm^2) 0.41 0.33 0.28 0.17 
ATA (cm^2) 0.23 0.19 0.16 0.10 
PTA (cm^2) 0.16 0.11 0.08 0.07 
Commissure 
Symmetric 2mm 4mm 6mm 8mm 
CL (cm) 0.50 0.58 0.65 0.64 
TH (cm) 0.36 0.31 0.23 0.17 
TA (cm^2) 0.36 0.27 0.18 0.11 
ATA (cm^2) 0.19 0.16 0.10 0.07 
PTA (cm^2) 0.13 0.10 0.07 0.04 
Trigone Symmetric 2mm 4mm 6mm 8mm 
CL (cm) 0.49 0.58 0.63 0.68 
TH (cm) 0.36 0.32 0.24 0.22 
TA (cm^2) 0.33 0.29 0.18 0.14 
ATA (cm^2) 0.21 0.18 0.11 0.08 





Deviation) Control Acute MI 




CL (cm) 0.15 0.11 0.11 0.07 
TH (cm) 0.08 0.04 0.10 0.12 
TA (cm^2) 0.12 0.09 0.11 0.18 
ATA (cm^2) 0.06 0.05 0.07 0.10 
PTA (cm^2) 0.05 0.02 0.04 0.06 
Commissure 
Anterolateral PM 2mm 4mm 6mm 8mm 
CL (cm) 0.12 0.12 0.15 0.14 
TH (cm) 0.11 0.15 0.11 0.07 
TA (cm^2) 0.18 0.20 0.12 0.10 
ATA (cm^2) 0.11 0.11 0.08 0.07 
PTA (cm^2) 0.07 0.07 0.04 0.02 
Trigone 
Anterolateral PM 2mm 4mm 6mm 8mm 
CL (cm) 0.16 0.13 0.17 0.21 
TH (cm) 0.14 0.16 0.14 0.08 
TA (cm^2) 0.22 0.20 0.19 0.13 
ATA (cm^2) 0.13 0.11 0.12 0.08 
PTA (cm^2) 0.09 0.07 0.05 0.06 
Commissure 
Symmetric 2mm 4mm 6mm 8mm 
CL (cm) 0.15 0.14 0.16 0.20 
TH (cm) 0.12 0.11 0.09 0.07 
TA (cm^2) 0.18 0.14 0.12 0.06 
ATA (cm^2) 0.11 0.08 0.08 0.04 
PTA (cm^2) 0.07 0.04 0.04 0.01 
Trigone Symmetric 2mm 4mm 6mm 8mm 
CL (cm) 0.15 0.17 0.16 0.21 
TH (cm) 0.12 0.15 0.09 0.08 
TA (cm^2) 0.17 0.19 0.10 0.08 
ATA (cm^2) 0.12 0.13 0.07 0.04 





B.3 Specific Aim 3 
B.3.1 Particle Image Velocimetry 
Presented below are representative images of the left ventricular filling through a mitral 
valve with normal and altered papillary muscle positioning at low and high flows. 
  
Figure B-22 Normal Papillary Muscle Position: Low Flow. 
  
Figure B-23 Normal Papillary Muscle Position: High Flow. 
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Figure B-24 Anterolateral Papillary Muscle Displaced Anteriorly, Posteriorly, 
Apically: Low Flow. 
  
Figure B-25 Anterolateral Papillary Muscle Displaced Anteriorly, Posterior, 




Figure B-26 Symmetric Anterior, Posterior, and Apical PM Displacement: Low 
Flow. 
  








Figure B-28 Posteromedial Papillary Muscle Displaced Anteriorly, Posteriorly, 
Apically: Low Flow. 
  
Figure B-29 Posteromedial Papillary Muscle Displaced Anteriorly, Posterior, 








The following Matlab codes are included: 
1. MicroCT.M: Micro-computed tomography point cloud generation from black and 
white (post-threshold) images 
2. EnsembleAVG.M: ensemble average hemodynamic data 
3. MAA.M: calculates mitral annular area from en-face images (echo or high-speed) 
 
C.1 MicroCT.M 
%This program reads in an image stack of black and white 
%micro-CT geometries (already passed through band-pass thresholding. 
%The program will write out a .txt file of geometry point cloud. 
  
%% change value of numims to reflect total number of images to be 
processed 
numims = 631;  
  
%% change filepath to reflect directory where black and white images 
are stored 
filepath = ('C:\Users\Jean-Pierre\Desktop\2010 09 09\microCT_'); 




%% change output_filename to reflect desired of point cloud 




%% loop through all images 
for i = 1:numims; 
 286 
    %% print i on screen to see which image the code is currently 
segmenting 
    i 
    im = imread(sprintf('%s%4.4d.tif',filepath,i)); 
    im = double(im); 
    %% use canny edge detection 
    BW = edge(im, 'canny'); 
     
    [x,y]=find(BW~=0); 
    output=[x y ones(length(x),1)*i]; 





%% This program reads in raw hemodynamic data over 10 cycles acquired 
%% through lab view.  The program ensemble averages the data and .   
%% creates an excel spreadsheet. The excel spreadsheet will contain a  
%% column for each acquired parameter, typically flow, left atrial 
pressure, 







%% Change input_file and output_file to reflect labview text file for  

























data = time; 





% Mitral Annular Area Calculator 
% Description: Digital photographs are read in. According to a scale 
mitral 
% annulus area (MAA) is manually segmented and calculated. 
  
% picture of annulus is read in and displayed 




% distance between two points (distance 10mm) on a scale is calculated 
ref = ginput(2); 
dist = sqrt( (ref(2,1)-ref(1,1))^2 + (ref(2,2)-ref(1,2))^2 ); 
  
% calculating orifice area 
N = ginput(); % inner perimeter of annulus is manually picked 
pixelArea = polyarea(N(:,1),N(:,2)); % area in pixels^2 
mmAreaSept = pixelArea/dist/dist*100 % area in mm^2 
  






COMPUTER AIDED DESIGN 
In this appendix, the CAD files of the modified left heart simulator are presented.  These 
include: 
1. Left ventricular chamber 
2. Left ventricular apical plate with papillary muscle through wall fitting 
3. Papillary muscle ball (ball and socket joint) 
4. Papillary muscle socket  
5. Left atrial chamber 
6. Left atrial basal plate 

















[1] Liao, J., I. Vesely. A structural basis for the size-related mechanical properties of 
mitral valve chordae tendineae. Journal of Biomechanics 2003. 
 
 
[2] Jensen, M.Ø.J., A.A. Fontaine, A.P. Yoganathan. Improved In Vitro 
Quantification of the Force Exerted by the Papillary Muscle on the Left 
Ventricular Wall: Three-Dimensional Force Vector Measurement System. Annals 
of Biomedical Engineering 2001;29:406-413. 
 
 
[3] Ahmad, R.M., A.M. Gillinov, P.M. McCarthy et al. Annular Geometry and 
Motion in Human Ischemic Mitral Regurgitation: Novel Assessment With Three-
Dimensional Echocardiography and Computer Reconstruction. The Annals of 
Thoracic Surgery 2004;78:2063-2068. 
 
 
[4] Grashow, J., A. Yoganathan, M. Sacks. Biaixal Stress–Stretch Behavior of the 




[5] Rausch, M.K., F.A. Tibayan, D. Craig Miller et al. Evidence of adaptive mitral 




[6] Sacks, M.S., Y. Enomoto, J.R. Graybill et al. In-vivo dynamic deformation of the 
mitral valve anterior leaflet. Annals of Thoracic Surgery 2006;82:1369-77. 
 
 
[7] Rausch, M., W. Bothe, J.-P. Escobar-Kvitting et al. In-Vivo Dynamic Strains of 




[8] Nielsen, S.L., D.D. Soerensen, P. Libergren et al. Miniature C-shaped transducers 





[9] Askov, J.B., J.L. Honge, M.O. Jensen et al. Significance of force transfer in mitral 
valve-left ventricular interaction: In vivo assessment. The Journal of Thoracic and 
Cardiovascular Surgery 2012. 
 
 
[10] Grigioni, F., M. Enriquez-Sarano, K.J. Zehr et al. Ischemic Mitral Regurgitation : 
Long-Term Outcome and Prognostic Implications With Quantitative Doppler 
Assessment. Circulation 2001;103:1759-1764. 
 
 
[11] Watanabe, N., Y. Ogasawara, Y. Yamaura et al. Mitral Annulus Flattens in 
Ischemic Mitral Regurgitation: Geometric Differences Between Inferior and 
Anterior Myocardial Infarction: A Real-Time 3-Dimensional Echocardiographic 
Study. Circulation 2005;112:I-458-462. 
 
 
[12] Magne, J., M. Sénéchal, J.G. Dumesnil et al. Ischemic Mitral Regurgitation: A 
Complex Multifaceted Disease. Cardiology 2009;112:244-259. 
 
 
[13] Tibayan, F.A., F. Rodriguez, M.K. Zasio et al. Geometric Distortions of the 




[14] He, S., J. Jack D. Lemmon, M.W. Weston et al. Mitral Valve Compensation for 
Annular Dilation: In Vitro Study into the Mechanisms of Functional Mitral 




[15] Tahta, S.A., J.H. Oury, J.M. Maxwell et al. Outcome after mitral valve repair for 




[16] Romano, M.A., H.J. Patel, F.D. Pagani et al. Anterior Leaflet Repair With Patch 




[17] Peeler, B.B., I.L. Kron. Suture Relocation of the Posterior Papillary Muscle in 
Ischemic Mitral Regurgitation. Operative Techniques in Thoracic and 




[18] Little, S.H. Is it really getting easier to assess mitral regurgitaiton using proximal 




[19] Wang, Q., W. Sun. Finite Element Modeling of Mitral Valve Dynamic 
Deformation Using Patient-Specific Multi-Slices Computed Tomography Scans. 
Annals of Biomedical Engineering 2012:1-12. 
 
 
[20] Mansi, T., I. Voigt, B. Georgescu et al. An integrated framework for finite-
element modeling of mitral valve biomechanics from medical images: 
Application to MitralClip intervention planning. Medical image analysis 2012. 
 
 
[21] neumann, d., s. grbic, T. Mansi et al. Multi-modal pipeline for comprehensive 
validation of mitral valve geometry and functional computational models. 2013. 
 
 
[22] Lamas, G.A., G.F. Mitchell, G.C. Flaker et al. Clinical Significance of Mitral 
Regurgitation After Acute Myocardial Infarction. Circulation 1997;96:827-833. 
 
 
[23] Koelling, T.M., K.D. Aaronson, R.J. Cody et al. Prognostic significance of mitral 
regurgitation and tricuspid regurgitation in patients with left ventricular systolic 
dysfunction. American Heart Journal 2002;144:524-529. 
 
 
[24] Bonow, R.O., B.A. Carabello, K. Chatterjee et al. ACC/AHA 2006 Guidelines for 




[25] Bolling, S.F., S. Li, S.M. O'Brien et al. Predictors of Mitral Valve Repair: Clinical 
and Surgeon Factors. The Annals of Thoracic Surgery 2010;90:1904-1912. 
 
 
[26] Gillinov, A., D. Cosgrove, E. Blackstone et al. Durability of mitral valve repair 
for degenerative disease. J Thorac Cardiovasc Surg 1998;116:734-743. 
 
 
[27] Gillinov, A.M., P.N. Wierup, E.H. Blackstone et al. Is repair preferable to 
replacement for ischemic mitral regurgitation? The Journal of thoracic and 




[28] Shuhaiber, J., R.J. Anderson. Meta-analysis of clinical outcomes following 




[29] Vassileva, C.M., T. Boley, S. Markwell et al. Meta-analysis of short-term and 
long-term survival following repair versus replacement for ischemic mitral 
regurgitation. Eur J Cardiothorac Surg 2011;39:295-303. 
 
 
[30] Adams, D.H., A.C. Anyanwu. The Cardiologist's Role in Increasing the Rate of 




[31] Adams, D.H., A. Anyanwu. Seeking a higher standard for degenerative mitral 




[32] He, S., A.A. Fontaine, E. Schwammenthal et al. Integrated Mechanism for 
Functional Mitral Regurgitation : Leaflet Restriction Versus Coapting Force: In 
Vitro Studies. Circulation 1997;96:1826-1834. 
 
 
[33] He, S., M.W. Weston, J. Lemmon et al. Geometric distribution of chordae 
tendineae: an important anatomic feature in mitral valve function. J Heart Valve 
Dis 2000;9:495-501; discussion 502-3. 
 
 
[34] He, S., J.H. Jimenez, Z. He et al. Mitral Leaflet Geometry Perturbations with 
Papillary Muscle Displacement and Annular Dilation: an In-Vitro Study of 




[35] Jimenez, J.H., D.D. Soerensen, Z. He et al. Effects of Papillary Muscle Position 




[36] Padala, M., R.A. Hutchison, L.R. Croft et al. Saddle Shape of the Mitral Annulus 
Reduces Systolic Strains on the P2 Segment of the Posterior Mitral Leaflet. The 




[37] Rabbah, J.-P., N. Saikrishnan, A. Yoganathan. A Novel Left Heart Simulator for 
the Multi-modality Characterization of Native Mitral Valve Geometry and Fluid 
Mechanics. Annals of Biomedical Engineering 2012;[Epub ahead of print]:1-11. 
 
 
[38] Rabbah, J.-P., B. Chism, A. Siefert et al. Effects of Targeted Papillary Muscle 




[39] Siefert, A.W., J.P.M. Rabbah, K.J. Koomalsingh et al. In Vitro Mitral Valve 
Simulator Mimics Systolic Valvular Function of Chronic Ischemic Mitral 
Regurgitation Ovine Model. The Annals of Thoracic Surgery 2013;95:825-830. 
 
 
[40] Gorman, J.H., R.C. Gorman, B.M. Jackson et al. Annuloplasty ring selection for 
chronic ischemic mitral regurgitation: lessons from the ovine model. Annals of 
Thoracic Surgery 2003;76:1556-1563. 
 
 
[41] Zhu, F., Y. Otsuji, G. Yotsumoto et al. Mechanism of Persistent Ischemic Mitral 
Regurgitation After Annuloplasty: Importance of Augmented Posterior Mitral 
Leaflet Tethering. Circulation 2005;112:I-396-I-401. 
 
 
[42] Alfieri, O., M. De Bonis. Mitral Valve Repair for Functional Mitral 




[43] Grossi, E.A., C.S. Bizekis, A. LaPietra et al. Late Results of Isolated Mitral 




[44] Hung, J., L. Papakostas, S.A. Tahta et al. Mechanism of Recurrent Ischemic 
Mitral Regurgitation After Annuloplasty. Circulation 2004;110:II-85-II-90. 
 
 
[45] Matsunaga, A., S.A. Tahta, C.M.G. Duran. Failure of Reduction Annuloplasty for 





[46] McGee, J.E.C., A.M. Gillinov, E.H. Blackstone et al. Recurrent mitral 
regurgitation after annuloplasty for functional ischemic mitral regurgitation. 
Journal of Thoracic and Cardiovascular Surgery 2004;128:916-924. 
 
 
[47] Kuwahara, E., Y. Otsuji, Y. Iguro et al. Mechanism of Recurrent/Persistent 
Ischemic/Functional Mitral Regurgitation in the Chronic Phase After Surgical 




[48] Braun, J., N.R. van de Veire, R.J.M. Klautz et al. Restrictive Mitral Annuloplasty 




[49] Kongsaerepong, V., M. Shiota, A.M. Gillinov et al. Echocardiographic Predictors 
of Successful Versus Unsuccessful Mitral Valve Repair in Ischemic Mitral 
Regurgitation. The American Journal of Cardiology 2006;98:504-508. 
 
 
[50] Gelsomino, S., R. Lorusso, G. De Cicco et al. Five-year echocardiographic results 
of combined undersized mitral ring annuloplasty and coronary artery bypass 




[51] Magne, J., P. Pibarot, F. Dagenais et al. Preoperative Posterior Leaflet Angle 
Accurately Predicts Outcome After Restrictive Mitral Valve Annuloplasty for 
Ischemic Mitral Regurgitation. Circulation 2007;115:782-791. 
 
 
[52] Calafiore, A.M., S. Gallina, M. Di Mauro et al. Mitral valve procedure in dilated 




[53] Roshanali, F., M.H. Mandegar, M.A. Yousefnia et al. A Prospective Study of 
Predicting Factors in Ischemic Mitral Regurgitation Recurrence After Ring 
Annuloplasty. The Annals of Thoracic Surgery 2007;84:745-749. 
 
 
[54] Fattouch, K., P. Lancellotti, S. Castrovinci et al. Papillary muscle relocation in 
conjunction with valve annuloplasty improve repair results in severe ischemic 





[55] Hvass, U., T. Joudinaud. The papillary muscle sling for ischemic mitral 




[56] Kron, I.L., G.R. Green, J.T. Cope. Surgical relocation of the posterior papillary 




[57] Kincaid, E.H., R.D. Riley, M.H. Hines et al. Anterior leaflet augmentation for 
ischemic mitral regurgitation. The Annals of Thoracic Surgery 2004;78:564-568. 
 
 
[58] Hines, M.H., E.H. Kincaid, A.L. Cook et al. Anterior leaflet augmentation for 
ischemic mitral regurgitation in patients with anomalous left coronary artery from 
the pulmonary artery and preserved left ventricular function. The Journal of 
thoracic and cardiovascular surgery 2011;In Press, Corrected Proof. 
 
 
[59] Wong, V.M., J.F. Wenk, Z. Zhang et al. The Effect of Mitral Annuloplasty Shape 
in Ischemic Mitral Regurgitation: A Finite Element Simulation. Annals of 
Thoracic Surgery 2012;93:776-782. 
 
 
[60] Prot, V., R. Haaverstad, B. Skallerud. Finite element analysis of the mitral 
apparatus: annulus shape effect and chordal force distribution. Biomechanics and 
Modeling in Mechanobiology 2009;8:43-55. 
 
 
[61] Votta, E., F. Maisano, S.F. Bolling et al. The Geoform Disease-Specific 




[62] Kunzelman, K.S., D.W. Quick, R.P. Cochran. Altered collagen concentration in 




[63] Avanzini, A. A Computational Procedure for Prediction of Structural Effects of 





[64] Reimink, M.S., K.S. Kunzelman, R.P. Cochran. The effect of chordal replacement 
suture length on function and stresses in repaired mitral valves: a finite element 
study. J Heart Valve Dis 1996;5:365-75. 
 
 
[65] Kunzelman, K., M.S. Reimink, E.D. Verrier et al. Replacement of Mitral Valve 
Posterior Chordae Tendineae with Expanded Polytetrafluoroethylene Suture: A 
Finite Element Study. Journal of Cardiac Surgery 1996;11:136-145. 
 
 
[66] Salgo, I.S. Effect of Annular Shape on Leaflet Curvature in Reducing Mitral 
Leaflet Stress. Circulation 2002;106:711-717. 
 
 
[67] Xu, C., C.J. Brinster, A.S. Jassar et al. A novel approach to in vivo mitral valve 




[68] Carpentier, A., D.H. Adams, F. Filsoufi. Carpentier's reconstructive valve 
surgery. Maryland Heights, Missouri: Saunders, 2010. 
 
 
[69] He, S., J. Jimenez, Z. He et al. Mitral leaflet geometry perturbations with papillary 
muscle displacement and annular dilatation: an in-vitro study of ischemic mitral 
regurgitation. J Heart Valve Dis 2003;12:300-7. 
 
 
[70] Fenoglio, J.J., Tuan-Duc-Pham, A.L. Wit et al. Canine mitral complex. 




[71] Kunzelman, K.S., R.P. Cochran, C. Chuong et al. Finite element analysis of the 
mitral valve. J Heart Valve Dis 1993;2:326-240. 
 
 
[72] Grande-Allen, K.J., A. Calabro, V. Gupta et al. Glycosaminoglycans and 
proteoglycans in normal mitral valve leaflets and chordae: association with 
regions of tensile and compressive loading. Glycobiology 2004;14:621-633. 
 
 
[73] Kunzelman, K.S., R.P. Cochran, S. Murphree et al. Differential Collagen 
Distribution in the Mitral Valve and Its Influence on Biomechanical Behaviour. 




[74] Lam, J.H., N. Ranganathan, E.D. Wigle et al. Morphology of the human mitral 
valve. I. Chordae tendineae: a new classification. Circulation 1970;41:449-458. 
 
 
[75] Ranganathan, N., J.H. Lam, E.D. Wigle et al. Morphology of the human mitral 
valve. II. The valve leaflets. Circulation 1970;41:459-467. 
 
 
[76] Sedransk, K.L., K.J. Grande-Allen, I. Vesely. Failure mechanics of mitral valve 
chordae tendineae. J Heart Valve Dis 2002;11:644-650. 
 
 
[77] Ritchie, J., J. Jimenez, Z. He et al. The material properties of the native porcine 




[78] Lim, K.O., D.R. Boughner. Morphology and relationship to extensibility curves 
of human mitral valve chordae tendineae. Circulation research 1976;39:580-585. 
 
 
[79] Millington-Sanders, C., A. Meir, L. Lawrence et al. Structure of chordae 




[80] Quill, J.L., A.J. Hill, T.G. Laske et al. Mitral leaflet anatomy revisited. J Thorac 
Cardiovasc Surg 2009;137:1077-1081. 
 
 
[81] Degandt, A.A., P.A. Weber, H.A. Saber et al. Mitral Valve Basal Chordae: 




[82] Anderson, R.H., M. Kanani. Mitral valve repair: critical analysis of the anatomy 
discussed. Multimedia Manual of Cardiothoracic Surgery 2007;0219:2147:1-9. 
 
 
[83] Joudinaud, T.M., C.L. Kegel, E.M. Flecher et al. The papillary muscles as shock 
absorbers of the mitral valve complex. An experimental study. European journal 




[84] Gorman, J.H., R.C. Gorman, B.M. Jackson et al. Distortions of the mitral valve in 




[85] Madu, E.C., D.S. Baugh, I.A. D&apos;Cruz et al. Left ventricular papillary 
muscle morphology and function in left ventricular hypertrophy and left 
ventricular dysfunction. Medical science monitor : international medical journal 
of experimental and clinical research 2001;7:1212-1218. 
 
 
[86] Ormiston, J.A., P.M. Shah, C. Tei et al. Size and motion of the mitral valve 
annulus in man. I. A two-dimensional echocardiographic method and findings in 
normal subjects. Circulation 1981;64:113-120. 
 
 
[87] Chan, J.K.M., R. Merrifield, R.R. Wage et al. Two-dimensional M-Mode display 
of the mitral valve from CMR cine acquisitions: insights into normal leaflet and 
annular motion. J Cardiovasc Magn Reson 2008;10:A351. 
 
 
[88] Boltwood, C.M., C. Tei, M. Wong et al. Quantitative echocardiography of the 
mitral complex in dilated cardiomyopathy: the mechanism of functional mitral 
regurgitation. Circulation 1983;68:498-508. 
 
 
[89] Levine, R.A., M.O. Triulzi, P. Harrigan et al. The relationship of mitral annular 
shape to the diagnosis of mitral valve prolapse. Circulation 1987;75:756-767. 
 
 
[90] Ahmad, R.M., A.M. Gillinov, P.M. McCarthy et al. Annular Geometry and 
Motion in Human Ischemic Mitral Regurgitation: Novel Assessment With Three-
Dimensional Echocardiography and Computer Reconstruction. Annals of 
Thoracic Surgery 2004;78:2063-2068. 
 
 
[91] Rausch, M.K., W. Bothe, J.P. Kvitting et al. Characterization of mitral valve 




[92] Gorman III JH, J.B., Moainie SL, Enomoto Y, Gorman RC. Influence of Inotropy 





[93] Yiu, S.F., M. Enriquez-Sarano, C. Tribouilloy et al. Determinants of the Degree 
of Functional Mitral Regurgitation in Patients With Systolic Left Ventricular 
Dysfunction : A Quantitative Clinical Study. Circulation 2000;102:1400-1406. 
 
 
[94] Veronesi F, C.C., Sugeng L Quantification of Mitral Apparatus Dynamics in 
Functional and Ischemic Mitral Regurgitation Using Real-time 3-Dimensional 




[95] Timek, T.A., G.R. Green, F.A. Tibayan et al. Aorto-mitral annular dynamics. 
Annals of Thoracic Surgery 2003;76:1944-1950. 
 
 
[96] Levine, R.A., M.D. Handschumacher, A.J. Sanfilippo et al. Three-dimensional 
echocardiographic reconstruction of the mitral valve, with implications for the 
diagnosis of mitral valve prolapse. Circulation 1989;80:589-598. 
 
 
[97] Gorman, J.H., B.M. Jackson, Y. Enomoto et al. The effect of regional ischemia on 
mitral valve annular saddle shape. Annals of Thoracic Surgery 2004;77:544-548. 
 
 
[98] Tibayan, F.A., F. Rodriguez, F. Langer et al. Annular Remodeling in Chronic 




[99] Ryan, L.P., B.M. Jackson, H. Hamamoto et al. The influence of annuloplasty ring 








[101] Itoh, A., D.B. Ennis, W. Bothe et al. Mitral annular hinge motion contribution to 
changes in mitral septal-lateral dimension and annular area. The Journal of 
Thoracic and Cardiovascular Surgery 2009;138:1090-9. 
 
 
[102] Kaplan SR, B.G., Gaddipatti A. . Three-dimensional echocardiographic 
assessment of annular shape changes in the normal and regurgitant valve. 




[103] Jimenez, J.H., S.W. Liou, M. Padala et al. A saddle-shaped annulus reduces 
systolic strain on the central region of the mitral valve anterior leaflet. The Journal 
of Thoracic and Cardiovascular Surgery 2007;134:1562-8. 
 
 
[104] Padala, M., R.A. Hutchison, L.R. Croft et al. Saddle Shape of the Mitral Annulus 
Reduces Systolic Strains on the P2 Segment of the Posterior Mitral Leaflet. 
Annals of Thoracic Surgery 2009;88:1499-1504. 
 
 
[105] Jimenez, J.H., D.D. Soerensen, Z. He et al. Effects of a saddle shaped annulus on 
mitral valve function and chordal force distribution: an in vitro study. Annals of 
Biomedical Engineering 2003;31:1171-1181. 
 
 
[106] Kunzelman, K.S., R.P. Cochran. Stress/Strain Characteristics of Porcine Mitral 
Valve Tissue: Parallel versus perpendicular collagen orientation. Journal of 
Cardiac Surgery 1992;7:71-8. 
 
 
[107] May-Newman, K., F.C. Yin. Biaxial mechanical behavior of excised porcine 




[108] Chen, L., F.C.P. Yin, M.D et al. The Structure and Mechanical Properties of the 




[109] Imanaka, K., S. Takamoto, T. Ohtsuka et al. The Stiffness of Normal and 




[110] Liao, J., L. Yang, J. Grashow et al. The Relation Between Collagen Fibril 
Kinematics and Mechanical Properties in the Mitral Valve Anterior Leaflet. 
Journal of Biomechanical Engineering 2007;129:78-87. 
 
 
[111] Krishnamurthy, G., D.B. Ennis, A. Itoh et al. Material properties of the ovine 
mitral valve anterior leaflet in vivo from inverse finite element analysis. American 





[112] Itoh, A., G. Krishnamurthy, J.C. Swanson et al. Active stiffening of mitral valve 
leaflets in the beating heart. American Journal of Physiology - Heart and 
Circulatory Physiology 2009;296:H1766-H1773. 
 
 
[113] Krishnamurthy, G., A. Itoh, W. Bothe et al. Stress–strain behavior of mitral valve 
leaflets in the beating ovine heart. Journal of Biomechanics 2009;42:1909-1916. 
 
 
[114] Stephens, E.H., N.d. Jonge, M.P. McNeill et al. Age-Related Changes in Material 
Behavoir of Porcine Mitral and Aortic Valves and Correlation to Matrix 
Composition. Tissue Engineering Part A 2010;16:867-878. 
 
 
[115] Grashow, J., M. Sacks, J. Liao et al. Planar Biaxial Creep and Stress Relaxation of 




[116] Skallerud, B., V. Prot, I. Nordrum. Modeling active muscle contraction in mitral 




[117] Grande-Allen, K.J., J.E. Barber, K.M. Klatka et al. Mitral valve stiffening in end-
stage heart failure: Evidence of an organic contribution to functional mitral 




[118] Sacks, M.S., Z. He, L. Baijens et al. Surface Strains in the Anterior Leaflet of the 




[119] He, Z., M. Sacks, L. Baijens et al. Effects of Papillary Muscle Position on In-




[120] He, Z., J. Ritchie, J.S. Grashow et al. In Vitro Dynamic Strain Behavior of the 





[121] Bothe, W., J.C. Swanson, N.B. Ingels et al. How much septal-lateral mitral 
annular reduction do you get with new ischemic/functional mitral regurgitation 
annuloplasty rings? The Journal of Thoracic and Cardiovascular Surgery 
2010;140:117-21, 121 e1-3. 
 
 
[122] Amini, R., C.E. Eckert, K. Koomalsingh et al. On the in vivo deformation of the 
mitral valve anterior leaflet: effects of annular geometry and referential 
configuration. Annals of Biomedical Engineering 2012;40:1455-67. 
 
 
[123] Salgo, I.S., J.H. Gorman, III, R.C. Gorman et al. Effect of Annular Shape on 








[125] Chaput, M., M.D. Handschumacher, J.L. Guerrero et al. Mitral Leaflet Adaptation 
to Ventricular Remodeling. Circulation 2009;120:S99-S103. 
 
 
[126] Chaput, M., M.D. Handschumacher, F. Tournoux et al. Mitral Leaflet Adaptation 
to Ventricular Remodeling. Circulation 2008;118:845-852. 
 
 
[127] Timek, T.A., D.T. Lai, P. Dagum et al. Mitral Leaflet Remodeling in Dilated 
Cardiomyopathy. Circulation 2006;114:I-518-I-523. 
 
 
[128] Stephens, E.H., T.A. Timek, G.T. Daughters et al. Significant Changes in Mitral 
Valve Leaflet Matrix Composition and Turnover With Tachycardia-Induced 
Cardiomyopathy. Circulation 2009;120:S112-S119. 
 
 
[129] Stephens, E.H., T.C. Nguyen, A. Itoh et al. The Effects of Mitral Regurgitation 
Alone Are Sufficient for Leaflet Remodeling. Circulation 2008;118:S243-S249. 
 
 
[130] Dal-Bianco, J.P., E. Aikawa, J. Bischoff et al. Active Adaptation of the Tethered 




[131] Obadia, J.F., C. Casali, J.F. Chassignolle et al. Mitral subvalvular apparatus: 




[132] Goetz, W.A., H.-S. Lim, E. Lansac et al. The aortomitral angle is suspended by 




[133] Clark, R.E. Stress-strain characteristics of fresh and frozen human aortic and 
mitral leaflets and chordae tendineae. Implications for clinical use. The Journal of 
Thoracic and Cardiovascular Surgery 1973;66:202-208. 
 
 
[134] Lim, K.O., D.R. Boughner. Mechanical properties of human mitral valve chordae 




[135] Lim, K.O., D.R. Boughner, C.A. Smith. Dynamic elasticity of human mitral valve 




[136] Kunzelman, K.S., R.P. Cochran. Mechanical properties of basal and marginal 
mitral valve chordae tendineae. ASAIO transactions / American Society for 
Artificial Internal Organs 1990;36:M405-8. 
 
 
[137] Salisbury, P.F., C.E. Cross, P.A. Rieben. Chorda tendinea tension. American 
journal of physiology 1963;205:385-392. 
 
 
[138] Lomholt, M., S.L. Nielsen, S.B. Hansen et al. Differential tension between 
secondary and primary mitral chordae in an acute in-vivo porcine model. J Heart 
Valve Dis 2002;11:337-345. 
 
 
[139] Nielsen, S.L., S.B. Hansen, K.O. Nielsen et al. Imbalanced chordal force 
distribution causes acute ischemic mitral regurgitation: mechanistic insights from 
chordae tendineae force measurements in pigs. The Journal of Thoracic and 




[140] Nielsen, S.L., H. Nygaard, A.A. Fontaine et al. Chordal force distribution 
determines systolic mitral leaflet configuration and severity of functional mitral 
regurgitation. Journal of the American College of Cardiology 1999;33:843-853. 
 
 
[141] Nielsen, S.L., H. Nygaard, L. Mandrup et al. Mechanism of incomplete mitral 
leaflet coaptation--interaction of chordal restraint and changes in mitral leaflet 
coaptation geometry. Insight from in vitro validation of the premise of force 
equilibrium. Journal of Biomechanical Engineering 2002;124:596-608. 
 
 
[142] Nielsen, S.L., T.A. Timek, G.R. Green et al. Influence of anterior mitral leaflet 




[143] Jimenez, J.H., D.D. Soerensen, Z. He et al. Mitral valve function and chordal 
force distribution using a flexible annulus model: an in vitro study. Annals of 
Biomedical Engineering 2005;33:557-566. 
 
 
[144] Jimenez, J.H., D.D. Soerensen, Z. He et al. Effects of papillary muscle position on 




[145] Jimenez-Mejia, J.H. The effects of mitral annular dynamics and papillary muscle 
position of chordal force distribution and valve function: an in vitro study. 2003. 
 
 
[146] Granier, M., M.O. Jensen, J.L. Honge et al. Consequences of mitral valve 
prolapse on chordal tension: ex vivo and in vivo studies in large animal models. 
The Journal of Thoracic and Cardiovascular Surgery 2011;142:1585-1587. 
 
 
[147] He, Z., C. Jowers. A novel method to measure mitral valve chordal tension. 
Journal of Biomechanical Engineering 2009;131:014501. 
 
 
[148] He, S., A.A. Fontaine, E. Schwammenthal et al. Integrated mechanism for 
functional mitral regurgitation: leaflet restriction versus coapting force: in vitro 




[149] Padala, M., L. Gyoneva, A.P. Yoganathan. Effect of anterior strut chordal 
transection on the force distribution on the marginal chordae of the mitral valve. 
The Journal of Thoracic and Cardiovascular Surgery 2012;144:624-633.e2. 
 
 
[150] Nielsen, S.L., M. Lomholt, P. Johansen et al. Mitral ring annuloplasty relieves 
tension of the secondary but not primary chordae tendineae in the anterior mitral 
leaflet. The Journal of Thoracic and Cardiovascular Surgery 2011;141:732-737. 
 
 
[151] Ostli, B., J. Vester-Petersen, J.B. Askov et al. In Vitro System for Measuring 
Chordal Force Changes Following Mitral Valve Patch Repair. Cardiovascular 
Engineering and Technology 2012;3:263-268. 
 
 
[152] Messas, E., J.L. Guerrero, M.D. Handschumacher et al. Chordal cutting: a new 




[153] He, Z., C.W. Jowers. Effect of mitral valve strut chord cutting on marginal chord 
tension. J Heart Valve Dis 2008;17:628-634. 
 
 
[154] Hashim, S.R., A. Fontaine, S. He et al. A three-component force vector cell for in 
vitro quantification of the force exerted by the papillary muscle on the left 
ventricular wall. Journal of Biomechanics 1997;30:1071-1075. 
 
 
[155] Bursi, F., M. Enriquez-Sarano, S.J. Jacobsen et al. Mitral Regurgitation After 




[156] Grigioni, F., D. Detaint, J.-F. Avierinos et al. Contribution of ischemic mitral 
regurgitation to congestive heart failure after myocardial infarction. Journal of the 
American College of Cardiology 2005;45:260-267. 
 
 
[157] Watanabe, N., Y. Ogasawara, Y. Yamaura et al. Geometric Differences of the 
Mitral Valve Tenting Between Anterior and Inferior Myocardial Infarction with 
Significant Ischemic Mitral Regurgitation: Quantitation by Novel Software 
System with Transthoracic Real-time Three-dimensional Echocardiography. 
Journal of the American Society of Echocardiography : official publication of the 




[158] Vergnat, M., A.S. Jassar, B.M. Jackson et al. Ischemic Mitral Regurgitation: A 
Quantitative Three-Dimensional Echocardiographic Analysis. The Annals of 
Thoracic Surgery 2011;91:157-164. 
 
 
[159] Kumanohoso, T., Y. Otsuji, S. Yoshifuku et al. Mechanism of higher incidence of 
ischemic mitral regurgitation in patients with inferior myocardial infarction: 
Quantitative analysis of left ventricular and mitral valve geometry in 103 patients 




[160] Bax, J.J., J. Braun, S.T. Somer et al. Restrictive Annuloplasty and Coronary 
Revascularization in Ischemic Mitral Regurgitation Results in Reverse Left 
Ventricular Remodeling. Circulation 2004;110:II-103-II-108. 
 
 
[161] Filsoufi, F., S.P. Salzberg, D.H. Adams. Current Management of Ischemic Mitral 
Regurgitation. Mount Sinai Journal of Medicine 2005;72:105-115. 
 
 
[162] Braun, J., J.J. Bax, M.I.M. Versteegh et al. Preoperative left ventricular 
dimensions predict reverse remodeling following restrictive mitral annuloplasty in 




[163] Magne, J., P. Pibarot, J.G. Dumesnil et al. Continued Global Left Ventricular 
Remodeling Is Not the Sole Mechanism Responsible for the Late Recurrence of 
Ischemic Mitral Regurgitation after Restrictive Annuloplasty. Journal of the 
American Society of Echocardiography 2009;22:1256-1264. 
 
 
[164] Little, S.H., S.R. Igo, B. Pirat et al. In Vitro Validation of Real-Time Three-
Dimensional Color Doppler Echocardiography for Direct Measurement of 
Proximal Isovelocity Surface Area in Mitral Regurgitation. The American Journal 
of Cardiology 2007;99:1440-1447. 
 
 
[165] de Agustín, J.A., P. Marcos-Alberca, C. Fernandez-Golfin et al. Direct 
Measurement of Proximal Isovelocity Surface Area by Single-Beat Three-
Dimensional Color Doppler Echocardiography in Mitral Regurgitation: A 





[166] Thavendiranathan, P., S. Liu, S. Datta et al. Quantification of Chronic Functional 
Mitral Regurgitation by Automated 3-Dimensional Peak and Integrated Proximal 
Isovelocity Surface Area and Stroke Volume Techniques Using Real-Time 3-
Dimensional Volume Color Doppler Echocardiography: In Vitro and Clinical 
Validation. Circulation: Cardiovascular Imaging 2013;6:125-133. 
 
 
[167] Choon-Hwai, Y., K. Thiele, W. Qifeng et al. Novel method of measuring valvular 
regurgitation using three-dimensional nonlinear curve fitting of doppler signals 
within the flow convergence zone. Ultrasonics, Ferroelectrics and Frequency 
Control, IEEE Transactions on 2013;60:1295-1311. 
 
 
[168] Votta, E., E. Caiani, F. Veronesi et al. Mitral valve finite-element modelling from 
ultrasound data: a pilot study for a new approach to understand mitral function 
and clinical scenarios. Philosophical Transactions of the Royal Society A: 
Mathematical, Physical and Engineering Sciences 2008;366:3411-3434. 
 
 
[169] Lim, K., J. Yeo, C.M. Duran. Three-dimensional asymmetrical modeling of the 




[170] Stevanella, M., E. Votta, A. Redaelli. Mitral Valve Finite Element Modeling: 
Implications of Tissues' Nonlinear Response and Annular Motion. Journal of 
Biomechanical Engineering 2009;131:121010. 
 
 
[171] Padala, M., M.S. Sacks, S.W. Liou et al. Mechanics of the mitral valve strut 




[172] Cochran, R.P., K.S. Kunzelman. Effect of papillary muscle position on mitral 




[173] Prot, V., B. Skallerud, G.A. Holzapfel. Transversely isotropic membrane shells 
with application to mitral valve mechanics. Constitutive modelling and finite 





[174] Einstein, D.R., K.S. Kunzelman, P. Reinhall et al. Non-linear fluid-coupled model 
of the mitral valve. J Heart Valve Dis 2005;14:376-85. 
 
 
[175] Dal Pan, F., G. Donzella, C. Fucci et al. Structural effects of an innovative 




[176] Wenk, J.F., Z. Zhang, G. Cheng et al. First Finite Element Model of the Left 
Ventricle With Mitral Valve: Insights Into Ischemic Mitral Regurgitation. Annals 
of Thoracic Surgery 2010;89:1546-1553. 
 
 
[177] Lau, K.D., V. Díaz-Zuccarini, P. Scambler et al. Fluid–structure interaction study 




[178] Bouma, W., I.C.C. van der Horst, I.J. Wijdh-den Hamer et al. Chronic ischaemic 
mitral regurgitation. Current treatment results and new mechanism-based surgical 
approaches. European Journal of Cardio-Thoracic Surgery 2010;37:170-185. 
 
 
[179] Kaji, S., M. Nasu, A. Yamamuro et al. Annular Geometry in Patients With 
Chronic Ischemic Mitral Regurgitation: Three-Dimensional Magnetic Resonance 
Imaging Study. Circulation 2005;112:I-409-I-414. 
 
 
[180] Jensen, H., M. Jensen, S. Ringgaard et al. Geometric determinants of chronic 
functional ischemic mitral regurgitation: insights from three-dimensional cardiac 
magnetic resonance imaging. The Journal of Heart Valve Disease 2008;17:16-22. 
 
 
[181] Watanabe, N., Y. Ogasawara, Y. Yamaura et al. Geometric deformity of the 
mitral annulus in patients with ischemic mitral regurgitation: a real-time three-




[182] Yamaura, Y., N. Watanabe, Y. Ogasawara et al. Geometric change of mitral valve 
leaflets and annulus after reconstructive surgery for ischemic mitral regurgitation: 
Real-time 3-dimensional echocardiographic study. The Journal of thoracic and 




[183] McCarthy, P.M. Does the intertrigonal distance dilate? Never say never. The 
Journal of Thoracic and Cardiovascular Surgery 2002;124:1078-1079. 
 
 
[184] Walmsley, R. Anatomy of human mitral valve in adult cadaver and comparative 
anatomy of the valve. British Heart Journal 1978;40:351-366. 
 
 
[185] Hill, A.J., P.A. Iaizzo. Comparative Cardiac Anatomy. Handbook of Cardiac 
Anatomy, Physiology, and Devices 2009:87-108. 
 
 
[186] Veronesi, F., C. Corsi, L. Sugeng et al. A Study of Functional Anatomy of Aortic-
Mitral Valve Coupling Using 3D Matrix Transesophageal Echocardiography / 
CLINICAL PERSPECTIVE. Circulation: Cardiovascular Imaging 2009;2:24-31. 
 
 
[187] Nielsen, S.L., H. Nygaard, A.A. Fontaine et al. Chordal force distribution 
determines systolic mitral leaflet configuration and severity of functional mitral 
regurgitation. Journal of the American College of Cardiology 1999;33:843-853. 
 
 
[188] Jimenez, J., D. Soerensen, Z. He et al. Effects of a Saddle Shaped Annulus on 
Mitral Valve Function and Chordal Force Distribution: An In Vitro Study. Annals 
of Biomedical Engineering 2003;31:1171-1181. 
 
 
[189] Nielsen, S.L., D.D. Soerensen, P. Libergren et al. Miniature C-Shaped 




[190] Gorman, J.H., III, R.C. Gorman, T. Plappert et al. Infarct Size And Location 
Determine Development Of Mitral Regurgitation In The Sheep Model. J Thorac 
Cardiovasc Surg 1998;115:615-622. 
 
 
[191] Jensen, H., M.O. Jensen, M.H. Smerup et al. Three-dimensional assessment of 
papillary muscle displacement in a porcine model of ischemic mitral 
regurgitation. J Thorac Cardiovasc Surg 2010;140:1312-1318. 
 
 
[192] Hashim, S.R., A. Fontaine, S. He et al. A three-component force vector cell for in 
vitro quantification of the force exerted by the papillary muscle on the left 




[193] Jimenez, J.H., S.W. Liou, M. Padala et al. A saddle-shaped annulus reduces 
systolic strain on the central region of the mitral valve anterior leaflet. The Journal 
of thoracic and cardiovascular surgery 2007;134:1562-1568. 
 
 
[194] Rausch, M.K., W. Bothe, J.-P.E. Kvitting et al. In vivo dynamic strains of the 
ovine anterior mitral valve leaflet. Journal of Biomechanics 2011;44:1149-1157. 
 
 
[195] Metscher, B.D. MicroCT for comparative morphology: simple staining methods 




[196] Bouxsein, M.L., S.K. Boyd, B.A. Christiansen et al. Guidelines for assessment of 
bone microstructure in rodents using micro–computed tomography. Journal of 
Bone and Mineral Research 2010;25:1468-1486. 
 
 
[197] Siefert, A., D. Icenogle, J.-P. Rabbah et al. Accuracy of a Mitral Valve 
Segmentation Method Using J-Splines for Real-Time 3D Echocardiography Data. 
Annals of Biomedical Engineering 2013;41:1258-1268. 
 
 
[198] Dyn, N., D. Levine, J.A. Gregory. A butterfly subdivision scheme for surface 
interpolation with tension control. ACM Trans Graph 1990;9:160-169. 
 
 
[199] Hui, H. Stero Particle Image Velocimetry Techniques: Technical Basis, System 
Setup, and Application. 
 
 
[200] Pu, M., P.M. Vandervoort, N.L. Greenberg et al. Impact of wall constraint on 
velocity distribution in proximal flow convergence zone Implications for color 




[201] Pu, M., P. Vandervoort, J. Rivera et al. Proximal flow constraint by the 
ventricular wall causes overestimation of regurgitant flow in mitral regurgitation: 
in-vitro assessment. Circulation, 1993:110-110. 
 
 
[202] Hopmeyer, J., E. Whitney, D.A. Papp et al. Computational simulations of mitral 
regurgitation quantification using the flow convergence method: Comparison of 
 318 




[203] Hopmeyer, J., S. He, K.M. Thorvig et al. Estimation of Mitral Regurgitation with 
a Hemielliptic Curve-Fitting Algorithm: In Vitro Experiments with Native Mitral 
Valves. Journal of the American Society of Echocardiography 1998;11:322-331. 
 
 
[204] Levine, R.A., L. Rodriguez, E.G. Cape et al. The proximal flow convergence 
method for calculating orifice flow rate requires correction for surrounding leaflet 
geometry. Journal of the American College of Cardiology 1991;17:A359-A359. 
 
 
[205] Yamachika, S., E. Cape, D. Savani et al. Role of three-dimensional valve angle on 
calculation of regurgitant volume by the proximal isovelocity surface area method 
in clinical valvular regurgitation. J Am Coll Cardiol 1993;21:3A. 
 
 
[206] Cape, E.G., J.D. Thomas, A.E. Weyman et al. Three-dimensional surface 
geometry correction is required for calculating flow by the proximal isovelocity 




[207] Utsunomiya, T., T. Ogawa, H. Tang et al. Doppler color flow mapping of the 
proximal isovelocity surface area: a new method for measuring volume flow rate 
across a narrowed orifice. Journal of the American Society of Echocardiography: 
official publication of the American Society of Echocardiography 1991;4:338. 
 
 
[208] Lawden, D.F. Elliptic functions and applications: Springer New York, 1989. 
 
 
[209] Gorman, R.C., J.S. McCaughan, M.B. Ratcliffe et al. Pathogenesis of acute 
ischemic mitral regurgitation in three dimensions. The Journal of thoracic and 
cardiovascular surgery 1995;109:684-693. 
 
 
[210] Messas, E., J.L. Guerrero, M.D. Handschumacher et al. Chordal Cutting:  A New 





[211] Ueno, T., R. Sakata, Y. Iguro et al. New Surgical Approach to Reduce Tethering 
in Ischemic Mitral Regurgitation by Relocation of Separate Heads of the Posterior 
Papillary Muscle. The Annals of Thoracic Surgery 2006;81:2324-2325. 
 
 
[212] Robb, J.D., M. Minakawa, K.J. Koomalsingh et al. Posterior leaflet augmentation 
improves leaflet tethering in repair of ischemic mitral regurgitation. European 
Journal of Cardio-Thoracic Surgery 2011;40:1501-1507. 
 
 
[213] Yosefy, C., R. Beeri, J.L. Guerrero et al. Mitral Regurgitation After Anteroapical 




[214] Gorman, J.H., R.C. Gorman, B.M. Jackson et al. Distortions of the Mitral Valve 




[215] Jimenez, J., D.D. Soerensen, Z. He et al. Effects of papillary muscle position on 




[216] Rahmani, A., A.Q. Rasmussen, J.L. Honge et al. Mitral valve mechanics 




[217] Jimenez, J.H., D.D. Soerensen, Z. He et al. Mitral Valve Function and Chordal 
Force Distribution Using a Flexible Annulus Model: An In Vitro Study. Annals of 
Biomedical Engineering 2005;33:557-566. 
 
 
[218] Smerup, M., J. Funder, C. Nyboe et al. Strut chordal-sparing mitral valve 
replacement preserves long-term left ventricular shape and function in pigs. The 
Journal of thoracic and cardiovascular surgery 2005;130:1675-1682. 
 
 
[219] Jensen, H., M.O. Jensen, M.H. Smerup et al. Impact of Papillary Muscle 
Relocation as Adjunct Procedure to Mitral Ring Annuloplasty in Functional 




[220] Nielsen, S.L., H. Nygaard, A.A. Fontaine et al. Papillary Muscle Misalignment 
Causes Mitral Reguritant Jets: an Ambiguous Mechanisms for Functional Mitral 
Regurgitation. The Journal of Heart Valve Disease 1999;8:551-64. 
 
 
[221] Kunzelman, K.S., D.R. Einstein, R.P. Cochran. Fluid–structure interaction models 
of the mitral valve: function in normal and pathological states. Philosophical 
Transactions of the Royal Society B: Biological Sciences 2007;362:1393-1406. 
 
 
[222] Kunzelman, K.S., M.S. Reimink, R.P. Cochran. Annular dilatation increases 
stress in the mitral valve and delays coaptation: a finite element computer model. 
Cardiovascular Surgery 1997;5:427-434. 
 
 
[223] Pouch, A.M., C. Xu, P.A. Yushkevich et al. Semi-automated mitral valve 




[224] Stevanella, M., F. Maffessanti, C. Conti et al. Mitral Valve Patient-Specific Finite 
Element Modeling from Cardiac MRI: Application to an Annuloplasty Procedure. 
Cardiovascular Engineering and Technology 2011;2:66-76. 
 
 
[225] Ionasec, R.I., I. Voigt, B. Georgescu et al. Patient-Specific Modeling and 
Quantification of the Aortic and Mitral Valves From 4-D Cardiac CT and TEE. 
Medical Imaging, IEEE Transactions on 2010;29:1636-1651. 
 
 
[226] Arnoldi, A., A. Invernizzi, R. Ponzini et al. Mitral Valve Models Reconstructor: a 
Python based GUI software in a HPC environment for patient-specific FEM 
structural analysis Innovations and Advances in Computer Sciences and 
Engineering. In: Sobh T, editor: Springer Netherlands, 2010:215-219. 
 
 
[227] Hammer, P., P. del Nido, R. Howe. Anisotropic Mass-Spring Method Accurately 
Simulates Mitral Valve Closure from Image-Based Models Functional Imaging 




[228] Wong, V.M., J.F. Wenk, Z. Zhang et al. The Effect of Mitral Annuloplasty Shape 
in Ischemic Mitral Regurgitation: A Finite Element Simulation. The Annals of 




[229] Mansi, T., I. Voigt, E. Mengue et al. Towards Patient-Specific Finite-Element 
Simulation of MitralClip Procedure Medical Image Computing and Computer-
Assisted Intervention. In: Fichtinger G, Martel A, Peters T, editors.: Springer 
Berlin / Heidelberg, 2011:452-459. 
 
 
[230] Tenenholtz, N.A., P.E. Hammer, R.J. Schneider et al. On the Design of an 
Interactive, Patient-Specific Surgical Simulator for Mitral Valve Repair. 
IEEE/RSJ International Conference on Intelligent Robots and Systems. San 
Francisco, California, USA, 2011. 
 
 
[231] Stewart, S., E. Paterson, G. Burgreen et al. Assessment of CFD Performance in 
Simulations of an Idealized Medical Device: Results of FDA’s First 




[232] Einstein, D.R., F. Del Pin, X. Jiao et al. Fluid–structure interactions of the mitral 
valve and left heart: Comprehensive strategies, past, present and future. 




[233] Bargiggia, G., C. Bertucci, F. Recusani et al. A new method for estimating left 
ventricular dP/dt by continuous wave Doppler-echocardiography. Validation 
studies at cardiac catheterization. Circulation 1989;80:1287-1292. 
 
 
[234] Kunzelman, K.S., R.P. Cochran, C. Chuong et al. Finite Element Analysis of the 
Mitral Valve. The Journal of Heart Valve Disease 1993;2:326-40. 
 
 
[235] Kim, W.Y., P.G. Walker, E.M. Pedersen et al. Left ventricular blood flow patterns 
in normal subjects: A quantitative analysis by three-dimensional magnetic 




[236] Reul, H., N. Talukder, E.W. Mu¨ller. Fluid mechanics of the natural mitral valve. 
Journal of Biomechanics 1981;14:361-372. 
 
 
[237] Domenichini, F., G. Pedrizzetti, B. Baccani. Three-dimensional filling flow into a 




[238] Kilner, P.J., G.-Z. Yang, A.J. Wilkes et al. Asymmetric redirection of flow 
through the heart. Nature 2000;404:759-761. 
 
 
[239] Kheradvar, A., H. Houle, G. Pedrizzetti et al. Echocardiographic Particle Image 
Velocimetry: A Novel Technique for Quantification of Left Ventricular Blood 




[240] Hong, G.-R., G. Pedrizzetti, G. Tonti et al. Characterization and Quantification of 
Vortex Flow in the Human Left Ventricle by Contrast Echocardiography Using 




[241] Lee, C.-H., P.J. Oomen, J.P. Rabbah et al. A high-fidelity and micro-anatomically 
accurate 3d finite element model for simulations of functional mitral valve. 




[242] McQueen, D.M., C.S. Peskin, E.L. Yellin. Fluid dynamics of the mitral valve: 
physiological aspects of a mathematical model. American Journal of Physiology - 
Heart and Circulatory Physiology 1982;242:H1095-H1110. 
 
 
[243] BELLHOUSE, B.J. Fluid mechanics of a model mitral valve and left ventricle. 
Cardiovascular Research 1972;6:199-210. 
 
 
[244] Meisner, J.S., D.M. McQueen, Y. Ishida et al. Effects of timing of atrial systole 
on LV filling and mitral valve closure: computer and dog studies. American 
Journal of Physiology - Heart and Circulatory Physiology 1985;249:H604-H619. 
 
 
[245] Little, R.C. The mechanism of closure of the mitral valve: a continuing 
controversy. Circulation 1979;59:615-8. 
 
 
[246] Lee, K., W.J. Stewart, H. Lever et al. Mechanism of outflow tract obstruction 





[247] Levine, R.A., G.J. Vlahakes, X. Lefebvre et al. Papillary Muscle Displacement 
Causes Systolic Anterior Motion of the Mitral Valve: Experimental Validation 




[248] Pekkan, K., B. Whited, K. Kanter et al. Patient-specific surgical planning and 
hemodynamic computational fluid dynamics optimization through free-form 




[249] Flachskampf, F.A., S. Chandra, A. Gaddipatti et al. Analysis of Shape and Motion 
of the Mitral Annulus in Subjects With and Without Cardiomyopathy by 
Echocardiographic 3-Dimensional Reconstruction. Journal of the American 
Society of Echocardiography 2000;13:277-287. 
 
 
[250] Kaplan, S.R., G. Bashein, F.H. Sheehan et al. Three-dimensional 
echocardiographic assessment of annular shape changes in the normal and 
regurgitant mitral valve. American Heart Journal 2000;139:378-387. 
 
 
[251] Rausch, M., W. Bothe, J.-P. Kvitting et al. Characterization of Mitral Valve 




[252] Joudinaud, T.M., C.L. Kegel, E.M. Flecher et al. The papillary muscles as shock 
absorbers of the mitral valve complex. An experimental study. European Journal 
of Cardio-Thoracic Surgery 2007;32:96-101. 
 
 
[253] Lebrun, F., P. Lancellotti, L.A. Piérard. Quantitation of functional mitral 
regurgitation during bicycle exercise in patients with heart failure. Journal of the 
American College of Cardiology 2001;38:1685-1692. 
 
 
[254] Rausch, M., W. Bothe, J.-P. Kvitting et al. Mitral Valve Annuloplasty. Annals of 
Biomedical Engineering 2012;40:750-761. 
 
 
[255] Pedersen, B., T. Bechsgaard. In Vitro Moedel of Left Side of the Heart: 




[256] Ritchie, J., J. Jimenez, Z. He et al. The material properties of the native porcine 
mitral valve chordae tendineae: An in vitro investigation. Journal of 
Biomechanics 2006;39:1129-1135. 
 
 
 
 
